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Abstract 
 
Neuronal  apoptosis  plays  a  critical  role  in  development  and  disease.    Developing 
sympathetic neurons require nerve growth factor (NGF) for their survival and die by 
apoptosis in its absence.  Studies with sympathetic neurons have provided important 
insights  into  the  molecular  mechanisms  of  neuronal  apoptosis  and  the  signalling 
pathways  that  regulate  the  cell  death  programme  in  neurons.    Bim  is  a  BH3-only 
member of the Bcl-2 family that increases in level after NGF withdrawal and which is 
required for NGF withdrawal-induced death.  Regulation of bim expression is complex 
and remains incompletely understood.   
By  analysing  the  DNA  sequence  of  the  rat  bim  promoter  I  identified  a 
conserved inverted CCAAT box (ICB) that is bound by the heterotrimeric transcription 
factor NF-Y in vitro and in chromatin.  Interestingly, mutational analysis revealed that 
the ICB is critical for the induction of a bim-LUC reporter construct following NGF 
withdrawal.  Use of a well-characterised dominant negative NF-YA mutant (YA13 m29) 
showed that NF-Y is required for bim promoter activity and its induction following NGF 
withdrawal.    Overexpression  of  YA13  m29  also  demonstrated  that  NF-Y  activity  is 
essential for the expression of the endogenous Bim protein and that NF-Y is important 
for apoptosis following NGF withdrawal.  Furthermore, I found that the transcriptional 
coactivators  CBP/p300  are  required  for  the  activation  of  bim-LUC  following  NGF 
withdrawal and that CBP/p300 may interact with NF-Y to enhance bim transcription. 
In  addition  to  this,  the  prosurvival  MEK/ERK  pathway  has  been  found  to 
inhibit  bim  expression  independently  of  the  PI3-K/Akt  pathway.    3'  RACE  and 
experiments  in  sympathetic  neurons  with  a  new  bim-LUC+3'UTR  reporter  construct 
revealed that this negative regulation is mediated through the bim 3' UTR.  Mutational 
analysis and RNA stability experiments have been employed to further investigate this 
mechanism. 
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Chapter 1: Introduction 
 
1.1 Introduction to apoptosis 
Apoptosis is a specific form of programmed cell death, in which a series of evolutionarily-
conserved biochemical events leads to a characteristic morphology and death.  Apoptotic 
cell death can be distinguished from necrosis, a form of traumatic cell death that results 
from a wide variety of acute cellular injuries.  Cells undergoing apoptosis display several 
morphological  characteristics  that  include  the  loss  of  membrane  asymmetry  and 
attachment,  cytoplasmic  shrinkage,  blebbing  of  the  plasma  membrane,  chromatin 
condensation and nuclear fragmentation (Kerr et al., 1972).  The chromosomal DNA in 
apoptotic  cells  is  cleaved  by  an  endonuclease  between  nucleosomes.    The  resulting 
fragments run as a ladder of bands on an agarose gel, whereas the DNA from necrotic cells 
usually runs as a smear (Wyllie et al., 1980).  Following cell death, apoptotic cells are 
removed  in  an  orderly  manner  by  neighbouring  phagocytes  and  this  process,  unlike 
necrosis, does not initiate an inflammatory response.  Apoptosis is an important process in 
mammalian development, and in normal tissue homeostasis, as well as in disease, where 
the dysregulation of apoptotic pathways causes a number of human pathologies.     
Apoptosis  is  perhaps  the  best-studied  form  of  programmed  cell  death.    Other 
modes of programmed cell death include autophagy, which involves the degradation of 
intracellular components through the lysosome (Schwartz et al., 1993).  There are also 
examples  of  non-apoptotic  programmed  cell  death  that  occur  in  a  caspase-independent 
fashion (Kroemer and Martin, 2005).  For example, caspase-independent cell death can be 
mediated by AIF (apoptosis-inducing factor) (Susin et al., 1999).  
The  molecular  mechanisms  of  apoptosis  have  been  the  subject  of  much 
investigation over recent years.  It is now apparent that the cell death programme involves 
many different genes that, together, tightly control the initiation and execution of apoptosis 
across a number of species.  However, many of the detailed mechanisms that regulate this 
important form of cell death still remain to be elucidated. 
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1.2 Apoptotic pathways 
Apoptosis can be initiated by a diverse range of intracellular and extracellular signals, such 
as DNA damage, hormones, or the withdrawal of cytokines or growth factors.  The first 
phase of apoptosis depends on the nature of the death signal to be integrated.  Therefore, 
depending on the type of apoptotic stimulus, the initiation phase of apoptosis can proceed 
via one of two major pathways, the extrinsic pathway and the intrinsic pathway (Figure 
1.1). 
 
1.2.1 The extrinsic pathway   
The  extrinsic  pathway  is  activated  when  proapoptotic  ligands  bind  to  specialised  cell 
surface receptors termed ‘death receptors’.  Death receptors belong to the tumour necrosis 
factor  (TNF)  receptor  superfamily  (Locksley  et  al.,  2001).    The  best  characterised 
examples  are  Fas  (CD95/Apo1),  TNF  receptor  1  (p55/CD120a),  TRAMP  (WSL-
1/Apo3/DR3/LARD), TRAIL-R1 (DR4) and TRAIL-R2 (DR5/Apo2/KILLER) (Tartaglia 
et al., 1993; Dhein et al., 1995; Kitson et al., 1996; Bodmer et al., 1997; MacFarlane et al., 
1997; Pan et al., 1997).  Fas ligand (CD95 ligand) binds Fas, TNFα and TNFβ bind to 
TNFR1, TWEAK (Apo3 ligand) binds to TRAMP and TRAIL (Apo2 ligand) is the ligand 
for both TRAIL-R1 and TRAIL-R2 (Pan et al., 1997; Ashkenazi and Dixit 1998; Marsters 
et al., 1998).  Upon ligand binding, death receptors recruit adaptor proteins such as Fas-
associated death domain (FADD) or TNFR-associated death domain (TRADD), and these 
interactions are mediated by a single death domain (DD) located on the intracellular side of 
the  death  receptor  (Ashkenazi  and  Dixit,  1998).    FADD  also  recruits  caspase-8  and 
caspase-10 to form the death-inducing signalling complex (DISC).  Once assembled, the 
DISC induces the activation of caspase-8, which directly activates other members of the 
caspase family (in type I cells) or which cleaves Bid and thereby triggers the release of 
proapoptotic  factors  from  the  mitochondria  and  the  subsequent  activation  of  more 
downstream effector caspases (type II cells) (Wajant, 2002). 
   16 
Figure 1.1  The intrinsic and extrinsic pathways of apoptosis.  
 
The intrinsic pathway is initiated when Bcl-2 family proteins integrate apoptotic stimuli 
and regulate the release of apoptogenic factors from the mitochondria.  Mitochondrial 
outer membrane permeabilisation (MOMP) leads to the release of cytochrome c and the 
activation of APAF1, which together with dATP and caspase-9, form the apoptosome.  
Here, caspase-9 is activated and this activates the downstream effector caspases, caspase-
3 and caspase-7.  The extrinsic pathway is initiated following the binding of a death 
ligand to a death receptor, for example Fas ligand to Fas.  Fas then recruits FADD, which 
together with caspase-8 and caspase-10, forms the DISC.  Activated caspase-8 cleaves 
Bid to initiate the intrinsic pathway and also activates the downstream effector caspases, 
caspase-3 and caspase-7.  The intrinsic and extrinsic pathways merge at this point and 
activated  caspase-3  and  activated  caspase-7  cleave  a  series  of  protein  substrates  to 
execute cell death.  In the absence of apoptotic stimuli the caspase cascade is inhibited by 
the negative regulators XIAP and FLIP.  Adapted from Riedl and Salvesen (2007) and 
Youle and Strasser (2008). 
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  1.2.2 The intrinsic pathway   
The intrinsic pathway of apoptosis, also known as the mitochondrial pathway, hinges on 
the balance of activity between proapoptotic and antiapoptotic members of the Bcl-2 
family.  When cells are exposed to apoptotic stimuli, Bcl-2 family proteins regulate the 
permeabilisation of the mitochondrial outer membrane (MOMP) via a mechanism that is 
not  well  understood  (Chipuk  and  Green,  2008).    MOMP  facilitates  the  release  of 
apoptogenic  factors  from  the  mitochondrial  intermembrane  space  into  the  cytoplasm 
(Chipuk  et  al.,  2006).    These  include  SMAC/DIABLO  (second  mitochondria-derived 
activator  of  caspase/direct  IAP-binding  protein  with  low  pI)  and  cytochrome  c.  
Cytochrome c and the cytosolic adaptor protein APAF-1 (apoptotic protease activating 
factor 1), along with dATP, form a large protein structure, the apoptosome (Acehan et al., 
2002).  Once formed, the apoptosome recruits and induces the activation of caspase-9, 
which then activates downstream effector caspases (Riedl and Salvesen, 2007).   
  There is, however, some cross-talk between the extrinsic and intrinsic pathways.  
For example in type II cells, the BH3-only protein Bid is cleaved by caspase 8 (activated 
by the extrinsic pathway) and truncated Bid subsequently translocates to the mitochondria 
to activate the intrinsic pathway (Luo et al., 1998).  The intrinsic and extrinsic pathways 
then merge downstream during the proteolytic caspase cascade that leads to the execution 
of apoptosis. 
 
1.2.3 Caspases: structure, activation and substrates 
Apoptotic caspases are cysteine proteases that can either be initiator (apical) caspases or 
effector (executioner caspases).  At least 14 distinct mammalian caspases have now been 
identified (Shi, 2004).  The initiator caspases include caspase-2, caspase-8, caspase-9 and 
caspase-10,  and  the  effector  caspases  include  caspase-3,  caspase-6  and  caspase-7.  
Caspases  are  synthesised  as  single-chain  catalytically-inactive  zymogens  that  must 
undergo proteolytic cleavage for apoptosis to proceed (Shi, 2004).  Initiator caspases 
contain N-terminal prodomains of around 90 amino acids that are important for their 
function,  compared  to  only  20-30  important  residues  in  the  prosequence  of  effector 
caspases  (Yan  and  Shi,  2005).    Effector c aspase  zymogens  are  activated  by  their 
intrachain cleavage, mediated by a specific initiator caspase.  For example, procaspase-3   19 
is activated through internal cleavage by caspase-9, which separates the large and small 
subunits (Yan and Shi, 2005).  Intrachain cleavage increases the catalytic activity of the 
effector caspase by several orders of magnitude (Shi, 2004).  Initiator caspases undergo 
autocatalytic  intrachain  cleavage,  but  this  only  enhances  their  catalytic  activity  by  a 
modest degree, compared to the activation of effector caspases (Stennicke and Salvesen, 
1999; Srinivasula et al., 2001).  For instance, caspase-9 is only marginally more active 
compared  to  procaspase-9,  but  upon  association  with  the  apoptosome,  its  catalytic 
activity  increases  up  to  2000-fold  (Rodriguez  and  Lazebnik,  1999;  Srinivasula et  al., 
2001).  The effector caspases in turn execute cell death by organising the degradation of 
cellular  organelles  (Yuan  and  Horvitz,  2004).    The  effector  caspases  are  selective 
proteases,  but  they  cleave  a  large  number  of  polypeptides  during  apoptosis.    A  few 
examples include: ICAD, the inhibitor of the caspase-activated DNase (CAD), which 
cleaves chromosomal DNA between nucleosomes, the cytoplasmic proteins Gelsolin and 
Gas-2, the nuclear proteins Lamin A and Lamin B1 and a range of protein kinases such as 
PKN, MEKK-1 and Mst1 kinase (Kaufmann, 1989; Lazebnik et al., 1993; Brancolini et 
al., 1995; Erhardt et al., 1997; Kothakota et al., 1997; Kamada et al., 1998; Takahashi et 
al., 1998).  This process leads to the characteristic morphology that apoptotic cells share 
and subsequently dead cells are removed by neighbouring phagocytes in a process termed 
efferocytosis (deCathelineau and Henson, 2003). 
 
1.2.4 Inhibitors of caspases 
Activation of caspases by death receptor-associated scaffolds can be regulated by FLIP 
(FLICE-inhibitory  protein),  which  can  bind  the  prodomains  of  procaspase-8  and  -10, 
thereby  inhibiting  their  recruitment  to  CD95/Fas  and  TFNR1-induced  activation 
complexes (Han et al., 1997; Inohara et al., 1997; Irmler et al., 1997; Srinivasula et al., 
1997).  Caspase activity can also be regulated by interactions with IAPs (inhibitor of 
apoptosis proteins).  Eight distinct mammalian IAPs have now been described: XIAP (X-
linked inhibitor of apoptosis protein), c-IAP1 (cellular-inhibitor of apoptosis protein 1), c-
IAP2  (cellular-inhibitor  of  apoptosis  protein  2),  ML-IAP  (melanoma-inhibitor  of 
apoptosis protein)/Livin, ILP-2 (inhibitor of apoptosis like protein-2), NAIP (neuronal 
apoptosis inhibitor protein), Bruce/Apollon and survivin.  XIAP, c-IAP1 and c-IAP2 bind   20 
to, and inhibit, active caspase-3 and -7 at sub-nanomolar (XIAP) to submicromolar (c-
IAP-1 and c-IAP-2) concentrations (Deveraux et al., 1997; Roy et al., 1997; Duckett et 
al., 1998).  They also bind to procaspase-9 and prevent its activation (Deveraux et al., 
1998).  Upon induction of apoptosis, Smac/Diablo is released into the cytosol, where it 
interacts  with  multiple  IAPs  and  counters  their  inhibitory  effect  (Chai  et  al.,  2000; 
Wilkinson et al., 2004).  IAPs contain at least one BIR (baculoviral IAP repeat) domain, 
which are important for their inhibitory function (Hinds et al., 1999; Sun et al., 1999; Sun 
et al., 2000). 
 
1.3 The Bcl-2 family 
The  intrinsic  pathway  of  apoptosis  depends  on  the  Bcl-2  (B-cell  CLL/Lymphoma  2) 
family  of  proteins,  which  regulate  the  release  of  proapoptotic  factors  from  the 
mitochondrial intermembrane space (Figure 1.1).   
 
1.3.1 Bcl-2 family subgroups 
The Bcl-2 family can be divided into three main groups, based on how many of the four 
BH (Bcl-2 homology) domains they share (Figure 1.2A). 
  Antiapoptotic Bcl-2 proteins, for example Bcl-2, Bcl-xL (Bcl-2 related gene, 
long isoform) and Mcl-1 (myeloid cell leukaemia 1) contain BH domains 1-4 and are 
often,  but  not  always,  associated  with  the  outer  mitochondrial  membrane.    This 
interaction is facilitated by the transmembrane domain (TM), that many of the other Bcl-
2 relatives also share (Figure 1.2A).  The function of the antiapoptotic Bcl-2 proteins is to 
engage and inhibit the proapoptotic Bcl-2 proteins (Chipuk and Green, 2008). 
  The multi-domain proapoptotic Bcl-2 proteins include Bax (Bcl-2 associated x 
protein) and Bak (Bcl-2 antagonist killer 1).  Bax and Bak contain BH domains 1-3 and 
are  directly  responsible  for  mitochondrial  outer  membrane  permeabilisation  (MOMP) 
(Leber et al., 2007).  Bax and Bak are essential for MOMP, because their combined 
deletion renders cells resistant to multiple apoptotic insults and inhibits the release of 
cytochrome c from the mitochondria (Lindsten et al., 2000; Wei et al., 2001).  However, 
the  exact  mechanism  by  which  Bax  and  Bak  induce  MOMP  is  still  unclear.    It  was 
originally thought that Bax and Bak function in a redundant, parallel fashion (Wei et al.,  
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Figure 1.2  The Bcl-2 family.   
 
(A) The Bcl-2 family comprises three sub-groups that contain between one and four Bcl-
2 homology (BH) domains.  Antiapoptotic Bcl-2 family members have four BH domains.  
The  proapoptotic  sub-family  contains  BH  domains  1-3.    The  BH3-only  sub-group 
comprises proapoptotic proteins that share only the BH3 domain in common with the 
other sub-groups.  Most members of the Bcl-2 family contain a transmembrane domain 
(TM) and are therefore typically associated with membranes.  Adapted from Taylor et al. 
(2008). 
  
(B) The antiapoptotic protein neutralisation model.  The BH3-only proteins Bid, Bim and 
Puma can bind and neutralise all antiapoptotic Bcl-2 members.  A combination of other 
BH3-only  proteins  is  required  to  promote  apoptosis  since  each  can  neutralise  only  a 
subset of antiapoptotic proteins, for example Bad can bind to Bcl-2, Bcl-xL and Bcl-W, 
whereas Noxa can bind to Mcl-1 and A1.  Adapted from Chipuk and Green (2008). 
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2001),  whereas  now  it  has  become  evident  that  the  two  proteins  require  different 
mechanisms of activation (Leber et al., 2007), although Bax is the better studied of the 
two.  In the absence of apoptotic stimuli, Bax is a monomeric protein that is primarily 
cytosolic or loosely bound to membranes (Antonsson et al., 2001).  Upon activation, 
through protein-protein interactions with other Bcl-2 family members, Bax translocates to 
the mitochondria and forms higher order oligomers (Wolter et al., 1997; Gross et al., 
1998; Antonsson et al., 2000).  Suzuki et al. (2000) first analysed the 3D structure of Bax 
and demonstrated that cytosolic Bax has its C-terminus (TM domain) inserted into its 
hydrophobic  groove  (the  canonical  BH3  binding  site),  which  would  prevent  its 
dimerisation with BH3-only proteins.  The authors showed, however, that to be able to 
insert  into  the  mitochondrial  outer  membrane,  Bax  must  undergo  a  conformational 
change that displaces the C-terminal TM domain from the hydrophobic pocket (Suzuki et 
al., 2000).  It is thought that outer membrane permeabilisation occurs after Bax and/or 
Bak  form  multiple  oligomers  that  insert  into  the  lipid  bilayer,  thus  forming  aqueous 
channels (Leber et al., 2007).  Additionally, there is some evidence that other proteins 
may be involved, for example it has been proposed that Bak is held in check by VDAC2 
(Cheng et al., 2003). 
  The third sub-group of the Bcl-2 family comprises the BH3-only proapoptotic 
proteins (Figure 1.2A).  The BH3-only proteins are so-called because they share only the 
BH3  domain  in  common  with  their  Bcl-2  relatives.    Examples  include  Bid  (BH3 
interacting domain death agonist), Hrk/Dp5 (Harakiri/Death protein 5) and Bim (Bcl-2 
interacting mediator of cell death).   BH3-only proteins function as integrators of stress 
signalling  pathways  within  the  cell  and  they  directly  activate  the  intrinsic  pathway 
through  protein-protein  interactions  with  their  Bcl-2  family  relatives  (Bouillet  and 
Strasser, 2002).  
 
1.3.2 The direct activation and the indirect activation models 
The exact nature of the protein-protein interactions that result in the activation of Bax and 
Bak, and thus initiate MOMP, remain unclear.  In fact, this subject is highly controversial 
and central to much debate over recent years.  Current evidence suggests that BH3-only 
proteins activate Bax and Bak, either by indirectly antagonising antiapoptotic proteins   24 
(the  indirect  activation  model)  or  through  direct  binding  to  Bax  and  Bak  (the  direct 
activation/hierarchy model) (Galonek and Hardwick, 2006). 
  The indirect activation model is based on the idea that in healthy cells Bax and 
Bak are sequestered by antiapoptotic Bcl-2 family members, such as Bcl-2 and Mcl-1, 
and following apoptotic stimuli, BH3-only proteins engage the antiapoptotic proteins, 
thereby releasing Bax and Bak (which are then free to induce MOMP).  Several BH3-
only proteins can only bind certain prosurvival Bcl-2 proteins, for example Noxa and 
Hrk/Dp5, whereas Puma, Bid and Bim can engage all of the prosurvival proteins (Figure 
1.2B) (Chen et al., 2005; Willis and Adams, 2005; Willis et al., 2007).  It appears that 
different  combinations  of  BH3-only  proteins  are  required  depending  on  which 
prosurvival relatives are expressed in a certain cell type.  For example, in sympathetic 
neurons, the antiapoptotic proteins Bcl-2 and Bcl-xL inhibit the release of cytochrome c 
and protect against NGF withdrawal-induced death (Frankowski et al., 1995; Greenlund 
et al., 1995; Whitfield et al., 2001).  Following NGF withdrawal, only three BH3-only 
proteins are upregulated: Hrk/Dp5, Puma and Bim, and cytochrome c release and cell 
death is dependent on Bax (Deckwerth et al., 1996; Imaizumi et al., 1997; Harris and 
Johnson, 2001; Putcha et al., 2001; Whitfield et al., 2001; Besirli et al., 2005).  One 
problem with the indirect activation model is that not all of the proapoptotic effector 
proteins (Bax and Bak) appear to be sequestered by antiapoptotic proteins (Sedlak et al., 
1995;  Hsu  and  Youle,  1997;  Cheng  et  al.,  2003).    Also,  much  data  concerning 
interactions  between  the  BH3-only  proteins  and  the  prosurvival  proteins  has  been 
generated  by  the  use  of  synthetic  BH3  domain  peptides  that  often  lack  secondary 
structure (Chen et al., 2005; Kuwana et al., 2005).  It remains unclear whether these 
fragments recapitulate the activity of the full-length proteins. 
  The  direct  activation  model  is  built  around  the  idea  that  certain  BH3-only 
proteins can directly bind to and activate Bax and Bak.  Initially, it was shown that Bid 
could  induce  the  oligomerisation  of  Bak  (Wei  et  al.,  2000).    Following  this,  it  was 
reported, again using BH3 peptides, that Bid, Puma and Bim can directly induce the 
activation of Bax and Bak and cytochrome c release (Letai et al., 2002; Kuwana et al., 
2005).  This sub-set of BH3-only proteins was thus termed ‘activator’ proteins and the 
remaining  BH3-only  proteins  (for  example  Noxa  and  Hrk/Dp5)  were  classified  as   25 
‘sensitisers’.  Based on these findings, the direct activation model was adapted into a 
hierarchical  structure  whereby,  following  apoptotic  stimuli  ‘sensitisers’  bind  to 
proapoptotic Bcl-2 proteins which then release the ‘activators’, which in turn bind to and 
induce  the  activation  of  Bax  and  Bak  (Galonek  and  Hardwick,  2006).    However, 
experimental evidence for this model is also mixed.  It has not been demonstrated that the 
‘activators’ can bind to Bax and Bak with strong affinity and therefore it is generally 
accepted that a direct interaction is not essential for apoptosis to proceed (Chipuk and 
Green, 2008).  In addition, the bim/bid double knockout mouse does not recapitulate the 
major apoptotic phenotype of the bak/bax double knockout mouse (Willis et al., 2007).  
Furthermore, Willis et al. (2007) used fibroblast knockout cell lines lacking Bim and Bid 
(and an absence of appreciable levels of Puma) to demonstrate that apoptosis via the 
intrinsic pathway can still be achieved in the absence of so-called ‘activators’. 
  Several studies have established a mechanism for Bcl-2 family protein-protein 
interactions, in which the  -helical BH3 domain of the proapoptotic proteins inserts into 
a  hydrophobic  groove  formed  by  the  juxtaposition  of  the  BH1-3  domains  of  the 
antiapoptotic  Bcl-2  proteins  (Sattler  et  al.,  1997).    In  further  support  of  the  direct-
activation  model,  Gavathiotis  et  al.  (2008)  used  a  ‘hydrocarbon  stapling’  method  to 
overcome  the  loss  of  alpha-helical  structure  when  BH3  peptides  are  synthetically 
produced without their parent protein.  The authors showed that a Bim SAHB (stabilised 
 -helix of Bcl-2 domains) could directly engage Bax, but it did not bind to the canonical 
BH3 binding site, instead Bim SAHB bound to a homologous hydrophobic cleft on the 
other side of Bax (Gavathiotis et al., 2008).  They demonstrated that Bim SAHB binding 
to Bax induced its oligomerisation and the release of cytochrome c in vitro, and this was 
inhibited by mutagenesis of key residues at this new interface (Gavathiotis et al., 2008).   
    As a further level of complexity to the debate, Merino et al. (2009) generated 
mice that had the Bim BH3 domain replaced by that of Bad, Noxa, or Puma.  They 
demonstrated that the mutant proteins could engage the usual prosurvival relatives but 
could no longer bind to Bax.  The authors concluded that the proapoptotic activity of Bim 
is not simply caused by its ability to engage prosurvival relatives or only by its ability to 
bind  Bax  (Merino  et  al.,  2009).    Taken  together,  mounting  evidence  supports  an 
integrated model, whereby apoptosis can proceed via the indirect model, but for maximal   26 
execution  of  apoptosis  to  proceed  then  Bim  (and  possibly  other  BH3-only  proteins) 
transiently engages and directly activates Bax (Merino et al., 2009). 
 
1.3.3 Regulation of BH3-only proteins 
BH3-only proteins function as the integrators of prosurvival and proapoptotic stimuli 
within  the  cell  and  are  thus  tightly  regulated  by  a  number  of  upstream  signalling 
pathways.    For  example,  hrk/dp5  is  a  direct  target  of  the c -Jun  N-terminal  kinase 
(JNK)/c-Jun  pathway  in  sympathetic  neurons  and  cerebellar  granule  neurons,  and  is 
transcriptionally upregulated after survival factor withdrawal (Ma et al., 2007; Towers et 
al., 2009).  Growth factors induce the phosphorylation of Bad at Ser112, Ser136 and 
Ser155, which allows the chaperone protein 14-3-3 to bind and sequester phosphorylated 
Bad  in  the  cytoplasm  (Datta  et  al.,  2000).    After  growth  factor  withdrawal  Bad  is 
dephosphorylated and can therefore interact with other Bcl-2 family members (Datta et 
al.,  2000).    A  number  of  protein  kinases  have  been  proposed  to  mediate  Bad 
phosphorylation including Akt, Rsk, PAK, p70S6K and PKA (Datta et al., 2000).  Bad 
can also be phosphorylated at Ser128 by JNKs (Donovan et al., 2002; Konishi et al., 
2002).  Phosphorylation at Ser128 inhibits the interaction of Bad with 14-3-3, thereby 
increasing its proapoptotic activity (Donovan et al., 2002).  The noxa and puma genes are 
both direct targets of p53 (Jeffers et al., 2003; Shibue et al., 2003; Villunger et al., 2003).  
When thymocytes were cultured from WT, p53
-/- and puma
-/- mice that had been exposed 
to   radiation, p53
-/- cells were completely protected, however puma
-/- cells were also 
significantly protected compared to the WT cells (Villunger et al., 2003).  Recently it has 
been shown that puma is also a direct target of the JNK/c-Jun pathway in Huh-7 cells (a 
human hepatacytoma cell line) (Cazanave et al., 2009).  Less is known about the BH3-
only protein Bmf.  In healthy cells Bmf interacts with DLC2 (dynein light chain 2) and is 
then sequestered to myosin V motors (Puthalakath et al., 2001).  Following apoptotic 
stimuli,  Bmf  is  released  and  it  is  then  free  to  translocate  and  bind  to  Bcl-2  family 
members  (Puthalakath  et  al.,  2001).    Like  Bad  and  Bim,  Bmf  is  an  intrinsically 
unstructured protein and upon binding to Bcl-2 family relatives only the BH3 domain 
becomes structured (Hinds et al., 2007).  It is thought that most BH3-only proteins are 
unstructured  (Hinds  et  al.,  2007).    BH3-only  proteins  can  also  be  regulated  further   27 
downstream in the apoptotic pathway: following death receptor activation Bid is cleaved 
by caspase-8 to generate tBid (truncated Bid), which activates Bid by exposing its BH3 
domain  (Li  et  al.,  1998).    While  full-length  Bid  is  localised  to  the  cytosol,  tBid 
translocates to the mitochondria and has been shown to directly interact with Bax (Wei et 
al., 2000; Kuwana et al., 2002; Kuwana et al., 2005).  Furthermore, in type II cells such 
as hepatocytes, loss of bid renders cells resistant to Fas-induced apoptosis (Yin et al., 
1999; Jost et al., 2009).  Finally, Bim is a target of a number of regulatory mechanisms, 
which will be discussed in detail later in this chapter.   
  It is also of interest that many of the BH3-only single knockout mice, such as 
bad
-/-, do not have a major apoptotic phenotype.  This may be because there is a level of 
redundancy displayed between certain BH3-only proteins in different cell types (Chipuk 
and Green, 2008). 
 
1.4 Apoptosis in flies and worms 
Apoptosis was first recognised as a normal physiological process in the nematode worm 
Caenorhabditis elegans (C. elegans) (Ellis and Horvitz, 1986).  Genetic studies have 
since  demonstrated  that  the  apoptotic  pathway  shares  considerable  similarity  among 
mammals, flies and worms (Figure 1.3).  In C. elegans, four genes, egl-1, ced-9, ced-4 
and  ced-3,  function  in  sequence  to  regulate  the  initiation  and  execution  of  apoptosis 
(Putcha and Johnson, 2004).  CED-3 is a member of the caspase family and is essential 
for apoptosis in nematodes, functioning both as an initiator and an effector caspase (Ellis 
et al., 1991).  In cells that die by apoptosis during worm development, the BH3-only 
homologue EGL-1 binds to CED-9, and thereby releases CED-4 (Figure 1.3).  CED-9 is 
functionally and structurally similar to the mammalian prosurvival proteins, Bcl-2 and 
Bcl-xL.  CED-4 induces the activation of CED-3 and is the functional orthologue of the 
mammalian protein, Apaf-1 (Yang et al., 1998).  In Drosphila melanogaster (the fruit 
fly), Dapaf-1 is almost identical, in terms of sequence similarity, to Apaf-1.  Dapaf-1 
activates Dronc, an initiator caspase in flies.  Dronc then cleaves and activates DrICE 
(Figure  1.3).    Drosophila  also  has  Bcl-2-like  proteins:  the  proapoptotic  Bcl-2  family 
homologue  Debcl/Drob-1/dBorg-1/dBok  inhibits  the  antiapoptotic  Bcl-2  homologue   28 
example,  the 
regulation of caspases in Drosophila and mammals is completely dissimilar ( 
 
Figure  1.3  The  apoptotic  pathway  is  conserved  in  C.  elegans,  Drosophila  and 
mammals. 
 
Mammalian BH3-only proteins, such as Bid and Bim, are homologous to EGL-1 in C. 
elegans.  CED-9 is functionally and structurally similar to the mammalian prosurvival 
proteins, Bcl-2 and Bcl-xL.  The Drosophila Bcl-2-like proteins include the proapoptotic 
protein  Debcl/Drob-1/dBorg-1/dBok,  which  inhibits  the  antiapoptotic  protein 
Buffy/dBorg-2.    Proteins  that  initiate  the  activation  of  caspases  include  Apaf-1  and 
cytochrome  c  in  mammals,  Dapaf-1  in  Drosophila  and  CED-4  in  C.  elegans.    The 
apoptotic pathway in Drosophila and mammals includes the initiator caspases, Dronc and 
caspase-9,  respectively,  which  cleave  and  activate  the  effector  caspases,  DrICE,  and 
caspase-3  and  caspase-7,  respectively.    In  C.  elegans  CED-3  functions  both  as  the 
initiator and the effector caspase.  In mammals caspases can be inhibited by IAPs, which 
can be inhibited by Smac/Diablo.  In Drosophila, caspases can be inhibited by DIAP1, 
which can be inhibited by Hid/Grim/Reaper.  However, the mechanism by which the 
caspase  inhibitors,  IAPs  and  DIAP1  are  regulated,  are  not  conserved  across  species. 
Adapted from Yan and Shi (2005).   29 
Buffy/dBorg-2 (Figure 1.3) (Danial and Korsmeyer, 2004).  Additionally, Drosophila has 
IAP proteins, DIAP1, DIAP2 and dBruce.   
  However,  despite  the  striking  similarity  in  conservation  between  apoptotic 
pathways across species, some of the underlying mechanisms are quite different.  For 
example, the regulation of caspases in Drosophila and mammals is completely dissimilar 
(Yan and Shi, 2005).  In mammals, XIAP inhibits the catalytic activity of caspase-9, 
whereas in Drosophila, DIAP1 has no effect on the catalytic activity of Dronc (Yan et al., 
2004).  DIAP1 acts as an E3 ubiquitin ligase to target Dronc for degradation via the 
proteasome  (Wilson  et  al.,  2002;  Chai  et  al.,  2003).    Other  differences  include  the 
mechanism by which CED-9 inactivates CED-4, by directly binding to it, whereas in 
mammals Bcl-xL and Bcl-2 do not directly engage Apaf-1.  Furthermore, there is only 
limited data to support a role for cytochrome c in apoptosis in Drosophila (Arama et al., 
2006). 
 
  1.5 Apoptosis in development and disease 
1.5.1 Apoptosis during mammalian development 
The  death  of  cells  by  apoptosis  is  critical  for  normal  mammalian  development.    For 
instance, mice with a deletion of caspase-3 die prematurely due to a large excess of post-
mitotic,  terminally-differentiated  cells  in  their  central  nervous  system,  that  would 
normally be culled before that developmental stage by apoptosis (Kuida et al., 1996).  
The development of an organ or tissue is often the result of a pruning process in which an 
organ or tissue is sculpted from a mass of cells by apoptosis.  A classic example is in 
vertebrate limb bud development, during which apoptosis removes the cells between the 
developing  digits  (Saunders,  1966).    This  developmental  process  can  be  arrested  by 
treatment with different caspase inhibitors (Milligan et al., 1995).  In the immune system, 
apoptosis eliminates immature B lymphocytes and T lymphocytes that are ineffective and 
also those that elicit an autoimmune response (Werlen et al., 2003).  Apoptosis also 
occurs  extensively  in  the  nervous  system,  where  around  half  of  the  total  number  of 
neurons  formed  by  neurogenesis  die  by  apoptosis  during  development  (Oppenheim, 
1991). 
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  1.5.2 Apoptosis in disease   
Apoptosis is associated with a wide range of human pathologies that can be broadly 
categorised  into  two  groups:  those  in  which  there  is  an  increase  in  cell  survival  (or 
diseases  associated  with  an  inhibition  of  apoptosis),  and  those  in  which  there  is  an 
increase in cell death (hyper-active apoptosis).   
  The  development  of  cancers  is  associated  with  the  inhibition  of  apoptosis.  
Generally, due to the sensitivity of the intrinsic pathway, more tumours arise through 
defective signalling in the intrinsic pathway than the extrinsic pathway (Johnstone et al., 
2002).  A common cause of tumourigenesis is the mutation of genes that regulate cell 
proliferation and cell death or survival, such as ras, c-myc or p53.  Another crucial factor 
in tumourigenesis is the balance between proapoptotic and antiapoptotic Bcl-2 family 
members.  Bcl-2 is upregulated in a range of neoplastic conditions and its overexpression 
has been shown to protect different cell types from a wide range of apoptotic insults 
(Shimizu et al., 1995; Gajewski and Thompson, 1996; Ibrado et al., 1997).  For example, 
the bcl-2 gene was originally identified as a translocated gene in follicular lymphoma 
(Tsujimoto et al., 1984; Bakhshi et al., 1985; Cleary et al., 1986) and the overexpression 
of bcl-2 in Eµ-bcl-2/myc transgenic mice accelerates lymphomagenesis (Strasser et al., 
1990).  Other pathologies associated with an inhibition of apoptosis include a range of 
autoimmune conditions and certain viral infections (Reed 2002). 
  Many  neurodegenerative  diseases  are  characterised  by  the  gradual  loss  of 
specific  sets  of  neurons.    These  include  Alzheimer’s  disease,  amyotrophic  lateral 
sclerosis,  Parkinson’s  disease,  retinitis  pigmentosa  and  different  forms  of  cerebellar 
degeneration (Thompson, 1995).  There is increasing evidence to suggest that apoptosis is 
a mechanism by which neuronal cells die in a number of these conditions and neurons 
often die by apoptosis in cell culture and animal models of human neurodegenerative 
disorders (Yankner, 1996; Estus et al., 1997; Nijhawan et al., 2000; Yuan and Yankner, 
2000; Tatton et al., 2003; LeBlanc, 2005; Cottet and Schorderet, 2009).  Additionally, 
apoptosis is one of the mechanisms by which neurons die following an acute injury to the 
nervous system, such as traumatic brain injury or stroke (Charriaut-Marlangue et al., 
1996; Martin, 1998).    31 
  Due to the numerous studies that support a relevant role for apoptosis in the 
aetiology of many diseases, the development of pharmacologic agents has recently been 
focused  on  targeting  different  stages  of  the  apoptotic  pathway.    Drugs  that  inhibit 
apoptosis  include  the  small  molecule  JNK  inhibitor  D-JNK-1,  demonstrated  to  be  an 
effective  neuroprotectant  in  models  of  stroke  (Borsello  et  al.,  2003).    In  addition,  a 
number of caspase inhibitors have been developed, for example the pan-caspase inhibitor 
IDN-6556, which has been tested for use during liver transplantations, (Baskin-Bey et al., 
2007; Masuoka et al., 2009).  Chemotherapy drugs that activate apoptosis often do so 
from upstream, for example Cisplatin induces apoptosis by damaging DNA and thereby 
activating p53, which in turn activates the transcription of puma and other proapoptotic 
genes (Alderden et al., 2006; Jiang et al., 2006; Yu and Zhang, 2008).  However, more 
recently specific activators of the intrinsic pathway have been developed, for example the 
BH3-mimetic  ABT-737  that  binds  prosurvival  proteins  such  as  Bcl-2  and  induces 
Bax/Bak-dependent killing (Oltersdorf et al., 2005; van Delft et al., 2006).  Additionally, 
a  number  of  studies  demonstrate  that  IAP  proteins  are  elevated  in  almost  all  human 
malignancies (Tamm et al., 2000; Yang et al., 2003; Tamm et al., 2004).  Therefore, a 
number  of  Smac  mimetics  have  now  been  developed,  which  bind  IAP  proteins  and 
abrogate their inhibitory activity (Varfolomeev et al., 2007; Vucic and Fairbrother, 2007). 
 
1.6 Neuronal apoptosis 
1.6.1 Apoptosis in the developing mammalian nervous system 
Many types of developing vertebrate neurons are thought to compete for the limiting 
amounts of neurotrophic factors that their target tissues secrete.  Cells that fail to acquire 
sufficient amounts of neurotrophin subsequently die by apoptosis (Oppenheim, 1991).  
This process is important for establishing neuronal populations of the correct size and for 
eliminating neurons that have made inappropriate connections (Barde, 1989; Yuan and 
Yankner, 2000). 
  Developmental  neuronal  apoptosis  has  been  particularly  well  studied  in  the 
developing peripheral nervous system.  During development, cells of the neural crest give 
rise to post-ganglionic sympathetic neurons.  In this process, neural crest cells migrate 
ventrally from the margins of the dorsal neural tube to form a column of sympathetic   32 
ganglion  primordia  that  then  coalesce  to  form  sympathetic  ganglia  and  eventually 
establish the superior cervical ganglion (SCG) (Glebova and Ginty, 2005).  During late 
embryonic  and  early  postnatal  development,  sympathetic  neurons  depend  on  nerve 
growth factor (NGF) for survival (Figure 1.4).  NGF signalling is critical for sympathetic 
neuron development as ngf
 -/- knockout mice show almost complete loss of sympathetic 
neurons (Crowley et al., 1994).  In addition, sympathetic neurons do not only require 
NGF.   For example, nt-3
-/- knockout mice only retain half of the sympathetic neurons that 
would normally survive (Ernfors et al., 1994; Farinas et al., 1994).  NT-3 is required as 
an intermediate target-derived factor that mediates proximal sympathetic axon extension 
(Glebova and Ginty, 2005).    
 
1.6.2 Models for studying NGF withdrawal-induced apoptosis 
Developing  sympathetic  neurons  isolated  from  early  postnatal  rats  retain  their 
dependence on NGF in vitro and can therefore be kept in culture for extended periods in 
its presence (Martin et al., 1988).  In the absence of NGF, cultured sympathetic neurons 
die  by  apoptosis,  usually  within  24-48  hours,  displaying  all  the  classic  hallmarks 
associated  with  this  form  of  programmed  cell  death  (Deckwerth  and  Johnson,  1993; 
Edwards and Tolkovsky, 1994; Estus et al., 1994) (Figure 1.5B).  Early studies with 
sympathetic neurons demonstrated that apoptosis requires de novo gene expression, as 
cell death in this context can be blocked by inhibitors of RNA and protein synthesis 
(Martin et al., 1988) (Figure 1.5A).  NGF withdrawal activates the intrinsic pathway of 
apoptosis in sympathetic neurons (Neame et al., 1998; Putcha et al., 2002, Wright et al., 
2007) (Figure 1.1).  In addition, a number of genes have now been demonstrated to be 
critical regulators of apoptosis in sympathetic neurons (section 1.6.3).  A major advantage 
of the sympathetic neuron model is that its cell biology is extremely well defined in vitro 
and  in  vivo.    Thus,  sympathetic  neurons  have  become  a  classic  model  for  studying 
neuronal apoptosis. 
  The rat pheochromocytoma cell line (PC12) has also been used extensively to 
study neuronal apoptosis (Greene and Tischler, 1976; Pittman et al., 1993).  PC12 cells, 
and their subline PC6-3 cells, can be routinely cultured and then differentiated into a 
neuronal-phenotype in low-serum conditions together with NGF (Figure 1.5C   33 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4  Order of events during development of the sympathetic nervous system 
in mouse.   
 
Embryonic (E) time points and postnatal (P) time points are approximate.  Sympathetic 
neurons are dependent on NGF for their survival from approximately E17 through to P10.  
NGF is also required for sympathetic axon growth into peripheral target organs, but the 
extent  of  this  requirement  varies  greatly  between  target  organs  (Glebova  and  Ginty, 
2004).  Adapted from Glebova and Ginty (2005). 
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and their subline PC6-3 cells, can be routinely cultured and then differentiated into a 
neuronal-phenotype in low-serum conditions together with NGF (Figure 1.5C).  Like 
sympathetic neurons, the withdrawal of NGF from cultures of neuronally differentiated 
PC12 cells results in cell death by apoptosis in a transcription-dependent manner (Pittman 
et al., 1993) (Figure 1.5).  PC12 cells provide a suitable alternative to primary cells for 
studying  cell  death  induced  by  growth  factor  deprivation.    This  is  important  for 
experiments in which large cell populations are required, as one of the major limitations 
to the sympathetic neuron model is that only around 12,000 cells can be isolated from 
each 1-day-old rat (Whitfield et al., 2004).  
  Additionally, there are several other model systems used for studying apoptosis 
in neuronal cells.  For example, cerebellar granule neurons (CGNs) can be isolated from 
the cerebellum of postnatal rats and mice and maintained in vitro in medium containing 
10%  serum  and  depolarising  concentrations  of  KCl  (25  mM)  (Bilimoria  and  Bonni, 
2008).  Subsequently, apoptosis can be induced by KCl/serum deprivation (Gallo et al., 
1987; D’Mello, 1993).  Spinal motoneurons can also be used for studying apoptosis, 
since they can be isolated from E14 rats and E12.5 mice and maintained in the presence 
of neurotrophic factors such as BDNF and GDNF and therefore apoptosis can be induced 
following growth factor withdrawal (Henderson et al., 1995).  
 
1.6.3 The NGF withdrawal-induced death pathway     
NGF-dependent sympathetic neurons and neuronally differentiated PC12 cells are well 
characterised models of neuronal apoptosis and a considerable amount has been learned 
about  the  role  of  Bcl-2  family  members,  caspases,  IAP  proteins  and  the  signalling 
pathways that regulate the cell death programme using these systems.  
  One  of  the  first  genes  involved  in  this  pathway,  to  be  identified,  was  the 
basic/leucine zipper transcription factor c-Jun, a member of the AP-1 family (Estus et al., 
1994; Ham et al., 1995).  Following NGF withdrawal, c-jun mRNA and protein levels 
increase  rapidly  and  microinjection  of  a  c-Jun  antibody,  the  expression  of  a  c-Jun 
dominant-negative  protein,  or  the  conditional  knockout  of  the  c-jun  gene,  protects 
sympathetic neurons against NGF withdrawal-induced death (Estus et al., 1994; Ham et   35 
Figure 1.5  Models for studying NGF withdrawal-induced apoptosis.  
 
A)  Schematic  of  nerve  growth  factor  withdrawal-induced  death  in  neuronal  models.  
Developing  sympathetic  neurons  are  dependent  on  NGF  for  their  survival,  as  are 
neuronally differentiated PC6-3 cells.  In both systems, withdrawal of NGF results in cell 
death by apoptosis.  This can be prevented by the use of inhibitors of transcription and 
protein synthesis, actinomycin-D and cycloheximide, respectively.  This demonstrates 
that apoptosis requires de novo gene expression. 
 
B) Sympathetic neurons were isolated from 1-day-old rats and maintained in the presence 
of NGF for 5-7 days.  Following NGF withdrawal for 16 hours, the cells begin to display 
apoptotic changes.  By 48 hours after NGF withdrawal, most of the cells are dead.  The 
scale bar represents 50 µm. 
 
C) PC6-3 stock cells can be differentiated into a neuronal phenotype when cultured in the 
presence of NGF for 7 days.  Differentiated PC6-3 cells undergo apoptosis when NGF is 
withdrawn.  The scale bar represents 50 µm. 
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al., 1995; Palmada et al., 2002).  Furthermore, c-Jun is phosphorylated by JNKs, which 
are  activated  following  NGF  withdrawal  and  JNK  activity  is  required  for  NGF 
withdrawal-induced death (Ham et al., 1995; Xia et al., 1995; Virdee et al., 1997; Eilers 
et  al.,  1998;  Harding  et  al.,  2001).    Early  studies  with  c-Jun  and  the  JNK  pathway 
implicated the mitochondria and thus the intrinsic pathway, which is now known to be 
activated by NGF-withdrawal in sympathetic neurons and neuronally differentiated PC12 
cells.    Following  NGF  withdrawal,  cytochrome  c  is  released  from  the  mitochondrial 
intermembrane space into the cytosol, where it is required for NGF withdrawal-induced 
death (Neame et al., 1998; Deshmukh and Johnson, 1998).  Apoptosis in this setting can 
be blocked by the microinjection of neutralising antibodies to cytochrome c (Neame et 
al., 1998).  The expression of a c-Jun dominant-negative protein inhibits the release of 
cytochrome c after NGF withdrawal, and the overexpression of MEKK1, which activates 
the JNK pathway, induces the release of cytochrome c and apoptosis in the presence of 
NGF (Whitfield et al., 2001).  These findings demonstrated that JNK/c-Jun signalling is 
critical  for  the  cell  death  programme  activated  by  NGF  withdrawal  in  sympathetic 
neurons. 
  Two downstream targets of the JNK/c-Jun pathway in sympathetic neurons and 
neuronally differentiated PC12 cells are the BH3-only proteins Bim and Hrk/Dp5 (Harris 
and  Johnson,  2001;  Whitfield  et  al.,  2001;  Towers  et  al.,  2009).    The  expression  of 
Hrk/Dp5 is largely restricted to the nervous system (Imaizumi et al., 1997).  Hrk/dp5 
mRNA and protein levels increase when cells are deprived of NGF, and peak at around 
18 hours following NGF withdrawal (Imaizumi et al., 1997; Towers et al., 2009).  The 
induction of hrk/dp5 mRNA requires mixed-lineage kinase (MLK) and JNK activity, AP-
1 activity and a conserved c-Jun/ATF-2 binding site in the hrk/dp5 promoter (Towers et 
al., 2009).  Furthermore, the overexpression of Hrk/Dp5 in microinjected sympathetic 
neurons  induces  apoptosis  (Imaizumi  et  al.,  1997).    However,  sympathetic  neurons 
isolated from hrk/dp5
-/- mice die only marginally slower than wild type neurons after 
NGF withdrawal (Imaizumi et al., 2004).  It is now apparent that Hrk/Dp5 makes a more 
minor contribution to the apoptotic pathway in these cells compared to Bim (Ham et al., 
2005).  Bim is also a target of survival signalling by the PI3-K/Akt and the MEK/ERK 
pathways in these cells, but this will be discussed later in this chapter.   38 
  Another BH3-only protein that is transcriptionally upregulated in NGF-deprived 
sympathetic neurons is Puma (Besirli et al., 2005).  Puma is a p53 target following DNA-
damage  in  sympathetic  neurons  (Wyttenbach  and  Tolovsky,  2006)  and   Np73,  a 
truncated form of the p53 family member p73, can protect sympathetic neurons against 
NGF withdrawal-induced death (Pozniak et al., 2000).  Conversely, another member of 
the p53 family, TAp63 increases in level after NGF withdrawal and is required for NGF 
withdrawal-induced death in vitro (Jacobs et al., 2005).  However, it remains unclear 
exactly  how  Puma  is  regulated  following  NGF  withdrawal.    It  is  possible  that  the 
transcription of puma is activated by TAp63 and/or by c-Jun, since puma has recently 
been demonstrated to be a c-Jun target gene (Cazanave et al., 2009).   
  The prolyl hydroxylase EglN3/SM-20 also increases in expression during NGF 
withdrawal-induced death and its overexpression leads to apoptosis in the presence of 
NGF in microinjected sympathetic neurons (Wax et al., 1994; Lipscomb et al., 1999).   
Surprisingly, the induction of EglN3/SM-20 in neuronally differentiated PC12 cells, leads 
to an increase in the total amount of cytochrome c as well as its release into the cytosol 
(Straub et al., 2003).  In addition, loss of egln3/sm-20 significantly protects sympathetic 
neurons from cell death following NGF withdrawal (Schlisio et al., 2008). 
    Two  antiapoptotic  Bcl-2  family  proteins  appear  to  be  important  in  this 
pathway, Bcl-2 and Bcl-xL.  The levels of bcl-2 and bcl-xl mRNA decrease following 
NGF withdrawal in sympathetic neurons and the overexpression of either protein can 
inhibit the release of cytochrome c and protect against NGF withdrawal-induced death 
(Frankowski  et  al.,  1995;  Greenlund  et  al.,  1995;  Whitfield  et  al.,  2001).    Also, 
sympathetic neurons isolated from Bcl-2 deficient mice die more rapidly than the wild 
type cells (Greenlund et al., 1995).   
  Apoptosis  induced  by  NGF  deprivation  is  dependent  on  the  proapoptotic 
multidomain protein Bax, which translocates from the cytosol to the mitochondrial outer 
membrane following NGF withdrawal in sympathetic neurons (Deckwerth et al., 1996; 
Putcha et al., 1999).  Bax
-/- mice have over two fold more sympathetic neurons compared 
to  wild  type  mice  and  are  resistant  to  NGF  withdrawal-induced  apoptosis  in  vitro 
(Deckwerth et al., 1996).  Interestingly, knockout of the related Bak protein has no effect 
on  NGF  withdrawal-induced  death  (Putcha  et  al.,  2002).    This  may  be  because   39 
sympathetic neurons, like hippocampal neurons and CGNs, cultured in vitro express N-
Bak and not Bak (Sun et al., 2001; Uo et al., 2005).  N-Bak is a neuron-specific splice 
variant of Bak that lacks the BH1 and BH2 domains and thus cannot function as a multi-
domain proapoptotic Bcl-2 protein (Sun et al., 2001; Uo et al., 2005) 
  Looking further downstream in the NGF withdrawal-induced death pathway, it 
has been demonstrated that caspases are critical effectors of cell death.  Treatment of 
NGF-deprived  sympathetic  neurons  and  neuronally  differentiated  PC12  cells  with 
caspase inhibitors, such as zVAD-fmk and BAF, prevents apoptosis (Deshmukh et al., 
1996; Park et al., 1998).  Moreover, caspase-3 plays a key role in this context, since 
sympathetic neurons isolated from caspase-3 deficient mice are protected from cell death 
(Wright et al., 2007).  In addition to the macromolecular synthesis that occurs following 
NGF withdrawal there is another pathway that does not require new protein synthesis: the 
development of competence to die in response to cytochrome c (Deshmukh and Johnson, 
1998).  For instance, the microinjection of cytochrome c into the cytosol of sympathetic 
neurons does not induce cell death in the presence of NGF (Deshmukh and Johnson, 
1998).  This is because NGF deprivation allows the cells to become competent to die 
(Deshmukh and Johnson, 1998).  It is now known that the activity of the caspase inhibitor 
XIAP  must  decrease  for  apoptosis  to  proceed  following  cytochrome  c  release,  since 
XIAP-deficient neurons die rapidly following the injection of cytochrome c as do cells 
that have been coinjected with Smac/Diablo together with cytochrome c (Deshmukh et 
al.,  2002).    In  fact,  XIAP  protein  levels  decrease  rapidly  in  sympathetic  neurons 
following NGF withdrawal (Potts et al., 2003).       
   
1.7 Trk receptor signalling 
1.7.1 Trk receptors 
The survival, differentiation and growth of developing vertebrate neurons depends on the 
availability of specific neurotrophins that are secreted by the target cells that the neurons 
innervate.  Trk (tropomyosin-related kinase) receptors, a family of three receptor tyrosine 
kinases, are the major class of neurotrophin cell-surface receptor (Kaplan et al., 1991).  
TrkA is the receptor for NGF, TrkB is the receptor for BDNF (brain-derived neurotrophic 
factor) and NT-4 (neurotrophin-4) and TrkC is the receptor for NT-3 (neurotrophin-3)   40 
(Figure 1.6).  However, there is some crossover between receptors.  NT-3 can bind to 
TrkA and TrkB, but with lower affinity than the primary ligands for these receptors and 
also with lower affinity than the binding of NT-3 to TrkC (Huang and Reichardt, 2003).  
Similarly, NT-4 can also bind to TrkC with lower affinity (Huang and Reichardt, 2003).  
  Members  of  the  Trk  family  of  tyrosine  kinase  receptors  are  differentially 
expressed in neurons of the central nervous system and the peripheral nervous system 
(Huang and Reichardt, 2003).  Sympathetic neurons express relatively high levels of the 
TrkA
 receptor and low levels of the TrkC receptor (Belliveau et al., 1997).  NGF is the 
primary neurotrophin for TrkA and a classic example of a target-derived neurotrophic 
factor (Levi-Montalcini, 1987).  The binding of NGF to axon terminals initiates local as 
well as retrograde signalling to cell bodies (Glebova and Ginty, 2005).  In the case of 
retrograde signalling, NGF-TrkA complexes are internalised and then transported from 
axon terminals to the cell body of neurons (Riccio et al., 1997; Watson et al., 1999; 
Kuruvilla et al., 2000; Lonze et al., 2002; Delcroix et al., 2003; Ye et al., 2003; Heerssen 
et al., 2004).  As further evidence that NGF-TrkA signalling is critical to sympathetic 
neuron development, TrkA
-/- knockout mice have virtually no postganglionic sympathetic 
neurons, a phenotype that is shared with ngf
  -/- knockout mice (Crowley et al., 1994; 
Smeyne et al., 1994; Fagan et al., 1996). 
   
1.7.2 Survival and death signalling via TrkA 
Trk  receptors  have  intrinsic  tyrosine  kinase  activity  and  can  thus  autophosphorylate 
(Barbacid, 1995).  Following the binding of NGF to TrkA, several tyrosine residues are 
phosphorylated within its intracellular cytoplasmic tail, which then serve as docking sites 
for the recruitment of a number of different binding proteins (Fruman et al., 1998; Qian et 
al., 1998).  NGF signalling activates several different intracellular signalling pathways, 
often via the small GTP-binding protein Ras.  Ras signalling is responsible for between 
40%  and  60%  of  neurotrophin-dependent  survival  (Kaplan  and  Miller,  2000).    In 
sympathetic neurons, the two major effectors of Ras-activated survival signalling are the 
PI3-K  (PI3-Kinase)/Akt  and  the  MEK  (MAPK  (mitogen  activated  protein  kinase) 
extracellular signal-regulated kinase kinase) / ERK (extracellular signal-regulated kinase)   41 
pathways  (Dudek  et  al.,  1997;  Crowder  and  Freeman,  1998;  Klesse  et  al.,  1999).  
Activated  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6  Neurotrophins and their receptors. 
 
The neurotrophins and their primary receptors are shown in bold arrows whereas weaker 
interactions are shown in dashed arrows.  All four neurotrophins bind to p75NTR.  TrkA 
is  the  receptor  for  NGF,  TrkB  is  the  receptor  for  BDNF  and  NT-4  and  TrkC  is  the 
receptor for NT-3.  NT-3 can also bind to TrkA and TrkB, but with lower affinity than it 
binds to TrkC.  NT-4 can also bind to TrkC but with lower affinity than it binds to TrkB.  
Adapted from Gilbert (2006). 
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pathways  (Dudek  et  al.,  1997;  Crowder  and  Freeman,  1998;  Klesse  et  al.,  1999).  
Activated Akt can directly inhibit neuronal apoptosis by phosphorylating proapoptotic 
proteins or the transcription factors that regulate them (Kaplan and Miller, 2000).  For 
example, in sympathetic neurons activated Akt phosphorylates the transcription factor 
FOXO3a,  which  is  sequested  by  the  chaperone  protein  14-3-3  in  the  cytoplasm,  and 
therefore phosphorylated FOXO3a cannot translocate into the nucleus and activate the 
transcription of bim (Figure 1.8; Gilley et al., 2003). MEK/ERK signalling includes both 
the  MEK1/2/ERK1/2  and  the  MEK5/ERK5  pathways.    In  sympathetic  neurons  both 
signalling  pathways  are  stimulated  in  response  to  NGF  and  both  can  be  activated 
downstream from Ras (Kaplan and Miller, 2000; Wang and Tournier, 2006).  Recent 
studies have found that the deletion of the erk5 gene results in a significant increase in 
apoptosis in neonatal sympathetic neurons (Finegan et al., 2009). 
  Additionally,  in  sympathetic  neurons  NGF  signalling  leads  to  the 
phosphorylation of CREB (cAMP response element binding protein) on Ser133 (Riccio et 
al., 1997; Riccio et al., 1999).  CREB can be activated by multiple kinases (Kaplan and 
Miller,  2000),  and  studies  have  shown  that  CREB  is  a  critical  mediator  of  NGF-
dependent  gene  expression  in  sympathetic  neurons  (Riccio  et  al.,  1999).    Knockout 
experiments highlighted the critical role that CREB plays in neuronal development, since 
the loss of creb resulted in the decreased survival of sympathetic and sensory neurons and 
a  significant  impairment  in  the  process  of  axon  elongation  (Lonze  et  al.,  2002).  
Furthermore, in sympathetic neurons CREB activates the transcription of the prosurvival 
bcl-2 gene (Riccio et al., 1999).  
  The prosurvival MEK/ERK and PI3-K/Akt pathways act to suppress apoptosis 
and therefore the removal of NGF results in the loss of survival signals.  However, NGF 
withdrawal also induces the activation of a major proapoptotic pathway in sympathetic 
neurons, the MLK/JNK/c-Jun pathway (Figure 1.8; Estus et al., 1994; Ham et al., 1995; 
Xia et al., 1995; Eilers et al., 1998; Eilers et al., 2001; Harding et al., 2001; Whitfield et 
al., 2001).  
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1.7.3 p75 neurotrophin receptor 
In addition to Trk receptors, there is another class of neurotrophin cell surface receptor, 
the  p75  neurotrophin  receptor  (p75NTR)  (Kaplan  and  Miller,  1997).    All  four 
neurotrophins bind to p75NTR with similar affinity (Figure 1.6; Rodriguez-Tebar et al., 
1992).  The loss of p75 results in an increased number of sympathetic neurons in neonatal 
mice, but not in adult mice, thereby indicating that p75NTR is important for cell death 
during development (Bamji et al., 1998; Brennan et al., 1999).  A number of studies have 
implicated BDNF, and possibly NT-4, as the ligands that bind p75NTR and facilitate cell 
death during development (Bamji et al., 1998; Brennan et al., 1999; Deppmann et al., 
2008; Majdan et al., 2001).  Moreover, this has led to the proposal of a feed-forward loop 
in which target-derived NGF favours the emergence of a subset of neurons that have 
enhanced NGF signalling (Deppmann et al., 2008).  These high NGF-TrkA signalling 
neurons  can  then  kill  neighbouring  neurons  that  have  low  retrograde  NGF-TrkA 
signalling, via the p75NTR receptor, since NGF promotes TrkA expression and controls 
the expression of BDNF and NT-4 in sympathetic neurons (Deppmann et al., 2008). 
 
1.8 Bim 
1.8.1 Bim structure and function 
Bim is a BH3-only member of the Bcl-2 family.  The exonic structure of bim is conserved 
across  species  and  alternative  splicing  of  exons  3  and  4  results  in  the  generation  of 
several different Bim isoforms (Figure 1.7).  The major Bim variants include BimEL, BimL 
and  BimS  (Figure  1.7B),  which  differ  in  their  potency.    BimEL  is  the  major  isoform 
expressed  in  neuronal  cells  including  cerebellar  granule  neurons  (CGNs),  dorsal  root 
ganglion (DRG) neurons and sympathetic neurons (Putcha et al., 2001; Whitfield et al., 
2001). 
  Bim  is  an  unstructured  polypeptide  (Hinds  et  al.,  2007),  and  its  binding 
specificity, like that of the other BH3-only proteins, appears to be defined only by its 
BH3  domain  (Chen  et  al.,  2005).    The  proapoptotic  function  of  Bim  is  critical  for 
apoptosis via the intrinsic pathway, since Bim is one of just three BH3-only proteins that 
can sequester all five of their prosurvival relatives (Figure 1.2B; Chen et al., 2005).  In    44 
 
Figure 1.7  Structure of the bim gene and the major Bim isoforms. 
  
(A) The exonic structure of the bim gene.  The structure of bim is highly conserved 
between species: mouse, rat and human share an identical arrangement of exons 1-6 with 
longer introns present in human.  Coloured boxes indicate coding regions whereas white 
boxes indicate untranslated regions.  Exon 1 is untranslated and the ATG start codon for 
translation  is  located  14  nucleotides  from  the  beginning  of  exon  2  (O’Connor  et  al., 
1998).  
 
(B) The major Bim isoforms.  Exon 3 contains an ERK1/2 docking domain (FSF) and 
ERK1/2 phosphorylation sites including Ser65.  Exon 4 encodes the region that can bind 
DLC1 and JNK phosphorylation sites including Thr56 in BimL.  The BH3 domain lies 
between amino acids 150-159 in exon 5, and is critical for the induction of apoptosis 
(Boyd  et  al.,  1995).    Exon  6  contains  the  hydrophobic  transmembrane  domain  (TM) 
between amino acids 179-194, which is important for localisation to intracytoplasmic 
membranes (Kroemer, 1997).  The bim mRNA encodes BimEL which is 194 amino acids 
(aa) long.  Exon 3 is spliced out to produce BimL (140 amino acids) and exon 3 and exon 
4  are  spliced  out  to  produce  BimS  (110  amino  acids).    Adapted  from  Bouillet  et  al. 
(2001a) and Ley et al. (2005a). 
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addition, there is mounting evidence that Bim can also directly induce MOMP by binding 
to and activating Bax (Letai et al., 2002; Kuwana et al., 2005; Gavathiotis et al., 2008). 
  Bim is important for apoptosis in many cell types, for example in cerebellar 
granule neurons deprived of KCl, lymphocytes deprived of cytokines such as IL2, or 
fibroblasts deprived of serum (Putcha et al., 2001; Bouillet et al., 2002; Ewings et al., 
2007).  In sympathetic neurons bim RNA and Bim protein levels increase following NGF 
withdrawal and peak at around 16 hours later (Putcha et al., 2001; Whitfield et al., 2001).  
The overexpression of BimEL in sympathetic neurons is sufficient to induce the release of 
cytochrome c and apoptosis in the presence of NGF, whereas the microinjection of bim 
antisense oligonucleotides significantly protects the cells from NGF withdrawal-induced 
death (Whitfield et al., 2001; Gilley et al., 2003).  Moreover, sympathetic and sensory 
neurons  isolated  from  bim
-/-  knockout  mice  are  significantly  protected  from  trophic 
factor-induced death (Whitfield et al., 2001; Coultas et al., 2007).  
  Bim deficient mice have markedly increased haematopoietic cell numbers with 
two to four fold increases in the number of myeloid and lymphoid cells (Bouillet et al., 
1999).  Bim loss also prevents polycystic kidney disease (PKD) and other degenerative 
conditions caused by abnormal apoptosis induced by the knockout of bcl-2 (Bouillet et 
al., 2001b).  Furthermore, Bim has also been demonstrated to play a role in retinal neuron 
death during development and also in cell culture and animal models of Alzheimer’s 
disease and Parkinson’s disease (Biswas et al., 2007a; Doonan et al., 2007; McKerman 
and Cotter, 2007; Perier et al., 2007).  
 
1.8.2 Transcriptional regulation of bim 
A number of different transcriptional mechanisms have been reported to regulate bim 
expression.    In  sympathetic  neurons  or  PC12  cells  dependent  on  NGF  for  survival, 
transcriptional control of bim involves at least three different signalling pathways (Figure 
1.8).  A number of studies have supported a critical role for MLK-JNK-c-Jun signalling 
in bim regulation.  For instance, the overexpression of a dominant negative c-Jun protein 
or treatment with the MLK inhibitor CEP-1347 reduces bim induction following NGF 
deprivation in sympathetic neurons (Harris and Johnson, 2001; Whitfield et al., 2001).    47 
Additionally,  the  increase  in  Bim  protein  levels  after  NGF  withdrawal  is  reduced  in 
sympathetic  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8  Transcriptional regulation of bim in sympathetic neurons. 
 
Withdrawal  of  NGF  activates  the  proapoptotic  MLK/JNK/c-Jun  pathway,  which 
contributes to the induction of bim by a mechanism that is currently unknown.  The JNK 
pathway  can  be  inhibited  by  the  MLK  inhibitor  CEP-1347  or  by  the  expression  of 
dominant negative c-Jun.  NGF withdrawal leads to the activation of Cdk4 and the de-
repression of the b-myb and c-myb genes.  The Myb proteins bind to myb sites (indicated 
by circles) and activate bim.  NGF withdrawal also leads to a decrease in the prosurvival 
activity of PI3-K/Akt.  This leads to the dephosphorylation and nuclear translocation of 
FOXO3a, which subsequently binds to FOXO sites (indicated by squares).  This pathway 
can be inhibited by the PI3-K/Akt inhibitor LY294002 and the expression of the mutant 
FKH DBD (Gilley et al., 2003).   48 
Additionally,  the  increase  in  Bim  protein  levels  after  NGF  withdrawal  is  reduced  in 
sympathetic neurons isolated from jun
AA knockin mice, in which the c-jun gene lacks 
activating Ser63/Ser73 phosphorylation sites (Besirli et al., 2005).  Bim is also a target of 
FOXO transcription factors in sympathetic neurons and neuronal PC12 cells (Figure 1.8).  
Following  NGF  withdrawal,  FOXO3a  translocates  into  the  nucleus  and  binds  to  two 
conserved FOXO sites, thereby contributing to activation of bim transcription (Gilley et 
al.,  2003).    Mutation  of  these  sites,  in  the  context  of  a  bim-LUC  reporter  construct, 
greatly  reduces  bim  promoter  activation  following  NGF  withdrawal  and  the 
overexpression of constitutively active FOXO3a can activate bim-LUC in the presence of 
NGF and induce endogenous Bim expression (Gilley et al., 2003).  Furthermore, FOXO 
activity contributes to the NGF withdrawal-induced death of sympathetic neurons (Gilley 
et al., 2003).  More recently, a third transcriptional pathway has been reported to regulate 
bim  expression  in  neuronal  PC12  cells  (Figure  1.8).    NGF  deprivation  leads  to  the 
activation of Cdk4, which in turn phosphorylates members of the Rb family, leading to 
the dissociation of Rb family members and chromatin modifiers from a complex with 
E2F, and to de-repression of the b-myb and c-myb genes.  The Myb transcription factors 
then bind to Myb sites in the bim promoter and activate bim transcription (Biswas et al., 
2005). 
  Some  of  the  signalling  pathways  and  transcription  factors  that  regulate  bim 
transcription are cell type-specific whereas other mechanisms appear to be more general.  
For example, in pro-B and T cells, trophic factor deprivation and inhibition of PI3-K 
activity cause FOXO3a dephosphorylation, induction of Bim expression and FOXO3a-
dependent apoptosis (Dijkers et al., 2000, Dijkers et al., 2002; Stahl et al., 2002).  On the 
other  hand,  the  ER  stress-induced  activation  of  bim  transcription  involves  different 
mechanisms.    Puthalakath  et  al.  (2007)  showed  that  Bim  is  essential  for  ER  stress-
induced apoptosis in a range of cell types.    The authors found that ER stress activates 
bim transcription and this activation does not involve FOXO3a but the stress-induced 
transcription  factor  CHOP ( CCAAT/enhancer  binding  protein  homologous  protein).  
Furthermore, CHOP-C/EBP  can activate a bim-LUC reporter construct via a consensus 
CHOP-C/EBP  site located within intron 1 of the bim gene (Puthalakath et al., 2007).  
However, when this region of intron 1 (exon 1c) was deleted in the context of our bim-  49 
LUC reporter construct, there was no significant change in the induction of bim-LUC 
following  NGF  withdrawal,  suggesting  that  this  CHOP-C/EBP   binding  site  is  not 
important for the activation of bim following NGF withdrawal in sympathetic neurons 
(Gilley and Ham, 2005). 
 
1.8.3 Post-transcriptional regulation of bim 
Although transcriptional control is the predominant means of regulating gene expression 
is eukaryotes, a number of mechanisms exist whereby a gene is subject to important 
supplementary control between its initial transcription and protein synthesis.  
  Alternative  splicing  results  in  the  generation  of  a  number  of  different  Bim 
isoforms that consequently vary in their potency (O’Connor et al., 1998; U et al., 2001; 
Liu et al., 2002; Marani et al., 2002; Chen et al., 2004).   
  Additionally, recent data has implicated bim as a target for regulation via mRNA 
stability and translation.  Matsui et al. (2007) found that exposure to cytokines leads to 
the destabilisation of bim mRNA via AU-rich elements within a 1 kb section of the 3  
UTR in the Baf-3 cell line.  Furthermore, bim has now been added to the fast-expanding 
list of transcripts that are targets for regulation by miRNAs.  Ventura et al. (2008) found 
that mice with a conditional knockout of miR-17~92 die shortly after birth and that loss 
of miR-17~92 results in increased levels of Bim and inhibition of B cell development.  
This is consistent with the observation that Bim is important for controlling lymphocyte 
apoptosis (O’Connor et al., 1998; Bouillet et al., 1999; Bouillet et al., 2001b; Ventura et 
al., 2008).  Most recently, Terasawa et al. (2009) showed that bim mRNA expression is 
suppressed by miR-221 and miR-222, both of which are induced by NGF-stimulation in 
PC12 cells via the ERK1/2 pathway.  As further evidence to support bim as a miRNA 
target, Su et al. (2009) found that in embryonic stem cells deficient for Ago1-4 (core 
effectors of the miRNA pathway) Bim protein levels were significantly elevated. 
 
1.8.4 Post-translational regulation of Bim 
Over  the  last  decade  a  great  deal  has  been  discovered  about  the  post-translational 
mechanisms that regulate the Bim protein.  The major splice variants of Bim vary in their 
proapoptotic potency due to the different post-translational mechanisms that govern their   50 
activity (Ley et al., 2005a).  BimS is the most potent isoform with no post-translational 
mechanisms to restrain it and possibly for this reason it is less frequently expressed than 
the  other  two  major  isoforms  BimL  and  BimEL,  whereas  BimEL  is  the  most  tightly 
regulated isoform (O’Reilly et al., 2000; Ley et al., 2005a).   
  BimL and BimEL both retain exon 4 of the bim gene, which encodes a binding site 
for dynein light chain-1 (DLC1 or LC8), a component of the dynein motor complex 
(Figure 1.7B).  BimL and BimEL can therefore bind to, and be sequestered by, the DLC1 
component  of  the  dynein  motor  complex  (Puthalakath  et  al.,  1999).    However,  this 
interaction appears only to be relevant in certain cell types (Shinjyo et al., 2001; Gomez-
Bougie et al., 2005; Ley et al., 2005a).  Lei and Davis (2003) showed that JNK-mediated 
phosphorylation of Bim, at Thr56 in the DLC1 binding motif, can disrupt the interaction 
between BimL and DLC1 leading to increased proapoptotic activity in the HEK 293T cell 
line.  In addition, another mechanism for the phosphorylation of Bim by JNK has been 
described  for  neuronal  cells:  following  NGF  withdrawal,  BimEL  is  phosphorylated  by 
JNK at Ser65, which leads to interactions with Pin1 that stabilise BimEL and thereby 
potentiate neuronal apoptosis (Putcha et al., 2003; Becker et al., 2004; Bonni and Becker, 
2006).   
  BimEL  is  the  only  isoform  to  retain  exon  3  of  the  bim  gene  (Figure  1.7B).  
Initially  it  was  shown  that  BimEL  is  phosphorylated  by  the  MEK/ERK  pathway  in 
neuronal PC12 cells maintained in the presence of NGF (Biswas and Greene, 2002).  Ley 
et al. (2003) also demonstrated the ERK-mediated phosphorylation of BimEL in serum-
treated fibroblasts.  Later studies showed that the region of the Bim protein, encoded by 
exon  3,  contains  an  ERK1/2  docking  site  via  which  the  MEK1/2/ERK1/2  pathway 
promotes  the  phosphorylation  of  BimEL  at  Ser65  and  other  sites,  which  leads  to  its 
degradation via the proteasome (Figure 1.7; Luciano et al., 2003; Ley et al., 2004; Marani 
et al., 2004; Ley et al., 2005b; Ewings et al., 2007).  Moreover, Ewings et al. (2007) 
showed that the ERK1/2-dependent phosphorylation of BimEL leads to the dissociation of 
BimEL  from  complexes  with  Mcl-1  and  Bcl-xL.    The  authors  also  demonstrated  that 
mutations in the BH3 domain cause increased turnover of BimEL.  This work supports a 
model  in  which  active  ERK1/2  phosphorylates  BimEL  and  phosphorylated  BimEL 
dissociates from prosurvival proteins and in this unbound state is a target for degradation   51 
(Ewings et al., 2007).  It has also been suggested that phosphorylation of Bim by ERK 
1/2 inhibits its interaction with Bax (Harada et al., 2004). 
  The mechanism by which BimEL is targeted for degradation by the proteasome is 
not completely understood.  Initially, Akiyama et al. (2003) proposed that the E3 ligase 
responsible for BimEL degradation is Cbl.  However, it was subsequently demonstrated 
that Cbl is, in fact, not required (Wiggins et al., 2007).  Recently, Dehan et al. (2009) 
showed that the F-box protein betaTrCP binds and promotes the proteasomal degradation 
of  phosphorylated  BimEL.    Furthermore,  it  has  now  been  demonstrated  that  Bim 
(primarily BimEL) is a target of the Cullin 2/Elongin -c/s ubiquitin-protein ligase complex 
and degradation by this pathway appears to be promoted by Drg binding to Bim isoforms 
(Ambrosini et al., 2009). 
 
1.9 Aims of this thesis 
The Bcl-2 family, BH3-only protein Bim plays an important role in NGF withdrawal-
induced death in sympathetic neurons, as well as in several other models of apoptosis.  
Although the roles of c-Jun and FOXO3a in regulating bim transcription have previously 
been studied by our group, there is still a considerable amount to be learned about the 
molecular mechanisms by which bim gene expression is controlled.   
  In this study, I will examine the role of the region of the bim promoter proximal 
to the major transcriptional start site and investigate how it controls bim basal promoter 
function and contributes to the activation of bim following NGF withdrawal.  This work 
will focus on a conserved NF-Y-binding CCAAT box that is located just upstream from 
the major transcriptional start site in the rat bim gene.  In addition, I will study how bim 
expression is regulated by the MEK/ERK signalling pathway in sympathetic neurons and 
I will investigate the role of the bim 3  UTR in this regulation. 
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Chapter 2: Materials and Methods 
 
2.1 Materials 
All stock chemicals, compounds, enzymes and other reagents were supplied by Sigma-
Aldrich unless stated otherwise. 
 
Table 1: Buffers and Solutions  
BUFFER/SOLUTION  COMPONENTS 
6 X DNA loading buffer  0.25% w/v bromophenol blue 
0.25% w/v xylene cyanol 
20% v/v glycerol 
50 mM EDTA 
LB medium  1% w/v bacto-tryptone (Difco, BD Biosciences Co.) 
0.5% w/v yeast extract (Difco, BD Biosciences Co.) 
17 mM NaCl (Fisher Scientific Inc.) 
LB agar  LB medium 
1.5% bacto-agar (Difco, BD Biosciences Co.) 
ChIP buffer A  5 mM PIPES-NaOH pH 8.0 
85 mM KCl 
0.5 mM PMSF 
2% v/v Sigma mammalian protease inhibitor cocktail 
ChIP SDS lysis buffer  1% w/v SDS 
10 mM EDTA 
50 mM Tris-HCl pH 8.0 
0.5 mM PMSF 
2% v/v Sigma mammalian protease inhibitor cocktail 
ChIP dilution buffer  0.01% w/v SDS 
1.1% v/v Triton X-100 
1.2 mM EDTA 
16.7 mM Tris-HCl pH 8.0   53 
167 mM NaCl  
0.5 mM PMSF 
2% v/v Sigma mammalian protease inhibitor cocktail 
ChIP low salt wash buffer  0.1% w/v SDS 
5 mM EDTA 
10 mM Tris-HCl pH 8.0 
150 mM NaCl 
ChIP 300 mM high salt      
wash buffer 
0.1% w/v SDS 
1% w/v Triton X-100 
2 mM EDTA 
20 mM Tris-HCl pH 8.0 
300 mM NaCl 
ChIP LiCl wash buffer  0.25 M LiCl 
1% IGEPAL-CA630 
1 mM EDTA 
10 mM Tris-HCl pH 8.0 
1% w/v deoxycholic acid sodium salt 
ChIP elution buffer  1% w/v SDS 
5 mM EDTA 
10 mM Tris-HCl pH 8.0 
300 mM NaCl 
Co-IP buffer A  10 mM Hepes pH 7.9 
10 mM KCl 
0.1 mM EDTA 
0.1 mM EGTA 
1 mM DTT 
0.5 mM PMSF 
2% v/v Sigma mammalian protease inhibitor cocktail 
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Co-IP buffer C  20 mM Hepes pH 7.9 
1 mM EDTA 
1 mM EGTA 
1 mM DTT 
1 mM PMSF 
25% v/v glycerol 
2% v/v Sigma mammalian protease inhibitor cocktail 
Co-IP non-denaturing lysis 
buffer 
1% v/v Triton-X100 
50 mM Tris-HCl pH 7.4 
300 mM NaCl 
5 mM EDTA 
0.02% v/v NaN3 pH 7.4   
1 mM PMSF 
2% v/v Sigma mammalian protease inhibitor cocktail 
TE buffer  10 mM Tris-HCl pH 8.0 
1 mM EDTA 
TM buffer  100 mM Tris-HCl pH 8.0 
50 mM MgCl2 
GTP C1 buffer  12.5 mM Hepes pH 7.9 
10% v/v glycerol 
100 mM KCl 
1 mM EDTA 
Hypotonic buffer  0.1% v/v Triton-X100 
20 mM Hepes pH 7.6 
20% v/v glycerol 
1 mM DTT  
10 mM NaCl 
1.5 mM MgCl2 
0.2 mM EDTA 
0.5 mM PMSF    55 
25 mM NaF 
25 mM  -glycerol phosphate 
2% v/v Sigma mammalian protease inhibitor cocktail 
Hypertonic buffer  hypotonic buffer  
500 mM NaCl 
Whole cell extract buffer  0.1% v/v NP40 (VWR International) 
250 mM KCl 
50 mM Hepes pH 7.9 
10% v/v glycerol 
0.2 mM EDTA 
0.2 mM EGTA 
4 mM NaF 
4 mM Na orthovanadate 
1 mM DTT 
2% v/v Sigma mammalian protease inhibitor cocktail 
SDS gel sample buffer  2 mM  -mercaptoethanol  
60 mM Tris-HCl pH 6.8   
0.01% w/v bromophenol blue 
2% w/v SDS 
SDS gel running buffer (1X)  192 mM glycine (VWR International) 
25 mM Tris base 
0.1% w/v SDS 
Stacking gel buffer  0.5 M Tris-HCl pH 6.8 
0.4% w/v SDS 
Resolving gel buffer  1.5 M Tris-HCl pH 8.8 
0.4% w/v SDS 
Transfer buffer (1X)  39 mM glycine  
48 mM Tris base 
20% v/v methanol 
0.037% w/v SDS   56 
Stripping buffer  50 mM  -mercaptoethanol 
62.5 mM Tris-HCl pH 6.8  
2% w/v SDS 
 
This table lists the components of the buffers and solutions that were prepared in this study. 
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2.2 Methods 
 
2.2.1 Cloning 
All oligonucleotide primers were custom-designed using MacVector 6.5.3 sequence 
analysis  software  (MacVector  Inc.)  and  synthesised  by  Sigma-Aldrich.    DNA 
sequencing was carried out by GATC Biotech and the sequences were analysed using 
FinchTV (Geospiza Inc.) and MacVector 6.5.3 software. 
 
2.2.1.1 3  Rapid amplification of cDNA ends (3  RACE) 
3   RACE  was  used  to  define  the  end  point  of  the  rat bim 3    UTR  for  subsequent 
cloning.  RACE was performed on rat lung poly A+ RNA with the Marathon cDNA 
Amplification Kit (all components were from Clontech, Takara Bio Co.).   
  First-strand synthesis was carried out in a volume of 5 µl with 1 µg of rat lung 
poly A+ RNA and the cDNA synthesis primer at a concentration of 2 µM (the cDNA 
synthesis primer is a modified lock-docking oligo (dT) primer that positions itself at 
the 3  end of a poly-A tail).  The mixture was incubated at 70ºC for 2 minutes and 
following a brief chill on ice the following components were added up to a volume of 
10 µl: 20 units of AMV (Avian Myeloblastosis Virus) reverse transcriptase and 1 mM 
dNTPs in 5 X first-strand buffer.  Following a 1 hour incubation at 42ºC, the mixture 
was placed on ice for 2 minutes to terminate first strand synthesis. 
  Second-strand synthesis was performed on the first-strand synthesis reaction 
product in a volume of 80 µl with 5 X second-strand reaction buffer, 0.2 µM dNTPs 
and 20 X second-strand enzyme cocktail.  After incubation at 16ºC for 1.5 hours, 6 
units of T4 DNA polymerase was added and the reaction was incubated for a further 45 
minutes at 16ºC.  Second-strand synthesis was terminated by the addition of 4 µl of an 
EDTA/glycogen mix.  The cDNA was extracted with 100 µl of phenol:chloroform: 
isoamyl alcohol (25:24:1) followed by chloroform:isoamyl alcohol (24:1).  Following 
the addition of a 0.5 X volume of 4 M ammonium acetate, the cDNA was precipitated 
with  ethanol,  pelleted  by  high-speed  centrifugation,  washed  with  80%  ethanol,  air 
dried and dissolved in 10 µl of sterile water.   58 
  Adaptor ligation was carried out on the double stranded cDNA in order to 
ligate the Marathon cDNA adaptor sequence to each end of the cDNA (the cDNA must 
have the adaptor terminal structure for RACE to proceed).  The cDNA was incubated 
with the Marathon cDNA adaptor at 1 µM and 5 X DNA ligation buffer plus 400 units 
of T4 DNA ligase, in a volume of 10 µl.  The ligation was incubated at 16ºC overnight 
followed by inactivation at 70ºC for 5 minutes.  The library of adaptor double stranded 
(ds) cDNA was then used for RACE PCR. 
  3  RACE PCR was carried out on the adaptor ds cDNA with the bim-specific 
primer  5 -CTTCTGGTGTTTTGAGGTCTGTGGAC-3   at  0.2  µM,  the  AP1  primer 
(the AP1 primer anneals to the adaptor sequence at the cDNA ends) at 0.2 µM, 50 X 
Advantage 2 Polymerase mix and 10 X cDNA PCR buffer, in a volume of 50 µl.  PCR 
conditions were 95ºC for 2 minutes followed by 35 cycles of 95ºC for 30 seconds, 
64ºC for 30 seconds and 68ºC for 3 minutes. 
  PCR  products  were  visualised  on  a  2.5%  agarose  gel  containing  ethidium 
bromide at 0.5 µg/ml.  Bands of the correct size were cloned into pGEM-T using the 
pGEM-T  Easy  Vector  System  as  specified  by  the  manufacturer  (Promega 
Corporation).  The sequenced clones were analysed in order to determine the end point 
of the rat bim 3  UTR. 
 
2.2.1.2 Plasmid constructs 
The bim-LUC reporter was constructed by Dr. Jonathan Gilley (Gilley et al., 2003).  It 
consists of a 5.2 kb fragment, containing the region immediately 5  to the rat bim 
initiator codon, sub-cloned into pGL3-Basic (Promega Corporation).   
  The bim-LUC CCAAT (-) construct was generated using the complementary 
oligonucleotide primers 5 -GAGCCCGCGGTGAGCTCGCGCCGGAGCGGG-3  and 
5 -CCCGCTCCGGCGCGAGCTCACCGCGGGCTC-3 .    The  altered  bases 
(underlined) create four point mutations in the inverted CCAAT box.  Mutagenesis was 
carried  out  using  the  QuikChange  II  XL  site-directed  mutagenesis  kit  (Stratagene 
Corporation).    Here,  the  desired  mutations  are  incorporated  by  polymerase  chain 
reaction (PCR).  The PCR products are then treated with the restriction endonuclease 
DpnI to digest the methylated, non-mutated parental DNA template.  The remaining   59 
double  stranded  DNA  is  then  transformed  into  XL10-Gold  ultracompetent  cells 
(Stratagene).    PCR  components  were:  50  ng  of  template  (bim-LUC),  0.2  µM 
complementary primers, 0.2 µM dNTPs, 2.5 units of PfuTurbo DNA polymerase and 
10 X reaction buffer, in a volume of 50 µl.  PCR conditions were 95ºC for 2 minutes 
followed by 18 cycles of 95ºC for 50 seconds, 60ºC for 50 seconds and 68ºC for 15 
minutes.    DNA  sequencing  confirmed  that  the  mutations  had  been  incorporated 
correctly. 
  The bim-LUC+3 UTR reporter was generated by PCR amplification of the rat 
bim 3  UTR from a restriction fragment cloned from the PAC clone 215h9.  215h9 was 
obtained from the rat P1 artificial chromosome (PAC) library RPC131 (generated by P. 
Y.  Woon  and  P.  de  Jong,  UK  Human  Genome  Mapping  Project  Resource  Centre, 
Cambridge, UK).  Primers were used to generate the 3  UTR in two fragments.  For 
fragment 1 the primers were 5 -CTCACTAGTCAGGAGCTTCGTGCAG-3  and 5 -
CTCCTACAAGGCACAAAACCCG-3 .    For  fragment  2  the  primers  were  5 -
CTATACGGATGTCCCTGTACTGTATC-3   and  5 -CTCACTAGTCATGAGAGCT 
AGTCGCAA-3 .  These primers add SpeI restriction sites to the 5  end of fragment 1 
and the 3  end of fragment 2.  PCR reactions were carried out with the following 
components: 50 ng of template (PAC clone 215h9), 0.2 µM complementary primers, 
0.2 µM dNTPs, 2.5 units of PfuTurbo DNA polymerase and 10 X reaction buffer, in a 
volume of 50 µl.  PCR conditions were 95ºC for 2 minutes followed by 25 cycles of 
95ºC for 30 seconds, 56ºC for 45 seconds and 72ºC for 3 minutes.  Fragments 1 and 2 
were  cloned  into  pGEM-T  using  the  pGEM-T  Easy  Vector  System  for  sequence 
confirmation  and  then  the  3   UTR  was  assembled  in  pBluescript  SK  (Stratagene 
Corporation)  using  a  unique  BglII  restriction  site  within  the  4.2-kb  region  to  link 
fragments 1 and 2.  The 3  UTR was excised using SpeI and sub-cloned into bim-LUC, 
using an XbaI restriction site downstream of the Luciferase reporter gene and upstream 
of the SV40 late poly (A) signal.  There was originally one other XbaI site present in 
bim-LUC (within intron 1) that was mutated to leave the XbaI site used here as unique.  
Mutagenesis was performed using the QuikChange II XL site-directed mutagenesis kit 
as described previously.  Microinjection experiments were carried out to confirm that 
mutating this site had no effect on bim-LUC.  To generate bim-LUC+3 UTR (F2),   60 
fragment 2 was excised from pGEM-T using the 3  SpeI site (incorporated by PCR) 
and a SpeI site within pGEM-T (located just upstream of the 5  end of fragment 2) and 
sub-cloned into bim-LUC. 
  The  bim-LUC+3 UTR(4xAREmut)  construct  was  generated  using  the 
following  complementary  primer  pairs:  5 -GCCACTTCCGTTTTGTAAATATGTA 
CCTCCTTAGCTCAGTTGCTCC-3   and  5 -GGAGCAACTGAGCTAAGGAGG 
TACATATTTACAAAACGGAAGTGGC-3 , 5 -CCTGTTTCCTCCTTCCAGTGTTG 
TATATATCTGACTATGTATTAGATTAGG-3  and 5 -CCTAATCTAATACATAGT 
CAGAATATATACAACACTGGAAGGAGGAAACAGG-3 ,  5 -GCTGTAACTTGT 
AGAGTCATTGTATATGTATTTTCTGCTTATGTAATGTCTTACG-3   and  5 -CG 
TAAGACATTACATAAGCAGAAAATACATATACAATGACTCTACAAGTTACA
GC-3 .  Three rounds of mutagenesis successfully incorporated point mutations into the 
four conserved AU-rich elements (AREs) within the rat bim 3  UTR (mutated bases are 
underlined).  Mutagenesis was carried out using the QuikChange II XL site-directed 
mutagenesis kit as described previously. 
  YA13 m29 was kindly provided by Dr. Roberto Mantovani (University of 
Milan,  Italy).    YA13  m29  is  a  dominant  negative  mutant  of  the  NF-YA  subunit 
(Mantovani  et  al.,  1994)  cloned  into  the  expression  vector  pSG5  (Stratagene 
Corporation). 
    The  expression  vector  for  p300  was  supplied  by  Upstate  (Millipore 
Corporation).    It  is  human  p300  cDNA  cloned  into  pCMV  ( CMVp300).    The 
expression vector pcDNA3.1 (Invitrogen Corporation), which is also under the control 
of the CMV promoter, was used as an empty vector control. 
    The  expression  vector  for  CBP  was  kindly  provided  by  Professor  Tony 
Kouzarides (The Gurdon Institute, Cambridge).  It is mouse CBP cDNA cloned into 
pRc/RSV (pRc/RSV-mCBP).  The expression vector pBJ9 , which is also under the 
control of the RSV promoter, was used as an empty vector control (also supplied by T. 
Kouzarides). 
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2.2.1.3 Restriction endonuclease digests 
Restriction endonucleases (Promega Corporation) were used to cleave double stranded 
DNA.  Typically, restriction digests were performed in a volume of 30 µl on 0.2-1.5 µg 
of substrate DNA, with a 2-10 fold excess of enzyme over DNA.  The digests were 
incubated for 2 hours at 37ºC (or the temperature that was optimal for each enzyme) 
and resolved by agarose gel electrophoresis. 
 
2.2.1.4 Ligations 
Typically, 3:1, 1:1 and 0:1 insert to vector ratios were set up for each ligation.  When 
ligations  were  carried  out  with  3  fragments  (for  cloning  of  the  bim-LUC+3 UTR 
reporter) the ratio was 3:3:1, 1:1:1 and 0:0:1.  The following equation was used to 
calculate the required amount of insert for a 3:1 ligation:  
                                           nginsert required = [(50 ngvector x kb insert)/kbvector] x 3 
 
For the ligation reaction, 1 unit of T4 DNA ligase (Promega Corporation) was mixed 
with the calculated amount of insert, 50 ng of vector and 10 X T4 ligase buffer, in a 
total volume of 10 µl.  The reaction was left overnight at 16ºC before transformation 
into competent cells. 
 
2.2.1.5 Agarose gel electrophoresis of DNA 
To analyse DNA by agarose gel electrophoresis, DNA samples were prepared in 6 X 
DNA loading buffer (Table 1) and resolved on 0.5-2.5% agarose gels (depending on 
the  size  of  the  DNA  to  be  visualised).    Agarose  gels  were  prepared  in  1  X  TBE 
(National Diagnostics Inc.) plus 0.5 µg/ml of ethidium bromide.  Images were captured 
using  a  UVIdoc  gel  documentation  system  (UVItec  Ltd.)  and  quantitated  using 
ImageQuant image analysis software (GE Healthcare Ltd.). 
  To purify DNA from agarose gels, the DNA fragment of interest was excised 
under UV light and then purified using the QIAquick gel extraction kit (QIAGEN Ltd.) 
as specified by the manufacturer. 
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2.2.1.6 Transformation of chemocompetent bacteria 
For  routine  cloning,  subcloning  efficiency  DH5   competent  cells  (Invitrogen 
Corporation) were used for bacterial transformation as follows:  competent cells were 
thawed  on  ice  and  50  µl  of  cells  was  aliquoted  into  a  chilled  14  ml  tube  per 
transformation.    Up  to  5  µl  (1-10  ng)  of  plasmid  DNA  was  mixed  into  each 
transformation reaction and the cells were incubated on ice for 30 minutes.  Control 
transformations were regularly carried out using pUC19 DNA as a positive control and 
no-DNA as a negative control.  The cells were heat shocked for 30 seconds in a 42ºC 
water bath and then placed on ice for 2 minutes.  Up to 950 µl of pre-warmed LB 
medium was added to each tube and the cells were incubated for 1 hour with shaking 
(225-250  rpm)  at  37ºC.    Transformation  reactions  were  spread  onto  pre-warmed 
selective plates (for example LB agar + 100 µg/ml of ampicillin) and the plates were 
incubated overnight at 37ºC.  Individual colonies were then selected for analysis. 
  For  cloning  of  large  or  difficult  constructs,  high  efficiency  XL10-Gold 
ultracompetent  cells  were  used  (Stratagene  Corporation).    Transformations  were 
carried  out  using  the  method  described  for  DH5   competent  cells,  but  with  the 
following  modification:    2  µl  of   -mercaptoethanol  was  added  to  each  aliquot  of 
competent cells for 10 minutes on ice prior to the addition of the plasmid DNA.  
 
2.2.2 Isolation of plasmid DNA 
Large quantities of purified plasmid DNA, for microinjection, were isolated as follows: 
A  single  bacterial  colony  was  picked  and  inoculated  into  2  ml  of  LB  medium 
containing 100 µg/ml of ampicillin (or the relevant selective antibiotic) for 5 hours at 
37ºC with shaking (225-250 rpm).  The starter culture was then transferred into 150 ml 
of LB medium containing 100 µg/ml of ampicillin and incubated for a further 16 hours 
at 37ºC with shaking.  The Plasmid DNA was isolated using the Genopure plasmid 
maxi kit (Roche Diagnostics Corporation) for high copy number plasmids, as described 
by the manufacturer.   63 
  For small quantities of DNA, used for cloning, a single bacterial colony was 
picked and inoculated into 2 ml of LB broth containing 100 µg/ml of ampicillin and 
incubated  overnight  at  37ºC  with  shaking  (225-250  rpm).    The  plasmid  DNA  was 
isolated  using  the  QIAprep  spin  miniprep  kit  (QIAGEN  Ltd.)  as  described  by  the 
manufacturer. 
  The concentration of the plasmid DNA was determined using a NanoDrop 
spectrophotometer (Nanomodel ND-1000).  A 260 nm / 280 nm absorbance ratio of 1.8 
is accepted as pure for DNA (if the ratio is significantly lower it may indicate the 
presence of protein, phenol or other contaminants). 
 
2.2.3 Isolation of RNA 
Total RNA was isolated from sympathetic neurons cultured for 7 days in vitro using 
the QIAGEN RNeasy mini kit with some modifications:  Neurons from 2 coverslips 
(approximately  1.6  X  10
4  cells)  for  each  treatment  (for  example;  +NGF,  +NGF 
+U0126, -NGF) were washed into 1.5 ml microfuge tubes using ice-cold PBS (-).  
Cells were spun down briefly to remove PBS (-) and resuspended by vortexing for 1 
minute in 350 µl of buffer RLT.  350 µl of 70% ethanol was added to the homogenised 
lysate before mixing well.  The sample was applied to an RNeasy mini column and 
centrifuged for 15 seconds at 8000 x g.  350 µl of buffer RW1 was then added to the 
RNeasy spin column, which was centrifuged for 15 seconds at 8000 x g.  An on-
column  DNase  digestion  was  then  performed  to  eliminate  genomic  DNA 
contamination  using  DNase  I  from  the  RNase-free  DNase  set  (QIAGEN  Ltd.).  
Another 350 µl of buffer RW1 was added to the RNeasy spin column to wash the 
RNA, which was then spun for 15 seconds at 8000 x g.  500 µl of buffer RPE was 
applied to the column and centrifuged for 15 seconds at 8000 x g followed by another 
500 µl of buffer RPE, which was centrifuged for 2 minutes at 8000 x g, and a further 1 
minute at full speed to dry the membrane.  The RNA was eluted from the column in 50 
µl  of  RNase-free  sterile  water.  1  µl  of  the  ribonuclease  inhibitor  RNaseOUT 
(Invitrogen) was added to each sample.  Isolation of RNA was carried out at room   64 
temperature, but the procedure was carried out rapidly and all RNA samples were 
stored at -80ºC.   
  RNA was concentrated, if necessary, by addition of 5 µg of glycogen and 5 µl 
of  3  M  sodium  acetate  (pH  5.3),  in  a  5  X  volume  of  ice-cold  ethanol  at  -20ºC 
overnight.  The samples were pelleted by centrifugation for 20 minutes at 15,700 x g at 
4ºC and the pellet was washed in 500 µl of ice-cold 70% ethanol.  The samples were 
centrifuged for a further 5 minutes at 15,700 x g at 4ºC and the pellet was air dried for 
2-3 minutes before being resuspended in an appropriate volume of RNase-free sterile 
water. 
  The  concentration  of  isolated  RNA  was  determined  using  a  NanoDrop 
spectrophotometer (model ND-1000).  A 260 nm / 280 nm absorbance ratio of 2 is 
accepted  as  pure  for  RNA  (if  the  ratio  is  significantly  lower  it  may  indicate  the 
presence of protein, phenol or other contaminants). 
 
2.2.4 cDNA synthesis 
cDNA was synthesised from isolated RNA samples using M-MLV (Moloney Murine 
Leukaemia Virus) reverse transcriptase (Invitrogen Corporation).  Up to 5 µg of total 
RNA was incubated with 1 mM dNTPs and 500 ng of oligo (dT)12-18 for 5 minutes at 
65ºC followed by the addition of 5 X M-MLV first strand buffer, 0.01 M DTT and 1 µl 
of RNaseOUT (Invitrogen Corporation).  The mixture was incubated for 2 minutes at 
37ºC before the addition of 200 units of M-MLV reverse transcriptase and incubation 
for 50 minutes at 37ºC.  The reaction was inactivated by incubation for 15 minutes at 
70ºC. 
 
2.2.5 Cell culture 
2.2.5.1 Sympathetic neuron culture 
Primary sympathetic neurons were cultured from the superior cervical ganglia (SCG) 
of  1-day-old  Sprague-Dawley  rats  bred  at  the  Biological  Services  Unit,  UCL,  as 
described  previously  (Whitfield  et  al.,  2004).    In  brief,  SCGs  were  isolated  using 
sterilised Dumont no. 5 forceps (Agar Scientific Ltd.) and dissociated by enzymatic   65 
treatment  in  a  0.025%  trypsin  solution  followed  by  a  0.1%  collagenase  solution 
(collagenase type II, Worthington Biochemical Corporation) for 30 minutes at 37ºC, 
respectively.    SCGs  were  further  dissociated,  mechanically,  using  a  P1000  Gilson 
pipetman.  The cell suspension was collected by centrifugation (200 x g for 10 minutes 
at room temperature) and pre-plated in SCG+ medium for 2 hours on an uncoated 
tissue culture dish.  This step allows non-neuronal cells, such as Schwann cells and 
fibroblasts,  to  attach  and  therefore  the  cell  suspension  is  enriched  for  sympathetic 
neurons  (Deckwerth  and  Johnson,  1993).    The  neurons  were  then  collected  by 
centrifugation, as previously, and counted in trypan blue solution using a modified 
Fuchs-Rosenthal haemocytometer.  Between 6,000-8,000 neurons were plated in 80 µl 
of SCG+ medium on 13 mm glass coverslips (VWR international Ltd.) coated with 
poly-L-lysine and laminin.  Each coverslip was placed in a 3.5 cm dish and after 2 
hours, cells were flooded with 2 ml of SCG+ medium.  Cells were maintained in 10% 
v/v CO2 at 37ºC and refed with fresh SCG+ medium at 1, 2 and 5 days in culture and 
subsequently  every  3  days.    SCG+  medium  was  SCG  medium  (DMEM  medium 
(D6546, Sigma) containing 10% foetal calf serum, 2 mM glutamine and penicillin-
streptomycin) supplemented with 2.5S NGF (Cedarlane Laboratories Ltd.) at 50 ng/ml 
and the antimitotic agents fluorodeoxyuridine and uridine at a final concentration of 20 
µM. 
 
2.2.5.2 PC6-3 cell culture 
PC6-3 cells, a subline of the PC12 (rat pheochromocytoma) cell line (Pittman et al., 
1993), were maintained in 5% v/v CO2 at 37ºC on 9 cm dishes coated with rat type I 
collagen (Upstate Biotechnology Inc.) at 2.5 µl/ml in PBS (-). 
  Undifferentiated PC6-3 cells were maintained in stock medium (RPMI 1640 
medium (21875, Gibco), containing 10% horse serum, 5% foetal calf serum, 2 mM 
glutamine and penicillin-streptomycin).  Cells were passaged once a week (usually at 
1:10).  To passage the cells, old medium was discarded, the cells were washed in 5 ml 
of PBS (Gibco, Invitrogen Corporation) and the cells were incubated with 2 ml of 
1xTrypsin/EDTA (Gibco, Invitrogen Corporation) for 5 minutes.  Stock medium was   66 
added up to 10 ml and cells were collected by centrifugation (800 x g for 5 minutes at 
room temperature).   
  PC6-3  cells  were  differentiated  into  a  neuronal  phenotype  for  5-7  days  in 
differentiation medium (RPMI 1640 medium containing 2% horse serum, 1% foetal 
calf  serum,  2  mM  glutamine  and  penicillin-streptomycin)  supplemented  with  NGF 
(Promega Corporation) at 100 ng/ml.  Typically, cells were seeded for differentiation 
at a density of 1 X 10
6 per 9 cm dish. 
 
2.2.5.3 NGF withdrawal and use of chemical inhibitors 
In NGF withdrawal experiments, neurons were rinsed twice with medium (without 
NGF) and then re-fed with medium containing an anti-NGF antibody at 100 ng/ml 
(Chemicon  International  Inc.).    The  PI3-K  inhibitor  LY294002  was  used  at  a 
concentration of 50 µM and the MEK/ERK inhibitor U0126 at a concentration of 10 
µM  (both  compounds  from  Promega  Corporation).    The  RNA  synthesis  inhibitor 
actinomycin-D was used at a concentration of 0.1 µg/ml.  In rat sympathetic neurons, 
bim mRNA levels peak at 16 hours following withdrawal of NGF (Whitfield et al., 
2001).  Therefore, treatment with chemical inhibitors and withdrawal of NGF was 
carried out for 16 hours.  When actinomycin-D was used in conjunction with U0126, 
cells  were  either  pre-treated  with  U0126  for  16  hours  prior  to  the  addition  of 
actinomycin-D or U0126 and actinomycin-D were added at the same time.  Following 
the addition of actinomycin-D, RNA was isolated from the cells over a time course.  
Chemical inhibitors were dissolved in DMSO and therefore equal volumes of DMSO 
were added to control (untreated) cells in each case. 
 
2.2.6 Microinjection 
Microinjection  experiments  were  carried  out  using  an  Axiovert  200  inverted 
microscope (Carl Zeiss Ltd.) fitted with a heated stage and CO2 chamber, using an 
Eppendorf  transjector  (model  5246)  and  micromanipulator  (model  5171).    Needles 
used for microinjection were pulled from borosilicate glass capillaries (Intracel Ltd.) 
using a Kopf Instruments gravity puller (model 720).   67 
  Sympathetic  neurons  were  cultured  in  vitro  for  5-7  days  prior  to 
microinjection.    Between  125  and  150  cells  were  injected  per  coverslip  and  each 
injection experiment was repeated at least 3 times.  Plasmids were injected into the 
nucleus of each cell and typically over 90% of cells survived injection.   
 
2.2.6.1 Dual luciferase assays 
Neurons were injected with luciferase reporter constructs in 0.5 X PBS (-Ca
2+, -Mg
2+) 
at  a  concentration  of  10  ng/µl,  with  the  exception  of  bim-LUC+3'UTR  and  its 
derivatives, which were injected at 14 ng/µl to allow an equivalent copy number for 
this larger construct.  The Renilla luciferase expression construct pRL-TK (Promega 
Corporation) was added to injection mixes at 5 ng/µl to control for injection efficiency 
(it is not activated by NGF withdrawal).  The expression vector for the NF-YA mutant 
(YA13  m29)  or  the  control  empty  vector  pSG5  were  injected  at  20  ng/µl.    The 
expression vector for p300, p300 in pCMV , or the control empty vector pcDNA3.1 
were injected at 50 ng/µl.  Luciferase assays were performed using the Dual-luciferase 
reporter  assay  system  (Promega  Corporation)  and  a  Lumat  LB9507  luminometer 
(Berthold Technologies Ltd.).  M1/M2 readings were produced by normalising Firefly 
output to Renilla output. 
 
2.2.6.2 Antibody co-injection experiments 
The p300 (C-20:Sc-585 X) and CBP (C-20:Sc-583 X) rabbit polyclonal antibodies 
(Santa Cruz Biotechnology Inc.) were diluted in PBS (-Ca
2+, -Mg
2+) and centrifuged in 
Microcon YM-3 centrifugal filters (Millipore Corporation) to remove sodium azide.  
Antibodies  were  injected  at  a  final  concentration  of  1  µg/µl  and  purified  rabbit 
immunoglobulin in PBS (Jackson ImmunoResearch Laboratories, Inc) was used as a 
control. 
 
2.2.6.3 Cell survival assays 
Neurons were injected with the YA13 m29 expression vector or the control empty 
vector (pSG5) at 200 ng/µl, along with 5 µg/µl of Texas red dextran (70,000 MW; 
Molecular Probes, Invitrogen Corporation) as a marker for injected cells.  Following   68 
withdrawal of NGF, the number of viable, morphologically-normal, injected cells was 
determined at time 0, 24, 48 and 72 hours.  Viable cells were counted in a blinded 
manner using a Zeiss Axiovert 200 inverted fluorescence microscope. 
 
2.2.6.4 Microinjection for immunocytochemistry 
Neurons were injected with the YA13 m29 expression vector or the control empty 
vector (pSG5) at 20 ng/µl along with 2.5 µg/µl of purified guinea pig IgG (Jackson 
ImmunoResearch Inc.) as a marker for injected cells.  Cells were fixed and stained as 
described in 2.2.12.  
 
2.2.7 Semi-quantitative RT-PCR 
RNA was isolated from sympathetic neurons and reverse transcribed as described in 
2.2.3 and 2.2.4.  50 ng of cDNA was used per 50 µl PCR reaction containing 0.2 mM 
dNTPs, oligonucleotide primers at 0.4 µM and 0.05 U/µl of REDTaq DNA polymerase 
in 1 X REDTaq PCR buffer (all from Sigma-Aldrich Corporation).  Primer pairs were 
as follows: bim 5 -CTACCAGATCCCCACTTTTC-3  and 5 -GCCCTCCTTCGTGT 
AAGTCTC-3   and  neurofilament-M  5 -ACGCTGGACTCGCTGGGCAA-3   and  5 -
GCGAGCGCGCTGCGCTTGTA-3 .    PCR  conditions  were  95ºC  for  2  minutes 
followed by 30 or 35 cycles of 95ºC for 30 seconds, 56ºC for 20 seconds and 72ºC for 
1 minute.  PCR products were visualised by agarose gel electrophoresis as described 
previously.  Images were captured using a UVIdoc gel documentation system (UVItec 
Ltd.) and quantitated using ImageQuant image analysis software (GE Healthcare Ltd.) 
Samples  were  analysed  at  30  and  35  cycles  and  the  average  mRNA  levels  were 
calculated.  Relative bim mRNA levels were calculated by normalising to the control 
neurofilament-M. 
 
2.2.8 Real-time quantitative PCR (qPCR) 
RNA  was  isolated  from  sympathetic  neurons  and  reverse  transcribed  as  described 
previously.  A bim specific primer and probe set was designed using the PrimerExpress 
software  v2.0  (Applied  Biosystems  Inc.):  bim  forward  primer  5 -CCAGGCCTT   69 
CAACCATTATCTC-3 ,  bim  reverse  primer  5 -GCGCAGATCTTCAGGTTCCT-3  
and  bim  probe  5 -TGCAATGGCTTCCATAAGGCCAGTCTCA-3 .    A  number  of 
forward primer, reverse primer and probe concentrations were tested to determine the 
optimal primer and probe concentration for measuring bim mRNA expression in my 
cDNA samples.  The combination of 300 nM forward primer and 900 nM reverse 
primer concentration was optimal as it produced the lowest cycle threshold (CT) value 
and the highest reaction Rn value (the Rn value is a measure of the fluorescent signal).  
The optimal probe concentration was 200 nM since this was the lowest concentration 
that did not affect the CT value.  Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) 
and Hypoxanthine phosphoribosyltransferase 1 (Hprt 1) were used as house-keeping 
(control)  genes.    Pre-optimised  Gapdh  (Rn99999916_S1)  and  Hprt  1 
(Mn00446968_m1) primer/probe sets were ordered from Applied Biosystems.  Bim 
qPCR reactions were set up with 300 nM forward primer, 900 nM reverse primer, 200 
nM probe and 1 X Taqman universal mastermix (Applied Biosystems Inc.)  Gapdh and 
Hprt 1 reactions were set up with 1 X Gapdh or Hprt 1 primer/probe set and 1 X 
Taqman universal mastermix.  PCR conditions were 95ºC for 20 seconds, followed by 
40 cycles of 95ºC for 1 second and 60ºC for 20 seconds. 
In order to analyse the data using the 2
-  CT relative quantitation method (Livak 
and Schmittgen, 2001), bim qPCR reactions must be equally efficient to Gapdh and 
Hprt 1 (in terms of the rate of amplification of the transcript).  Therefore, a standard 
curve was generated first to determine the qPCR efficiency at low and high cDNA 
concentrations (0.39 ng to 50 ng).  Bim, Gapdh and Hprt 1 were efficient at low and 
high cDNA concentrations, with correlation coefficients of 0.9986, 0.9999 and 0.9951, 
respectively.  The efficiency of each reaction was calculated using the formula: PCR 
efficiency = (10
(1/-s))-1 (Ginzinger, 2002) where s is the gradient of the standard curve 
and a slope of 3.3 equals 100% PCR efficiency.  The efficiency of the bim, Gapdh and 
Hprt 1 reactions were all 99%, therefore the 2
-  CT relative quantitation method could 
be used to determine the relative expression level of bim mRNA (where bim mRNA 
levels are calculated relative to Gapdh or Hprt 1 mRNA levels). 
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2.2.9 Chromatin immunoprecipitation (ChIP) 
Chromatin immunoprecipitation (ChIP) was performed as described by Alberts et al. 
(1998) with a number of modifications.  A chromatin immunoprecipitation assay kit 
from Upstate (Millipore Corporation) was used along with some additional buffers and 
reagents.    All  buffers  used  for  ChIP  are  described  in  Table  1.    PC6-3  cells  were 
differentiated by plating at a density of 1 X 10
6 cells (per 9 cm dish) in the presence of 
NGF and after 7 days the density had reached approximately 4 X 10
6 cells (per 9 cm 
dish).  The differentiated cells were kept in the presence of NGF or withdrawn from 
NGF for 16 hours before fixing with formaldehyde (37% formaldehyde was added to 
the culture medium to a final concentration of 1%) for 3 hours at room temperature to 
cross link proteins and DNA.  1.5 M glycine was added to 100 mM for a further 10 
minutes to quench the reaction.  The medium was removed and cells were rinsed in 
ice-cold PBS (-) plus 0.5 mM PMSF and 2% Sigma mammalian protease inhibitor 
cocktail before being scraped off the dishes in 2 ml of the PBS solution.  Cells were 
pooled for +NGF or -NGF and pelleted by centrifugation at 400 x g for 4 minutes at 
4ºC.  Each pellet was resuspended in buffer A + 0.5% NP40 and incubated for 10 
minutes at 4ºC on a rocking platform (Stuart Scientific Co.).  The lysates were pelleted 
by centrifugation at 400 x g for 4 minutes at 4ºC, re-suspended in 2 ml of buffer A (-
NP40), rocked for a further 10 minutes and centrifuged at 1200 x g for 5 minutes at 
4ºC.  The pellets were resuspended in 0.8 ml of ChIP SDS lysis buffer so that cells 
were at a concentration of approximately 1 X 10
7 nuclei/200 µl of buffer.  The samples 
were incubated on ice for 10 minutes before sonication with a Bandelin ultrasonic 
homogeniser (model HD2070) using a 3 mm microtip and 50% power.  Each lysate 
was sonicated for 12 pulses of 20 seconds, with 30 seconds on ice between each pulse 
(to  produce  DNA  fragments  approximately  200-1000  bp  long).    The  fragmented 
chromatin  was  then  centrifuged  at  15,700  x  g  for  10  minutes  at  4ºC  and  the 
supernatant, containing the chromatin, was recovered.  The chromatin was divided into 
200 µl aliquots (as samples for immunoprecipitation) and then diluted 10 fold in ChIP 
dilution buffer.  
  Lysates  were  pre-cleared  to  remove  proteins  binding  non-specifically  by 
incubation  with  20  µl  of  50%  protein  A/G-agarose  (without  DNA,  Santa  Cruz   71 
Biotechnology Inc.) in ChIP dilution buffer plus 10 µg/µl of BSA at 4ºC for 1 hour 
with rotation.  The agarose beads were pelleted by centrifugation for 2 minutes at 100 
x  g  and  the  pre-cleared  chromatin  was  recovered.    4  µg  of  each  antibody  for 
immunoprecipitation  (for  example  p300  C-20:Sc-585  X)  was  added  to  each  tube, 
which was then incubated overnight at 4ºC with rotation.  Millipore Bim (AB17003) 
and Santa Cruz MyoD (M-318:Sc-760 X) antibodies were used as negative controls.  
To recover the immune complexes, 15 µl of protein A/G-agarose (in ChIP dilution 
buffer  plus  BSA  at  10  µg/µl)  was  added  to  each  sample  for  2  hours  at  4ºC  with 
rotation.  The beads were pelleted and washed twice (for 5 minutes and 15 minutes at 
room temperature) in each of the following buffers: ChIP low salt wash buffer, ChIP 
300 mM high salt wash buffer, ChIP LiCl wash buffer and twice with TE buffer.  After 
the final wash, the beads were pelleted, re-suspended in 500 µl of ChIP elution buffer 
by vortexing and incubated at 65ºC overnight to reverse the cross links and release the 
immune complexes from the beads.  100 µg of glycogen was added and samples were 
treated with RNase A at 40 µg/µl for 1 hour at 37ºC followed by proteinase K at 40 
µg/µl  for  2  hours  at  56ºC.    The  samples  were  extracted  with  500  µl  of 
phenol:chloroform:isoamyl alcohol followed by chloroform:isoamyl alcohol.  This step 
was repeated and then the DNA was precipitated with ethanol, pelleted by high-speed 
centrifugation, washed with 70% ethanol, air dried and dissolved in 40 µl of TE buffer. 
  ChIP  samples  were  analysed  by  semi-quantitative  PCR  using  Taq  DNA 
polymerase and CoralLoad PCR buffer (QIAGEN Ltd.).  To detect binding of NF-Y to 
the inverted CCAAT box in the rat bim promoter the following primer pair was used: 
bim forward primer 5 -CAGGCCAAGTCACTAGGGTAAACAC-3  and bim reverse 
primer 5 -GAATCCGGTGACTGCAACGACAA-3 .  The same primer pair was used 
to detect binding of p300 and CBP to this region.  PCR conditions were 95ºC for 2 
minutes, followed by 25 or 30 cycles of 95ºC for 30 seconds, 60ºC for 30 seconds and 
72ºC for 30 seconds.  PCR products were run on non-denaturing 8% polyacrylamide 
gels (8% acrylamide/bis solution, 1 X TBE, 0.04% APS and 0.2% TEMED) in 1 X 
TBE  at  180  V  for  2  hours  and  stained  with  SYBR  Green  1  (Sigma  Aldrich 
Corporation).    Images  were  captured  using  a  UVIdoc  gel  documentation  system 
(UVItec  Ltd.)  and  quantitated  using  ImageQuant  image  analysis  software  (GE   72 
Healthcare Ltd.).  Samples were analysed between 25 and 30 cycles and the average 
amount of bim promoter DNA, precipitated by each antibody, was calculated. 
 
2.2.10 Co-Immunoprecipitation (Co-IP) 
All buffers used for Co-IP are described in Table 1.  A 50% slurry of protein A/G-
agarose (without DNA, Santa Cruz Biotechnology Inc.) was prepared in PBS (-) and 
added to a 1.5 ml microfuge tube containing 2 µg of the specific antibody (for example 
p300 C-20:Sc-585 X) resuspended in 500 µl ice-cold PBS (-).  This was also repeated 
for  the  non-specific  control,  purified  rabbit  immunoglobulin  in  PBS  (Jackson 
ImmunoResearch  Laboratories,  Inc).    The  mixtures  were  incubated  at  4ºC  for  90 
minutes on an orbital tube rotator (Stuart Scientific Co.).  The beads were collected by 
centrifugation at 15,700 x g for 2 seconds at 4ºC.  The supernatant containing the 
unbound  antibody  was  removed  and  the  beads  were  resuspended  in  1  ml  of  non-
denaturing lysis buffer.  The tubes were inverted 3 to 4 times to mix and the beads 
were collected by centrifugation at 15,700 x g for 2 seconds at 4ºC.  The beads were 
washed in 1 ml of non-denaturing lysis buffer and the beads collected as described in 
the previous step.  The antibody-bound beads were then stored at 4ºC for up to 6 hours 
prior to use. 
   Around 80 µg of nuclear lysate was added to each tube containing specific or 
control antibody-bound beads.  The mixture was incubated at 4ºC for 2 hours with 
rotation.  The beads were then collected by centrifugation at 15,700 x g for 2 seconds 
at 4ºC and the supernatant was removed.  The beads were resuspended in 1 ml of ice-
cold  wash  buffer,  the  tubes  inverted  for  4  to  6  times  to  mix,  and  the  beads  were 
collected by centrifugation at 15,700 x g for 2 seconds at 4ºC.  This wash step was 
repeated  3  times  and  the  final  supernatant  was  removed  to  leave  the  beads  in 
approximately 15 µl of wash buffer (containing the immune complexes).  The beads 
were resuspended in 30 µl of SDS gel sample buffer, boiled for 5 minutes at 100ºC and 
analysed by immunoblotting (as described in 2.2.13).  
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2.2.10.1 Preparation of nuclear extracts for Co-IP 
  PC6-3 cells were differentiated by plating at a density of 1 X 10
6 cells (per 9 cm dish) 
in the presence of NGF for 7 days.  Nuclear lysates were prepared from differentiated 
PC6-3 cells maintained in NGF and differentiated PC6-3 cells 16 hours following NGF 
withdrawal.  To prepare nuclear extracts the cells were washed twice in ice-cold PBS (-
) and then scraped off the dishes in 2 ml of PBS (per 9 cm dish).  Cells were pooled for 
+NGF or -NGF and pelleted by centrifugation at 400 x g for 5 minutes at 4ºC.  Each 
pellet was resuspended in 200 µl of buffer A and then incubated on ice for 15 minutes, 
prior to the addition of 10% NP40 to each lysate (15 µl of 10% NP40 per 200 µl 
lysate).  Samples were vortexed for 15 seconds and then incubated for 15 minutes at 
4ºC on an orbital tube rotator.  The lysates were pelleted by centrifugation at 15,700 x 
g for 30 seconds, resuspended in 200 µl of ice-cold buffer C and then incubated at 4ºC 
on an orbital shaker (Stuart Scientific Co.) at 150 rpm.  After 1 hour the lysate was 
vortexed for 30 seconds and then spun down for 10 minutes at 15,700 x g at 4ºC.  The 
supernatant was removed and this was the nuclear extract.   
 
2.2.11 Electrophoretic mobility shift assay (EMSA) 
Oligonucleotide pairs used for EMSA experiments were as follows: bim CCAAT wt 5'-
CTAGCCCGCGGTGATTGGGCGCCGGAG-3'  and  5'-CTAGCTCCGGCGCCCAA 
TCACCGCGGG-3'  and  bim  CCAAT  mut  5'-CTAGCCCGCGGTGAGCTCG 
CGCGGAG-3'  and  5'-CTAGCTCCGGCGCGAGCTCACCGCGGG-3'    (the  mutated 
bases of the ICB are underlined).  Oligonucleotides for a CCAAT box in the rat GTP 
Cyclohydrolase  I  gene  were  used  as  a  positive  control:  GTP  C1  WT  5'-
CTAGGCTCGGCCAATGAGAACGCCT-3'  and  5'-CTAGAGGCGTTCTCATT 
GGCCCGAGC-3'  and  GTP  C1  mut  5'-CTAGCTCGGGGAGCTGAGAACGCCT-3' 
and  5'-CTAGAGGCGTTCTCAGCTCCCCGAGC-3'  (Kapatos  et  al.,  2000).  
Oligonucleotide  pairs  were  annealed  as  follows;  2  µg  of  each  oligonucleotide  was 
mixed together with 10 µl of TM buffer (Table 1) and 80 µl of sterile water, incubated 
for 10 minutes at 80ºC and then slow cooled to room temperature.  The 5' overhangs of   74 
annealed oligonucleotides were labelled by filling in with Klenow polymerase (Roche 
Diagnostics Ltd.) and [ -
32P]dCTP (3000 Ci/mmol; PerkinElmer Inc.).    
  20 µl binding reactions were set up in GTP C1 binding buffer (Table 1) plus 1 
µg of poly (dI-dC) and 5 µg of BSA using 5 µg of cytoplasmic or nuclear extract from 
PC6-3 cells and 10 µg of whole cell extract from sympathetic neurons.  Supershift 
experiments were carried out by incubating samples on ice with antibodies (4 µg) for 2 
hours.  A Santa Cruz antibody against NF-YA (H-209: Sc-10779 X) was used along 
with  c-Jun  (H-79:  Sc-1694  X)  or  Fra-2  (L-15:  Sc-171  X)  antibodies  as  negative 
controls (also from Santa Cruz Biotechnology Inc.).  Samples were incubated with 0.4 
ng of 
32P-labelled oligonucleotide for 15 minutes at room temperature and loaded onto 
a 5%, native polyacrylamide gel (5% acrylamide/bis solution, 0.25 X TBE, 0.04 % 
APS and 0.2% TEMED) in 0.25 X TBE.  Electrophoresis was carried out at 180 V for 
2  hours  using  a  vertical  gel  electrophoresis  apparatus  (Whatman,  model  V15-17).  
After electrophoresis, the gel was fixed in a 10 % acetic acid / 10 % methanol solution 
for 20 minutes and dried at 80ºC under vacuum using a Biorad gel dryer (model 583).  
The bands were visualised by exposing the gel to MXB X-ray film (Kodak Ltd). 
 
2.2.11.1 Preparation of protein extracts for EMSA experiments 
  Nuclear  and  cytoplasmic  lysates  were  prepared  from  undifferentiated  PC6-3  cells, 
differentiated PC6-3 cells maintained in NGF and differentiated PC6-3 cells 16 hours 
following NGF withdrawal.  Protein extracts were prepared by a method based on that 
described by Wong et al. (1999): cells were washed twice in ice-cold PBS (-) (Gibco, 
Invitrogen Corporation) and left to swell for 5 minutes on ice in 500 µl (per 9 cm dish) 
of hypotonic buffer (Table 1).  Cells were scraped into a single cell suspension and the 
nuclei pelleted at 200 x g at 4ºC for 10 minutes.  The supernatant was removed and this 
was  the  cytoplasmic  extract.    The  pellet  was  resuspended  in  a  5  X  volume  of 
hypertonic buffer (Table 1).  The suspension was rocked for 1 hour at 4ºC in an orbital 
tube rotator and then spun at 15,700 x g in a microcentrifuge for 5 minutes at 4ºC.  The 
final supernatant was removed and this was the nuclear extract.   
    Whole cell extracts were prepared from sympathetic neurons (cultured for 7 
days in vitro) that were maintained in medium containing NGF or following NGF   75 
withdrawal for 16 hours using a method based on Schwarz et al., 1993: neurons from 4 
coverslips for each treatment were washed into 1.5 ml microfuge tubes (+ and –NGF, 
respectively) with ice cold PBS (-).  Cells were spun down briefly to remove PBS (-) 
and resuspended in 30 µl of whole extract buffer (Table 1).  Extracts were left for 20 
minutes on ice and then spun in a microcentrifuge at 15,700 x g for 30 minutes at 4ºC 
and the supernatant was collected. 
    Protease and phosphatase inhibitors were added to the protein extract buffers 
just before use and all protein extracts were stored at -80ºC.  Protein concentration was 
determined  using  the  Biorad  protein  assay  kit  (Biorad  Laboratories  Inc.),  which  is 
based on the method of Bradford (1976), with  -globulin as a standard.  
 
2.2.12 Immunocytochemistry 
  Neurons  were  fixed  in  4%  paraformaldehyde  at  room  temperature  for  20  minutes, 
washed in PBS (-) 3 times and permeabilised either in Triton X-100 (0.5% Triton X-
100 in PBS (-) for 5 minutes at room temperature) or in methanol (ice-cold MeOH for 
15 minutes) according to the primary antibody that was used.  After washing, blocking 
was carried out in 50% goat serum (Sigma-Aldrich Corporation) in 1% BSA in PBS (-) 
at room temperature for 30 minutes.  After washing, cells were incubated in primary 
antibody for 1 hour at room temperature at a dilution of 1:100 or 1:250 (in 1% BSA in 
PBS).    Cells  were  washed  as  detailed  above  and  incubated  in  a  FITC-conjugated 
secondary  antibody  (and  a  rhodamine  anti-guinea  pig  IgG  secondary  antibody  if 
neurons were microinjected) diluted 1:750 in 1% BSA in PBS, for 45 minutes at room 
temperature.  Coverslips were washed again and the nuclei were then stained with 
Hoechst 33342 dye at 1 µg/ml for 10 minutes at room temperature.  After washing 
three times in distilled water, coverslips were mounted onto glass slides in Citifluor 
AF1 glycerol/PBS solution and sealed using clear nail varnish.   Slides were stored at 
4ºC and viewed on a Zeiss Axioplan 2 fluorescence microscope (x63 magnification 
using  Zeiss  Immersol  oil)  and  cells  were  scored  in  a  blinded  manner  whenever 
possible.    Secondary-only  controls  were  carried  out  to  confirm  the  specificity  of 
primary antibodies and all antibodies used for immunofluorescence are listed in Table 
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Table 2: Antibodies used for immunofluorescence 
Antibody  Supplier  Dilution  Permeabilisation 
NF-YA 
H-209: Sc-10779  
Santa Cruz  1:250  Triton X-100 
Bim # 2819  Cell Signalling  1:100  Triton X-100 
p300 C-20:Sc-585    Santa Cruz  1:100  Methanol 
CBP C-20:Sc-583  Santa Cruz  1:100  Methanol 
 
This table lists the primary antibodies used for immunofluorescence, together with the working dilution 
and method of permeabilisation used for each antibody. 
 
2.2.13 Immunoblotting 
  Sympathetic neurons were cultured for 7 days in vitro and whole cell extracts were 
prepared as follows: neurons from 4 coverslips for each treatment (for example; + 
NGF, +NGF +U0126, -NGF) were washed into 1.5 ml microfuge tubes using ice-cold 
PBS (-).  Cells were spun down briefly to remove PBS (-) and lysed in 30 µl of SDS 
gel sample buffer (Table 1) by incubating at 100ºC for 15 minutes.  Lysates were 
stored  at  -80ºC  and  boiled  for  a  further  5  minutes  prior  to  loading.    Protein 
concentration was determined using the Biorad protein assay kit (Biorad Laboratories 
Inc.) with  -globulin as a standard. 
    Proteins were separated on a 12% SDS-polyacrylamide gel (Stacking gel: 4% 
acrylamide/bis solution, 0.125 M Tris-HCl pH 6.8, 0.1% SDS, 0.05% APS and 0.2% 
TEMED.  Resolving gel: 12% acrylamide/bis solution, 0.375 M Tris-HCl pH 8.8, 0.1% 
SDS, 0.05% APS and 0.2% TEMED) in 1 X SDS gel running buffer (Table 1) at 120 
V for 80 minutes using a Mini-PROTEIN III electrophoresis tank (Biorad laboratories 
Inc.).    Proteins  were  transferred  to  Immobilon-P  (Millipore  Corporation)  using  the 
Biorad Mini-PROTEIN III transfer system in 1x transfer buffer (Table 1) at 35 V for 2 
hours.   
    Membranes  were  blocked  for  1  hour  at  room  temperature  in  1  X  TBS 
containing  0.1%  Tween-20  and  5%  non-fat  milk  powder  (blocking  solution).    77 
Membranes were incubated overnight at 4ºC in primary antibody diluted in blocking 
solution at 1:1000 (Table 3).  Excess antibody was removed by washing 6 times for 10 
minutes in TBS containing 0.1% Tween-20 (TBS-T).  The membranes were incubated 
in horseradish peroxidase-conjugated secondary antibodies diluted 1:3500 in TBS-T 
(Table  3),  washed  as  previously  and  then  proteins  were  detected  with  the 
chemiluminescent  reagent,  ECL  (Amersham  Biosciences  Ltd).    The  bands  were 
visualised by exposure to MXB X-ray film (Kodak Ltd.) and scanned images were 
then quantitated using ImageQuant image analysis software (GE Healthcare Ltd.).  For 
re-probing,  membranes  were  stripped  of  bound  proteins  for  30  minutes  at  50ºC  in 
stripping buffer (Table 1).  All antibodies used for immunoblotting are listed in Table 
3. 
 
Table 3: Antibodies used for immunoblotting 
 
Antibody  Supplier  Dilution  Secondary Ab 
p44/42 (ERK1/2)  
# 9102 
Cell Signalling  1:1000  Anti-rabbit HRP 
(1:3500) 
Phospho-p44/42  
(phospho-ERK1/2) 
(Thr 202/Tyr 204) 
# 9101S 
Cell Signalling  1:1000  Anti-rabbit HRP 
(1:3500) 
AKT   
# 9272 
Cell Signalling  1:1000  Anti-rabbit HRP 
(1:3500) 
Phospho-AKT (Ser 473) 
# 9271S 
Cell Signalling  1:1000  Anti-rabbit HRP 
(1:3500) 
 
This table lists the antibodies, together with their working dilution and secondary antibody that were 
used for immunoblotting. 
 
2.2.14 Statistical analysis 
In each set of experiments data is normalised to a control sample in the presence of 
NGF (for example, bim-LUC +NGF).  All data are presented as the mean ± S.E. of   78 
multiple experiments.  The Paired Student’s T-test (for two-tailed distributions) was 
used as a test for statistical significance. *** represents a p-value of less than 0.001, ** 
represents a p-value of less than 0.01 and * represents a p-value of less than 0.05.  P-
values  less  than  0.05  were  considered  as  a  statistically  significant  difference.    All 
statistical comparisons were carried out using Microsoft Excel 2003. 
  For microinjection, the relative induction of a DNA construct was calculated 
by  dividing  the  normalised  luciferase  activity  in  the  presence  of  NGF  by  the 
normalised luciferase activity in the absence of NGF. 
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Chapter  3:  The  role  of  NF-Y  in  regulating  bim 
gene expression in sympathetic neurons. 
 
3.1 Introduction 
Bim is a potent proapoptotic protein in many different cell types and its expression is 
tightly  regulated  by  a  number  of  transcriptional  and  post-translational  mechanisms.  
Regulation of bim appears to vary between cell types, but in models of neuronal cell 
death, in which the cells are dependent on NGF for survival, transcriptional control of 
bim involves at least three pathways (Figure 1.8).  Bim mRNA and Bim protein levels 
increase when sympathetic neurons are deprived of NGF and overexpression of BimEL in 
these cells can induce cytochrome c release and apoptosis (Putcha et al., 2001; Whitfield 
et  al.,  2001).    A  number  of  studies  suggest  that  activation  of  the  MLK-JNK-c-Jun 
pathway is a key event for bim upregulation in sympathetic neurons: the overexpression 
of a dominant negative c-Jun protein reduces the increase in bim mRNA and protein 
levels that occurs after NGF withdrawal (Whitfield et al., 2001); the MLK inhibitor CEP-
1347 inhibits the increase in bim mRNA level (Harris and Johnson, 2001); the jun
AA 
knock-in  mutation  reduces  the  increase  in  Bim  protein  level  after  NGF  withdrawal 
(Besirli et al., 2005).  Furthermore, sympathetic neurons and sensory neurons isolated 
from bim
-/- knockout mice are partially protected against cell death following withdrawal 
of NGF, indicating that bim is required for NGF withdrawal-induced death (Whitfield et 
al., 2001; Coultas et al., 2007).  In addition to this, Gilley et al. (2003) identified two 
conserved  FOXO  sites  that  flank  the  bim  proximal  promoter  and  showed,  by 
microinjection  of  a  bim-LUC  reporter  construct,  that  mutation  of  these  sites  greatly 
reduces bim promoter activation following NGF withdrawal in sympathetic neurons.  Bim 
is also a target for PI3-K signalling and overexpression of constitutively active FOXO3a 
can induce Bim expression (Gilley et al., 2003).  Moreover, FOXO activity contributes to 
the NGF deprivation-induced death of sympathetic neurons (Gilley et al., 2003).  Finally, 
Biswas et al. (2005) identified two Myb binding sites in the bim promoter and, using 
neuronally differentiated PC12 cells, showed that bim is a target of a Cdk4-E2F pathway 
that leads to the de-repression of E2F-regulated myb genes and the induction of bim   80 
following NGF withdrawal.  These studies have provided detailed information on how 
bim is regulated following growth factor withdrawal.  However, the role of the region of 
the bim promoter proximal to the major transcriptional start site and how it controls basal 
promoter function and contributes to the activation of bim following NGF withdrawal 
still remains to be elucidated.  Since bim has a TATA-less promoter, I was interested to 
establish what factor(s) govern its basal promoter function and how these regulate bim 
expression following NGF deprivation in sympathetic neurons.  One candidate that I have 
investigated is NF-Y. 
     Nuclear factor-Y (NF-Y), also known as CBF or CP-1 (and HAP 2/3/5 in yeast), 
is a heteromeric transcription factor of 70 kDa that is formed by the interaction of three 
subunits  NF-YA,  NF-YB  and  NF-YC.    All  three  subunits  contain  core  domains, 
conserved through evolution, that are sufficient for subunit interactions and DNA binding 
(Hooft van Huijsduijen et al., 1990; Sinha et al., 1995).  Interestingly, the activation 
domains are less well conserved and in yeast, the activation domain is encoded by a 
fourth  subunit  (HAP4)  with  no  apparent  homologues  in  other  species  (Forsburg  and 
Guarente, 1989; Hooft van Huijsduijen et al., 1990; Gusmaroli et al., 2001).  The NF-YB 
and NF-YC core regions are highly homologous to histones H2A and H2B, respectively, 
and  their  dimerisation,  facilitated  through  strong  histone  fold  motif  interactions,  is  a 
prerequisite for NF-YA association (Caretti et al., 1999).  The NF-YB/NFY-C dimer is 
important  for  protein-protein  interactions  and  the  alpha-C  ( C)  helix  of  NF-YC  is  a 
docking site for c-MYC and p53 (Figure 3.1; Izumi et al., 2001; Romier et al., 2003; 
Imbriano et al., 2005).  NF-YA has two subdomains, an N-terminal region responsible 
for  contacting  the  NF-YB/NF-YC  dimer  (NF-YA1)  and  a  C-terminal  region  that  is 
responsible  for  sequence  specific  DNA  binding  (NF-YA2)  (Figure  3.1;  Olesen  and 
Guarente, 1990; Mantovani et al., 1994; Romier et al., 2003).   
  The  NF-Y  trimer,  once  formed,  recognises  and  binds  to  the  CCAAT  box 
element.  CCAAT boxes can be found in the forward (CCAAT) or reverse, inverted 
(ATTGG) orientation (known as an inverted CCAAT box, or a Y box) and are present 
in around 30% of eukaryotic promoters (Bucher, 1990).  The canonical CCAAT box is 
composed  of  a  strictly  conserved  central  pentanucleotide  sequence,  CCAAT  or 
ATTGG, with a highly preferred 5  and 3  surrounding sequence (Bucher, 1990).  The   81 
 
 
 
 
Figure 3.1  Model of the NF-Y/CCAAT complex. 
 
Model of how the transcription factor NF-Y binds to and distorts the DNA.  The NF-
Y/CCAAT complex was modelled following analysis of the crystal structure of the 
NF-YB-NF-YC dimer, as resolved by x-ray crystallography.  The DNA backbone is 
shown  as  ribbons  (purple)  with  the  CCAAT  pentanucleotide  labelled.    NF-YA  is 
shown in blue, NF-YB is shown in green and NF-YC is shown in orange.  The two 
alternative positions for the linker connecting the two subdomains of NF-YA (NF-YA1 
and NF-YA2) are shown as a blue dotted line.  Taken from Romier et al. (2003).  
 
AT boxes appears to be higher in TATA-less promoters, particularly in the reverse  
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ATTGG, with a highly preferred 5  and 3  surrounding sequence (Bucher, 1990).  The 
frequency of CCAAT boxes appears to be higher in TATA-less promoters, particularly in 
the reverse ATTGG orientation.  In promoters with a TATA box, the CCAAT box is 
typically located between -80 and -100 bp upstream of the major transcriptional start site, 
whereas in TATA-less promoters, it is usually found closer to the +1 signal (-66 on 
average) (Mantovani, 1998).  The CCAAT box is often found as a single copy element.  
Multiple CCAAT boxes can be found in the same promoter, but in every case they are 
separated  by  at  least  27  base  pairs  (Mantovani,  1999).  Studies  in  a  variety  of 
experimental systems have validated the importance of CCAAT box elements for the 
transcriptional  activation  of  different  genes.    However,  there  appears  to  be  some 
variability in the extent of CCAAT dependence between different classes of promoter.  
TATA-less promoters, containing only one or two other activator sites, seem to require an 
intact  CCAAT  whereas  TATA-containing  promoters,  that  have  other  powerful 
transcriptional  activator  binding  sites,  are  less  dependent  (Mantovani  et  al.,  1992; 
Liberati et al., 1998).  
  NF-Y binds to the CCAAT box, in the forward or reverse orientation, with high 
specificity and affinity (Kim and Sheffery, 1990; Bi et al., 1997).  Specific DNA binding 
involves both minor and major groove interactions and upon NF-Y binding, the DNA 
bends by approximately 60° to 80° (Figure 3.1; Ronchi et al., 1995; Liberati et al., 1998).  
This distortion of the DNA can facilitate protein-protein interactions between distally 
binding  factors,  since  they  are  brought  together  in  space  (Mantovani  et  al.,  1999).  
Analysis  of  the  NF-Y  crystal  structure  revealed  that  the  bound  NF-Y  trimer  spans  a 
considerable distance along the DNA (Figure 3.1; Romier et al., 2003).  This is consistent 
with  previous  biochemical  data  that  suggested  that  a  region  of  24-26  base  pairs  is 
occupied by NF-Y (Liang and Maity, 1998; Liberati et al., 1998; Mantovani et al., 1998).  
  NF-Y sites are often found in the proximal promoter regions of many genes 
where  they  play  a  critical  role  in  transactivation.    However,  a  recent  study,  using 
chromatin immunoprecipitation (ChIP) on chip analysis, revealed that NF-Y sites are not 
confined to the core promoters of genes, with around 40% located outside (Testa et al., 
2005).    This  suggests  that  that  the  NF-Y  mediated  transcriptional  network  is  quite 
complex.     83 
  One  function  of  NF-Y  is  to  govern  basal  transcription  and  NF-Y  has  been 
reported to associate with the TATA-box binding protein (TBP), TBP-associated factors 
(TAFs)  and  TFIID  (Bellorini  et  al.,  1997;  Frontini  et  al.,  2002).    Through  these 
interactions  NF-Y  can  facilitate  preinitiation  complex  formation  in  the  absence  of  a 
TATA box and recruit RNA polymerase II to the promoter (Kabe et al., 2005).   
  The  major  role  of  NF-Y  is  to  cooperate  with  other  transcriptional  activators 
located close by and therefore CCAAT boxes are usually flanked by at least one other 
functional promoter element.  The CCAAT box and the flanking element(s) are often 
precisely spaced to allow the binding factors to interact on the same side of the DNA 
helix (Mantovani 1999).  NF-Y can markedly increase the affinity of a neighbouring 
factor, such as SP-1, for the DNA (Wright et al., 1995).  Yoshida et al. (2000) showed 
that the basic leucine zipper protein ATF6 is induced by endoplasmic reticulum (ER) 
stress and binds cooperatively with NF-Y to induce the unfolded protein response (UPR).  
They found that when they mutated the CCAAT box, ATF6 could no longer bind to its 
target consensus sequence (Yoshida et al., 2000).  NF-Y can also recruit the coactivator 
p300/CBP to DNA to potentiate transcription and NF-Y can be acetylated by p300 (Li et 
al., 1998; Salsi et al., 2003).   
  A  number  of  groups  have  reported  that  p53/NF-Y  complexes  modulate  the 
activity of cell cycle promoters that are involved in the DNA damage response (Yun et 
al., 1999; Manni et al., 2001; Imbriano et al., 2005).  Upon DNA damage the p53/NF-Y 
complex recruits histone deacetylases (HDACs) and releases histone acetyltransferases 
(HATs), resulting in the repression of key cell cycle control genes (Imbriano et al., 2005).  
In  contrast,  mutant  p53/NF-Y  complexes  cause  aberrant  cell  cycle  regulation  by 
activating  proliferative  genes,  and  this  is  a  critical  point  in  their  gain-of-function,  in 
response to DNA damage (Di Agostino et al., 2006; Peart and Prives, 2006).   
  NF-Y  function  is  primarily  regulated  through  interactions  with  different 
transcription factors and transcriptional cofactors.  However, the activity of the NF-Y 
trimer appears to be governed by post-translational modification of the NF-YA subunit.  
NF-YA is a target for ubiquitination and acetylation (Manni et al., 2008).  NF-YA can 
also  be  phosphorylated  and  a  phosphorylation-deficient  mutant  form  of  NF-YA  has 
significantly reduced DNA-binding activity (Yun et al., 2003).    84 
   Functional studies have, so far, defined the importance of NF-Y in proliferation 
and control of the cell cycle.  A conditional deletion of both NF-YA alleles, in primary 
mouse embryonic fibroblasts, led to a block in cell cycle progression, indicating that NF-
Y dependent transcription is essential during early mouse development (Bhattacharya et 
al., 2003).  Abrogation of NF-Y function by the stable expression of an NF-YA dominant 
negative in mouse NIH 3T3 fibroblasts also resulted in a loss of cell cycle progression 
(Hu and Maity, 2000). 
  In the work described in this chapter, I have investigated the role of an inverted 
CCAAT box and NF-Y in the regulation of bim transcription in sympathetic neurons. 
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3.2 Results 
3.2.1  The  bim  proximal  promoter  contains  an  inverted  CCAAT  box  that  is 
conserved across species. 
To start to investigate how the region of the bim promoter proximal to the transcriptional 
start site regulates bim expression, I used the ConSite software to scan the promoter for 
potential  transcription  factor  binding  sites.    The  ConSite  website  uses  phylogenetic 
footprinting and transcription factor binding profiles to detect transcription factor binding 
sites within genomic sequences (Lenhard et al., 2003).  I identified an inverted CCAAT 
box  (ICB)  that  is  located  29  base  pairs  or  54  base  pairs  upstream  from  the  major 
transcriptional  start  site  in  rat  and  human  bim,  respectively  (Figure  3.2A).    ConSite 
predicts that a number of transcription factors can bind to the ICB, including the most 
common CCAAT-binding factor, NF-Y (Figure 3.2B).  NF-Y binds with strong affinity 
to the central pentanucleotide sequence (CCAAT or ATTGG) and has a highly preferred 
5   and  3   surrounding  sequence  (Figure  3.2C).    The  16  base  pair  region  of  the  bim 
promoter, that includes the central ATTGG, is highly conserved across human, rat and 
mouse and is a near perfect match to the consensus of an NF-Y binding site (Figure 
3.2C).           
  
3.2.2  NF-Y  binds  to  the  bim  ICB  in  the  presence  of  NGF  and  following  NGF 
withdrawal.    
To investigate whether NF-Y can bind to the ICB in the bim promoter, I carried out some 
electrophoretic mobility shift assays (EMSAs) (Figure 3.3).  To identify potential NF-Y 
binding complexes, oligos containing a previously identified CCAAT box in the rat GTP 
hydrolase gene (Kapatos et al., 2000) were used as a positive control (Figure 3.3A and 
B).  Initial EMSA experiments were performed with nuclear extracts from neuronally 
differentiated  PC6-3  cells  that  had  been  treated  with  NGF  for  7  days.    The  nuclear 
extracts contained proteins that bound the ICB and this binding (marked NF-Y complex) 
was  abolished  by  point  mutations  in  the  ATTGG  consensus  (mutant  probes)  (Figure 
3.3A).  To determine whether the specific protein complexes contained NF-Y, antibodies   86 
Figure 3.2  Identification of an inverted CCAAT box in the bim promoter.  
 
(A) Alignment of the proximal promoter sequences for the rat, mouse and human bim 
genes.    The  inverted  CCAAT  box  (ICB)  is  located  29  bp  or  54  bp  upstream  of  the 
transcriptional start site in rat and human, respectively.  The asterisks indicate bases that 
are conserved across all three species. 
  
(B) Transcription factors that can potentially bind to the ICB in the human and rat bim 
promoters identified using ConSite, http://www.phylofoot.org/consite.  
 
(C) The binding profile of NF-Y to an ICB (Jaspar database, http://jaspar.gene.reg.net).  
The probability of different nucleotides at each position of an ICB, bound by NF-Y, is 
shown (where 116 NF-Y binding ICB consensus sequences were analysed, adapted from 
the Jaspar database).  An alignment between the rat, mouse and human bim genes shows 
that there is a high level of conservation in this area. 
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specific to the NF-YA subunit or to c-Jun (as a negative control) were added to the 
binding reactions.  The c-Jun antibody did not alter the binding pattern observed whereas 
the  NF-Y  antibody  supershifted  (marked  SS)  the  entire  protein  complex,  thereby 
confirming that the protein complex bound to the bim CCAAT probe was NF-Y (Figure 
3.3B).  The binding of NF-Y to the bim ICB was similar to the binding of NF-Y to the 
GTP C1 positive control probe, which behaved in an identical fashion when antibodies 
against  the  NF-Y  complex  were  added  (Figure  3.2B).    To  investigate  whether  NF-Y 
present in sympathetic neurons could bind to the bim ICB, EMSA experiments were 
performed with whole cell extracts prepared from sympathetic neurons maintained in the 
presence of NGF (+NGF) or withdrawn from NGF (-NGF) for 16 hours (Figure 3.3C).  
Extracts from sympathetic neurons maintained in the presence of NGF reproduced the 
binding pattern that was observed with extracts from differentiated PC6-3 cells in Figure 
3.3B, and binding did not change following NGF withdrawal (Figure 3.3C).  The protein 
complexes were successfully supershifted with the NF-YA antibody but not with a Fra-2 
antibody, which was used as a negative control.  It is of interest to note that when oligos 
were tested, in preliminary experiments, that were 5 nucleotides shorter at the 5  end and 
3  end than those used in Figure 3.3, no specific binding was observed.  This confirms 
that the sequences flanking the highly conserved ATTGG are required for NF-Y binding, 
consistent with previous reports (Mantovani, 1998; Bucher, 1999).  However, it is still 
not known whether these distal bases are specifically recognised by NF-Y, or are simply 
necessary for proper distortion of the DNA for NF-Y binding, or both (Romier et al., 
2003).  
    To confirm that NF-Y can bind to the endogenous bim promoter, I performed 
some chromatin immunoprecipitation (ChIP) assays using the NF-YA antibody that had 
been  used  in  EMSA  experiments,  together  with  an  antibody  against  the  myogenic 
regulatory factor MyoD as a negative control.  ChIP is a powerful method for confirming 
in  vivo  DNA  binding  sites  of  transcription  factors,  but  a  large  number  of  cells  are 
required  in  conventional  ChIP  assays,  therefore  neuronally  differentiated  PC6-3  cells 
were  used  instead  of  sympathetic  neurons.    PC6-3  cells  were  differentiated  in  the 
presence of NGF for 7 days and then either maintained in the presence of NGF (+NGF)   89 
Figure 3.3  NF-Y can bind to the ICB in the promoter of bim. 
 
(A) Oligonucleotides used for EMSA experiments.  Point mutations were introduced into 
the CCAAT box consensus sequence in order to abolish binding and therefore identify 
specific complexes.  The mutated bases are underlined.   
 
(B) EMSA comparing bim CCAAT probes to the GTP C1 positive control probes, with 
nuclear extracts from PC6-3 cells differentiated in the presence of NGF for 7 days.  An 
NF-YA antibody (H-209: Sc-10779 X) was used to supershift the NF-Y/CCAAT box 
complex and a c-Jun antibody (H-79: Sc-1694 X) was used as a negative control. 
 
(C) EMSA with bim CCAAT probes and whole cell extracts from sympathetic neurons 
maintained in the presence of NGF (+NGF) or withdrawn from NGF (-NGF) for 16 
hours.    An  NF-YA  antibody  (H-209:  Sc-10779  X)  was  used  to  supershift  the  NF-
Y/CCAAT box complex and a Fra-2 antibody (L-15: Sc-171 X) was used as a negative 
control. 
 
Several experiments were performed in each case and representative results are shown.  
Free probe and the NF-Y complexes are indicated. 
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or withdrawn from NGF (-NGF) for 16 hours.  The binding of NF-Y to the ICB in the 
bim promoter was studied by PCR amplification of the immunoprecipitated chromatin 
samples, using PCR primers that amplify a 331 base pair region surrounding the ICB 
(Figure 3.4A).  This region does not contain any other potential NF-Y binding sites.  The 
negative  control  antibody  to  MyoD,  immunoprecipitated  background  levels  of  bim 
promoter chromatin, however this was significantly enriched by the antibody against NF-
YA in cells maintained in the presence of NGF and following NGF withdrawal (Figure 
3.4B  and  C).    Therefore,  NF-Y  is  bound  to  the  ICB  in  the  rat  bim  promoter  in  the 
presence of NGF and following NGF withdrawal for 16 hours, with no significant change 
in the affinity of NF-Y binding following withdrawal of NGF. 
  
3.2.3 The ICB is critical for bim promoter function and contributes to the activation 
of bim transcription following NGF withdrawal. 
A bim-LUC reporter construct is significantly activated following withdrawal of NGF in 
microinjected sympathetic neurons (Gilley et al., 2003).  Bim-LUC consists of 2.5 kb of 
the rat bim promoter, the non-coding exon 1 and the 2.5 kb intron 1 cloned upstream of 
the firefly luciferase gene (Figure 3.5A).  To determine whether the ICB is important for 
bim promoter activity point mutations were introduced into the ATTGG pentamer, within 
our bim-LUC reporter construct (Figure 3.5A).  The point mutations within the bim-LUC 
CCAAT(-) reporter construct are the same as those incorporated into the bim CCAAT 
mutant oligos in EMSA experiments (Figure 3.3), therefore the binding of NF-Y to the 
bim promoter, in the context of bim-LUC CCAAT(-), should be abolished.  To compare 
their activity the bim-LUC and bim-LUC CCAAT(-) constructs were microinjected into 
the nuclei of sympathetic neurons, together with the control Renilla luciferase construct, 
pRL-TK.  The injected cells were then either maintained in the presence of NGF (+NGF) 
or withdrawn from NGF (-NGF) for 16 hours, after which time relative luciferase activity 
was determined by the dual luciferase assay (Gilley et al., 2003; Pajak et al., 2003).  
Mutation of the ICB resulted in an 80% decrease in basal promoter activity when bim-
LUC and bim-LUC CCAAT(-) basal levels were compared (Figure 3.5B).  Following 
NGF withdrawal for 16 hours, the bim-LUC reporter was activated significantly (Figure    92 
Figure 3.4  NF-Y is bound to the endogenous bim promoter in the presence of NGF 
and following NGF withdrawal.  
 
PC6-3  cells  were  differentiated  in  the  presence  of  NGF  for  7  days.    The  neuronally 
differentiated  cells  were  then  either  maintained  in  the  presence  of  NGF  (+NGF)  or 
withdrawn from NGF (-NGF) for 16 hours.  After 16 hours, the cells were cross-linked 
with 1% formaldehyde and chromatin immunoprecipitations were performed using the 
NF-YA antibody (H-209: Sc-10779 X) or a MyoD antibody (M-318: Sc-760 X) as a 
negative control. 
 
(A)  PCR  primers  were  designed  that  flank  the  inverted  CCAAT  box  in  the  rat  bim 
promoter (the approximate locations of forward and reverse primers are shown by the 
filled arrows). 
 
(B) ChIP samples were analysed by semi-quantitative PCR and a representative image is 
shown.  The 1Kb+ DNA ladder was used as a molecular weight marker.   
 
(C) PCR was quantitated at 25 cycles and the average amount of bim promoter DNA, 
precipitated by each antibody, was calculated. ChIP was performed 4 times and data is 
presented  as  the  mean  ±  S.E.    There  is  a  significant  increase  in  the  amount  of  bim 
promoter DNA precipitated by the NF-YA antibody in both + NGF (*) and - NGF (**) 
conditions, compared to the negative control antibody.  
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3.5B) (bim-LUC is typically activated 2 fold following NGF withdrawal, Gilley et al., 
2003).  The basal levels of the two constructs, in the presence of NGF, were then set to 1 
and the induction factors of the constructs compared (Figure 3.5C).  This comparison 
shows  that  the  mutation  of  the  ICB  significantly  decreases  the  induction  of  the  bim 
promoter following NGF withdrawal, from 2.3 fold to 1.5 fold.  Taken together, these 
results suggest that the ICB is critical for bim basal promoter activity and contributes to 
the induction of bim following NGF withdrawal in sympathetic neurons. 
 
3.2.4 NF-Y is required for bim promoter activity and its induction following NGF 
withdrawal. 
To establish whether NF-Y binding is required for bim promoter function (and not only 
an intact CCAAT box), sympathetic neurons were microinjected with the YA13 m29 
expression vector (Figure 3.6).  YA13 m29 is a dominant negative mutant of the NF-YA 
subunit (Mantovani et al., 1994).  It can bind to the other NF-Y subunits but not to DNA 
and thus acts by forming inactive trimers with NF-YB and NF-YC.  The YA13 m29 
construct was microinjected into sympathetic neurons along with guinea pig IgG (gp 
IgG), as a marker for the injected cells, and after 24 hours the cells were stained with an 
antibody  against  NF-YA  to  detect  YA13  m29  (and  endogenous  NF-YA).    NF-YA 
immunostaining was considerably brighter in the nuclei of injected cells (Figure 3.6A), 
and approximately >90% of injected cells expressed high levels of NF-YA.  Therefore, 
YA13  m29  is  efficiently  expressed  in  microinjected  sympathetic  neurons,  where  it 
localises to the nucleus.  Sympathetic neurons were then co-microinjected with YA13 
m29, or the control empty vector pSG5, along with the bim-LUC reporter and pRL-TK.  
The injected cells were either maintained in the presence of NGF (+NGF) or withdrawn 
from  NGF  (-NGF)  for  16  hours,  after  which  time  relative  luciferase  activity  was 
determined  by  the  dual  luciferase  assay  (Figure  3.6B).    Expression  of  YA13  m29 
completely obliterated the induction of bim-LUC following NGF withdrawal and caused 
a  significant  decrease  in  the  basal  level  of  bim-LUC,  compared  to  the  control  pSG5 
(Figure 3.6B).   This demonstrates that NF-Y activity is required for the activation of 
bim-LUC following NGF withdrawal in sympathetic neurons. 
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Figure 3.5  The ICB is critical for basal promoter function and contributes to the 
induction of bim transcription following NGF withdrawal. 
 
Sympathetic neurons were microinjected with bim-LUC or bim-LUC CCAAT (-) (both at 
10 ng/µl) together with pRL-TK at 5 ng/µl (to control for injection efficiency).  The cells 
were maintained in medium containing NGF (+NGF) or withdrawn from NGF (-NGF) 
for  16  hours,  after  which  time  luciferase  activity  was  measured.    Microinjection 
experiments were carried out 5 times and data is presented as the mean ± S.E. 
 
(A) Structure of the bim-LUC and bim-LUC CCAAT (-) reporter constructs.  The bim-
LUC reporter contains 2.5 kb of the rat bim promoter, the non-coding Exon 1 and the 2.5 
kb intron 1 cloned upstream of the firefly luciferase gene.  The location of conserved 
FOXO binding sites, Myb binding sites and the ICB are shown.  The bim-LUC CCAAT 
(-) construct contains 4 point mutations within the ICB consensus that were introduced by 
site-directed mutagenesis. 
 
(B) Bim-LUC is activated significantly following NGF withdrawal (**).  Mutation of the 
ICB significantly decreases the basal promoter level of bim-LUC (***). 
 
(C) The basal levels of bim-LUC and bim-LUC CCAAT (-) were normalised to 1 and the 
induction factors of the two constructs were compared.  Mutation of the ICB significantly 
decreases the induction of bim-LUC following NGF withdrawal (*). 
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Figure 3.6  NF-Y is required for bim promoter activity and its induction following 
NGF withdrawal. 
 
(A) Immunocytochemistry showing that the NF-YA dominant negative mutant, YA13 
m29, localises to the nucleus in microinjected sympathetic neurons.  Cells were injected 
with the YA13 m29 expression vector at 20 ng/µl along with 2.5 µg/µl of guinea pig IgG 
(gp IgG).  After 24 hours, neurons were fixed and then stained with Hoechst dye, to 
visualise the nuclei, and antibodies to gp IgG (to identify injected cells) and NF-YA (H-
209:  Sc-10770)  to  detect  YA13  m29.    Several  experiments  were  performed  and 
representative images are shown.  The bar represents 20 µm. 
 
(B)  Co-microinjection  of  YA13  m29  with  bim-LUC.    Sympathetic  neurons  were 
microinjected with bim-LUC at 10 ng/µl along with pRL-TK (5 ng/µl), plus YA13 m29 
or the control empty vector pSG5 at 20 ng/µl.  The cells were maintained in medium 
containing NGF (+NGF) or withdrawn from NGF (-NGF) for 16 hours, after which time 
luciferase activity was measured.  Microinjection experiments were carried out 4 times 
and data is presented as the mean ± S.E.  Bim-LUC is activated significantly following 
NGF withdrawal when co-injected with pSG5 (**).  When bim-LUC is co-injected with 
YA13 m29, there is a significant decrease in basal promoter level (*) and the induction of 
bim-LUC, following NGF withdrawal, is lost. 
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3.2.5 NF-Y activity is required for Bim expression and contributes to apoptosis in 
NGF-deprived sympathetic neurons. 
To  investigate  whether  NF-Y  activity  is  required  for  endogenous  Bim  expression  I 
studied the effect of YA13 m29 on Bim protein levels (Figure 3.7).  Sympathetic neurons 
were microinjected with the YA13 m29 construct, or the control empty vector pSG5, 
along with gp IgG as a marker.  The injected cells were either maintained in the presence 
of NGF (+NGF) or withdrawn from NGF (-NGF) for 16 hours after which time the cells 
were fixed and stained and Bim expression was visualised with an anti-Bim antibody.  
Bim  is  present  in  the  cytoplasm  at  low  levels  in  the  presence  of  NGF,  but  strongly 
increases in level following NGF withdrawal (Figure 3.7A).  Following NGF deprivation 
almost 60% of the cells expressed high Bim levels, when injected with the control pSG5 
(Figure 3.7B).  However, when the cells were injected with the YA13 m29 construct the 
number of cells expressing high levels of Bim was significantly reduced to 10% (Figure 
3.7B).  Therefore, when NF-Y activity is inhibited by over-expression of the dominant 
negative NF-YA subunit, YA13 m29, endogenous Bim expression is markedly reduced. 
Finally, to investigate the role of NF-Y in programmed cell death, sympathetic 
neurons were microinjected with the YA13 m29 construct, or the control pSG5, together 
with Texas red dextran (as a marker for the injected cells).  The neurons were then either 
maintained in the presence of NGF (+NGF) or withdrawn from NGF (-NGF).  Following 
NGF withdrawal the number of viable injected cells was counted at time 0, 24, 48 and 72 
hours.    Cells  were  considered  viable  if  they  were  morphologically  normal  and  still 
retained Texas red dextran in the nucleus (Figure 3.8A).  Cell death kinetics are shown in 
Figure 3.8B.  There was no significant difference between neurons microinjected with 
YA13 m29 or pSG5, when the cells were maintained in the presence of NGF, although 
there  was  a  trend  towards  more  cell  death  with  the  YA13  m29  expression  vector.  
Following NGF withdrawal, the number of viable cells injected with the pSG5 control 
was below 20% at 72 hours, this is consistent with previous studies (Whitfield et al., 
2001;  Gilley  et  al.,  2003).    Cells  that  were  injected  with  YA13  m29  were  partially 
protected from cell death at 48 and 72 hours following NGF withdrawal.  The number of 
viable cells injected with YA13 m29 at 72 hours following NGF withdrawal was almost  
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Figure 3.7  NF-Y activity is required for expression of the endogenous Bim protein. 
 
(A)  Immunocytochemistry  showing  that  YA13  m29  reduces  Bim  expression  in 
microinjected sympathetic neurons.  Cells were injected with the YA13 m29 construct or 
the control empty vector pSG5 at 20 ng/µl along with 2.5 µg/µl of guinea pig IgG (gp 
IgG).  The cells were maintained in medium containing NGF (+NGF) or withdrawn from 
NGF (-NGF) for 16 hours.  Following NGF withdrawal, neurons were fixed and then 
stained with Hoechst dye, to visualise the nuclei, and antibodies to gp IgG (to identify 
injected cells) and Bim (Cell Signalling #2819).  In the presence of NGF cells either 
expressed  no  Bim  protein  or  low  levels  of  Bim  protein,  whereas  following  NGF 
withdrawal  many  cells  expressed  high  levels  of  Bim  protein.    Therefore,  cells  were 
scored as no/low Bim staining (comparable to +NGF conditions) or high Bim staining. 
The orange arrow indicates a sympathetic neuron injected with pSG5 that is expressing 
high levels of Bim protein.  The white arrow indicates a sympathetic neuron injected with 
YA13  m29  that  is  expressing  low  levels  of  Bim  protein.   Representative  images  are 
shown.  The bar represents 20 µm. 
 
(B)  Quantitation  of  immunocytochemistry  in  Figure  3.7A.    Immunocytochemistry 
experiments  were  carried  out  6  times  and  data  is  presented  as  the  mean  ±  S.E.  
Microinjection  of  the  YA13  m29  construct  significantly  decreases  Bim  expression 
following NGF withdrawal compared to the control pSG5 (**).    
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2-fold  that  of  the  control  (Figure  3.8C).    This  data  provides  evidence  that  NF-Y  is 
important for cell death in NGF-deprived sympathetic neurons. 
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Figure 3.8  NF-Y activity contributes to cell death following NGF withdrawal in 
sympathetic neurons. 
 
Sympathetic neurons were injected with the YA13 m29 construct or the control empty 
vector pSG5 at 200 ng/µl, along with 5 µg/µl of Texas red dextran as a marker for 
injected  cells.    The  cells  were  maintained  in  medium  containing  NGF  (+NGF)  or 
withdrawn from NGF (-NGF).  Following withdrawal of NGF, the number of viable, 
morphologically-normal, injected cells was determined at time 0, 24, 48 and 72 hours.  
Viable cells were counted in a blinded manner.  
 
(A) Examples of sympathetic neurons injected with pSG5, along with Texas red dextran, 
and either maintained in medium containing NGF (+NGF) or withdrawn from NGF (-
NGF) for 48 hours.  The bar represents 10 µm. 
 
(B) The number of viable injected cells at time 0, 24, 48 and 72 hours following NGF 
withdrawal.  Cell survival assays were carried out 4 times and data is presented as the 
mean ± S.E. 
 
(C) The number of viable injected cells at 72 hours following NGF withdrawal (as in 
Figure  3.8B).    Microinjection  of  the  YA13  m29  construct  significantly  increases  the 
percentage of viable cells at 72 hours -NGF compared to the control pSG5 (*).    
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3.3 Discussion 
In  sympathetic  neurons  the  level  of  bim  RNA  increases  substantially  following  NGF 
withdrawal, reaching a peak at 16 hours minus NGF (Whitfield et al., 2001; Gilley et al., 
2003).  I have shown that the bim promoter proximal to the major transcriptional start site 
contains a conserved inverted CCAAT box (ICB) that is bound by the transcription factor 
NF-Y.    To  investigate  whether  the  ICB  is  functionally  important,  I  microinjected 
sympathetic neurons with a previously characterised bim-LUC reporter construct (Gilley 
et  al.,  2003),  and  a  construct  in  which  the  ICB  consensus  was  mutated,  bim-LUC 
CCAAT (-).  These experiments provide evidence that the ICB is critical, in the context 
of the bim-LUC reporter construct, for the basal function of the rat bim promoter.  Even 
though there was an 80% decrease in the basal promoter activity when the ICB was 
mutated, the bim promoter is still functionally active, since in preliminary experiments I 
found that when I overexpressed constitutively active FOXO3a in the presence of NGF, 
the bim-LUC CCAAT (-) construct was still efficiently activated (bim-LUC CCAAT (-): 
2.4 fold induction; bim-LUC: 2.3 fold induction, n=3, unpublished data).  This is the first 
bim promoter element that has been shown to be important for basal promoter function 
and since the bim promoter does not contain a TATA box, it is likely that the NF-Y-
binding-ICB plays an important role in pre-initiation complex assembly as reported for 
other TATA-less promoters (Bellorini et al., 1997; Frontini et al., 2002; Kabe et al., 
2005).    Also,  microinjection  experiments  showed  that  the  ICB  contributes  to  bim 
activation following NGF withdrawal.  Therefore, there are now a number of promoter 
elements including the ICB, the FOXO sites, the Myb sites and a number of AP1 sites (R. 
Randall, J. Gilley, R. Hughes and J. Ham, unpublished data) that are important for bim 
activation  following  NGF  withdrawal.    Whether  these  promoter  elements  somehow 
cooperate for full activation of bim is explored in the next chapter. 
    The heterotrimeric transcription factor NF-Y has so far been identified as a key 
regulator of a number of genes, most commonly those involved in the cell cycle (Hu and 
Maity, 2000; Bhattacharya et al., 2003).  To establish whether NF-Y activity is required 
for  bim  promoter  function,  sympathetic  neurons  were  microinjected  with  a  dominant 
negative mutant of the NF-YA subunit, YA13 m29 (Mantovani et al., 1994).  The YA13 
m29 expression vector has been used in a number of studies to inhibit NF-Y activity (Su   106 
et al., 2005; Di Agostino et al., 2006; Xu et al., 2006; Benatti et al., 2008).  The YA13 
m29  construct  was  co-microinjected  into  sympathetic  neurons  where  it  significantly 
decreased  bim  basal  promoter  activity.    Furthermore,  expression  of  YA13  m29 
completely  abolished  activation  of  our  bim-LUC  reporter  construct  following  NGF 
withdrawal.  It is interesting that when NF-Y activity is inhibited, the induction of bim-
LUC following NGF deprivation is completely lost, whereas mutating the ICB, in the 
context of bim-LUC, simply reduces the fold activation of the construct.  Around 30% of 
eukaryotic promoters harbour CCAAT box elements in their promoters and it is likely 
that many of these bind NF-Y (Bucher 1990; Mantovani 1999).  Therefore, expression of 
YA13 m29 could affect any NF-Y-binding CCAAT boxes located in other genes that are 
activated following NGF withdrawal and there may even be additional CCAAT boxes in 
the bim gene, located outside of the proximal promoter.   
In  addition  to  the  effect  on  the  bim-LUC  reporter  construct,  YA13  m29 
expression  almost  completely  inhibits  Bim  protein  expression  following  NGF 
withdrawal.    Therefore,  NF-Y  activity  is  critical  for  endogenous  Bim  expression  in 
sympathetic  neurons.    Importantly,  expression  of  YA13  m29  partially  protects 
sympathetic neurons from NGF-withdrawal induced apoptosis.  The level of protection 
seen by inhibiting NF-Y activity is similar to the effect of a complete bim knockout on 
neuronal survival.  Whitfield et al. (2001) isolated sensory neurons from bim
-/- mice and 
at 48 hours after NGF deprivation only 10% of the wild type cells were viable, compared 
to almost 40% of the bim
-/- cells.  Additionally, Coultas et al. (2007) isolated sympathetic 
neurons from bim
-/- mice and they found that the number of viable cells following NGF 
deprivation  corroborated  this  data.    Here,  inhibition  of  NF-Y  activity  almost  entirely 
reproduces this effect, with almost 40% of cells surviving at 72 hours following NGF 
withdrawal.  This partial protection is probably due to the fact that the other BH3-only 
proteins  that  increase  in  level  after  NGF  withdrawal,  Puma  and  DP5,  can  partially 
compensate for the loss of Bim (Putcha and Johnson 2004; Ham et al., 2005).  This idea 
is supported by the observation that knockout of the puma gene alone has a similar effect 
to the loss of Bim (Wyttenbach and Tolkovsky, 2006). Importantly, my data indicates 
that NF-Y is a significant regulator of apoptosis in sympathetic neurons.   107 
  Interestingly, ChIP experiments showed that NF-Y is bound to the bim promoter 
in the presence of NGF and following NGF withdrawal, with no apparent change in 
binding affinity for the ICB.  This suggests that NF-Y may activate the transcription of 
bim by recruiting other DNA binding transcription factors or transcriptional co-factors 
that  are  regulated  by  NGF.    For  example,  following  withdrawal  of  NGF,  FOXO3a 
translocates from the cytoplasm into the nucleus and binds to the two conserved FOXO 
sites (Fig 3.9; Gilley et al., 2003).  This hypothesis will be addressed in the next chapter.  
Inhibition  of  NF-Y  activity  reproduces  the  loss  of  bim  activation  that  is 
observed, following NGF withdrawal, when the two conserved FOXO sites or the two 
Myb  sites  are  mutated  (Gilley  et  al.,  2003;  Biswas  et  al.,  2005).    In  addition,  the 
overexpression of a dominant negative c-Jun protein and the mutation of a number of 
AP1  sites  in  the  bim  promoter  also  abolish  the  activation  of  bim  following  NGF 
withdrawal (Whitfield et al., 2001; Randall et al., unpublished data).  Taken together, 
these  findings  indicate  that  each  of  the  promoter  elements  and  their  transcriptional 
activators  are  necessary,  but  not  sufficient,  for  the  activation  of  bim  in  neurons.  
Activation of individual pathways is sufficient for bim induction, but under physiological 
conditions,  following  NGF  withdrawal,  induction  of  multiple  proapoptotic  pathways 
appears to be essential.  For example, when bim expression is induced following the 
inhibition of PI3-K activity (resulting in FOXO activation), or by the overexpression of 
Mybs, bim levels are considerably less than that following NGF withdrawal (Gilley et al., 
2003; Biswas et al., 2005).  The lack of redundancy that is displayed between activating 
pathways  is  yet  another  means  by  which  bim  expression  is  stringently  regulated  in 
neurons. 
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Figure  3.9  Model  of  the  transcriptional  activation  of  the  bim  promoter  in 
sympathetic neurons.   
 
The transcription factors that bind to the bim proximal promoter in sympathetic neurons.  
The NF-Y trimer is bound to the ICB.  However, this can be inhibited by the dominant 
negative mutant YA13 m29.  Following NGF withdrawal, FOXO3a translocates into the 
nucleus  and  binds  to  the  two  FOXO  sites,  thereby  contributing  to  activation  of  bim 
transcription  (Gilley  et  al.,  2003).    Loss  of  NF-Y  activity  inhibits  activation  of  bim 
transcription  following  NGF  withdrawal  and  partially  protects  sympathetic  neurons 
against cell death. 
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Chapter 4: The role of CBP/p300 in activating bim 
gene expression in sympathetic neurons. 
 
4.1 Introduction 
Transcriptional  control  of  bim  involves  at  least  three  signalling  pathways  in 
sympathetic neurons.  The prosurvival PI3-K/Akt pathway inhibits bim transcription in 
the presence of NGF by phosphorylating FOXO3a and thereby preventing its nuclear 
translocation (Gilley et al., 2003).  The proapoptotic JNK/c-Jun pathway also activates 
bim transcription following NGF withdrawal although the precise mechanism remains to 
be established (Harris and Johnson, 2001; Whitfield et al., 2001; Besirli et al., 2005).  In 
addition the CDK4/Rb/E2F/Myb pathway contributes to bim activation following NGF 
deprivation (Biswas et al., 2005).  Finally, in the previous chapter I identified an inverted 
CCAAT box (ICB) in the bim proximal promoter that is bound by the transcription factor 
NF-Y.  I found that the NF-Y-binding-CCAAT box is essential for bim basal promoter 
activity  and  expression  of  the  YA13  m29  mutant  protein  inhibits  activation  of  bim 
transcription  and  reduces  Bim  protein  expression  following  NGF  withdrawal.    Thus, 
inhibition of NF-Y activity increased survival of NGF-deprived sympathetic neurons.  It 
is clear that NF-Y is necessary for bim activation following NGF withdrawal, but the 
mechanism by which NF-Y functions, and is regulated in this context, has yet to be 
elucidated, since NF-Y is bound to the ICB in the presence and absence of NGF.  
  The  transcriptional  activation  of  a  promoter  can  require  the  assembly  of  a 
number of regulatory multiprotein complexes, often involving the global transcriptional 
coactivators  CBP/p300.    CREB-binding  protein  (CBP)  and  p300  are  two  distinct  but 
highly homologous proteins that play a critical role in the transcriptional activation of a 
multitude of target genes.  Studies have shown that p300 and CBP perform overlapping 
and unique functions.  Mice completely lacking p300 or CBP and mice with one null 
p300 allele and one null cbp allele die during embryogenesis (Yao et al., 1998; Tanaka et 
al., 2000).  This suggests that the total amount of p300 and CBP is important during 
development and that p300 and CBP are present in the cell at limiting concentrations.  
Therefore  a  relatively  small  decrease  in  the  concentration  of  CBP/p300  can  be   110 
deleterious, for example in the human Rubinstein-Taybi syndrome where loss of one cbp 
allele  results  in  developmental  defects  (Petrij  et  al.,  1995).    In  addition  to  this,  it  is 
apparent  that  CBP  and  p300  have  unique  cellular  functions  in  some  systems.    For 
example,  cbp
+/-  mice  show  a  number  of  multilineage  defects  in  haematopoietic 
differentiation, which are not found in p300
+/- mice (Kung et al., 2000; Kasper et al., 
2006).  CBP/p300 have been implicated in a wide range of cellular processes such as 
proliferation and cell cycle control (Giles et al., 1998; Goodman and Smolik, 2000).  
Studies have also highlighted the importance of CBP/p300 in programmed cell death, 
with  an  emphasis  on  p53-dependent  apoptosis.    For  example,  the  expression  of  the 
adenovirus E1A oncoprotein, which targets CBP/p300, or the expression of a dominant-
negative version of p300, inhibits p53-dependent apoptosis (Avantaggiati et al., 1997; Gu 
et al., 1997).  Furthermore, a number of reports have described p300 and cbp as tumour 
suppressor genes, and the disruption of either p300 or cbp is associated with a range of 
human malignancies from leukaemias to solid tumours (Iyer et al., 2004).   
 CBP and p300 are universal transcriptional coactivators.  They can interact with 
over 350 viral and mammalian proteins of which 196 are encoded by essential genes in 
mice (Kasper et al., 2006).  For instance, CBP/p300 can interact with c-Jun and the Myb 
proteins  (Lee  et  al.,  1996;  Giordano  and  Avantaggiati,  1999;  Bessa  et  al.,  2001).  
CBP/p300 stimulate target gene expression, following their recruitment to promoters by 
DNA binding transcription factors, through a number of different mechanisms.  They can 
act  as  a  ‘bridge’  to  connect  sequence-specific  transcription  factors  to  the  basal 
transcription machinery (Shikama et al., 1997; Chan and La Thangue, 2001).  The large 
size of CBP and p300 allows multiple proteins to bind to them simultaneously, thereby 
facilitating their role as a ‘scaffold’ for different components of a transcriptional multi-
protein  complex.    A  well-characterised  example  is  the  interferon-beta  (IFN- ) 
enhanceosome.  Here, regulatory proteins including c-Jun/ATF-2 and NFkB are recruited 
to  the  IFN-   promoter  where  they  create  a  stereospecific  interaction  surface  for  the 
recruitment of CBP/p300 and the basal transcription machinery (Kim et al., 1998; Merika 
et al., 1998; Wathelet et al., 1998; Yie et al., 1999).  The formation of this stable complex 
promotes pre-initiation complex formation and allows multiple rounds of transcription to 
proceed (Kim et al., 1998; Merika et al., 1998; Wathelet et al., 1998; Yie et al., 1999).    111 
Thirdly,  CBP/p300  possess  intrinsic  histone  acetyltransferase  (HAT)  activity,  thereby 
linking transcription and chromatin remodelling.  CBP/p300 can acetylate the four core 
histones (Bannister and Kouzarides, 1996; Ogryzko et al., 1996; Das et al., 2009), but in 
addition to chromatin it seems that the major targets of acetylation by CBP/p300 are 
transcription factors (Li et al., 1998; Martinez-Balbas et al., 1998; Shikama et al., 2000).  
The list of transcription factors known to be acetylated by CBP/p300 is expanding and it 
has been shown that acetylation usually increases the DNA binding activity of the target 
protein (Soutogloou et al., 2000; Inoue et al., 2007).  For example, NF-Y can recruit p300 
and is itself a target for acetylation by the coactivator (Faniello et al., 1999; Li et al., 
1998).  FOXO3a can also interact with p300 and is acetylated by p300, but only when 
FOXO3a is in a dephosphorylated state (Mahmud et al., 2002; Perrot and Rechler, 2005).  
  CBP and p300 play a critical role as integrators of multiple signal transduction 
pathways  within  the  nucleus,  yet  relatively  little  is  understood  concerning  their 
regulation.  CBP/p300 are phosphoproteins and their phosphorylation appears to be under 
the control of the cell cycle, also both proteins contain protein kinase A (PKA) sites that 
contribute to their regulation (Yang et al., 1996; Perkins et al., 1997; Ait-Si-Ali et al., 
1998; Xu et al., 1998).  More recent findings have suggested that CBP/p300 become 
hyper-phosphorylated  upon  cellular  stress,  for  example  under  hypoxic  conditions 
(Zakrzewska et al., 2005). 
  CBP/p300 can activate the transcription of a multitude of target genes.  Since 
they can interact with the different regulatory factors, Myb, c-Jun, NF-Y and FOXO3a, 
that  govern  bim  promoter  activation,  I  was  interested  to  establish  whether  they  are 
important for bim activation following NGF withdrawal in sympathetic neurons.  
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4.2 Results 
4.2.1  CBP  and  p300  are  localised  to  the  nucleus  of  sympathetic  neurons  in  the 
presence of NGF and following NGF withdrawal. 
To investigate if CBP and p300 are important for activation of the bim promoter, I first 
had  to  confirm  that  they  are  expressed  in  sympathetic  neurons.    I  carried  out 
immunocytochemistry experiments on sympathetic neurons that were either maintained 
in the presence of NGF or deprived of NGF for 16 hours.  CBP and p300 localise to the 
nucleus of sympathetic neurons where they stained brightly in the presence of NGF and 
following NGF withdrawal with no apparent change in expression level (Figure 4.1A and 
B).  Approximately 95% of sympathetic neurons expressed high levels of CBP and p300 
(in +NGF and -NGF conditions).  CBP and p300 were not present in the nucleolus of 
sympathetic neurons (Figure 4.1A and B).  This staining pattern was also observed by 
Mikecz et al. (2000) who used the same p300 (C-20: Sc-585) and CBP (C-20: Sc-583) 
antibodies to study the co-localisation of CBP and p300 at RNA polymerase II-rich sites 
within the nucleus of different cell lines and found that nuclear substructure localisation 
of CBP/p300 is restricted to PML (promyelocytic leukaemia) protein-containing domains 
(Mikecz et al., 2000). 
I  also  carried  out  some  control  immunocytochemistry  experiments  using 
sympathetic neurons to confirm that in the absence of a primary antibody (secondary-
only  control)  there  was  no  specific  staining  (Figure  4.1C).    This  is  an  important 
experiment  as  I  have  used  the  same  FITC-conjugated  secondary  antibody  for  all 
immunocytochemistry experiments in this study. 
 
4.2.2 The ICB is required for activation of the bim promoter by p300. 
I have hypothesised that for efficient activation of the bim promoter the coactivators CBP 
and/or p300 may be required.  Furthermore, studies with p300 and CBP knockout mice 
have suggested that p300 and CBP are present at limiting concentrations in cells (Yao et 
al., 1998; Tanaka et al., 2000).  Therefore, if my hypothesis is correct, overexpression of 
p300  or  CBP  should  activate  the  bim  promoter.    Sympathetic  neurons  were  co-
microinjected with pRc/RSV-mCBP or the control empty vector pBJ9 , or CMVp300 or    113 
Figure 4.1  CBP and p300 are expressed in sympathetic neurons. 
 
(A) Immunocytochemistry showing that CBP is expressed in sympathetic neurons where 
it localises to the nucleus.  Neurons were maintained in medium containing NGF (+NGF) 
or withdrawn from NGF (-NGF) for 16 hours, after which time the cells were fixed and 
then stained with Hoechst dye, to visualise the nuclei, and an antibody to CBP (C-20: Sc-
583).  
 
(B) Immunocytochemistry showing that p300 is expressed in sympathetic neurons where 
it localises to the nucleus.  Neurons were maintained in medium containing NGF (+NGF) 
or withdrawn from NGF (-NGF) for 16 hours, after which time the cells were fixed and 
then stained with Hoechst dye, to visualise the nuclei, and an antibody to p300 (C-20: Sc-
585).  
 
(C) Immunocytochemistry control showing that there is no specific staining observed in 
the absence of a primary antibody.  Neurons were maintained in medium containing NGF 
(+NGF)  and  then  fixed  and  stained  with  Hoechst  dye,  to  visualise  the  nuclei,  and  a 
secondary antibody without the prior addition of a primary antibody.  
 
Several experiments were performed in each case and representative images are shown.  
The bar represents 20 µm. 
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the  control  empty  vector  pcDNA3.1,  together  with  the  bim-LUC  reporter  construct 
(Figure 4.2A).   Bim-LUC was significantly activated by overexpression of CBP or p300 
(Figure 4.2A).  To determine if the inverted CCAAT box (ICB) in the bim promoter, 
studied  in  Chapter  3,  is  important  for  activation  of  bim  by  CBP/p300,  sympathetic 
neurons were co-microinjected with CMVp300, or the control empty vector pcDNA3.1, 
along with the bim-LUC CCAAT (-) construct (Figure 4.2B).  Overexpression of p300 
did not activate bim-LUC CCAAT (-) (Figure 4.2B).  Therefore, the ICB must be intact 
for p300 to activate the bim-LUC reporter construct. 
 
4.2.3 CBP and p300 are important for activation of the bim promoter in sympathetic 
neurons.  
It has been demonstrated previously that the microinjection of specific antibodies can be 
used as a suitable alternative to conventional protein knockdown techniques (Arias et al., 
1994; Towers et al., 2009).  I co-injected antibodies specific to p300 or CBP together 
with the bim-LUC reporter construct to determine whether CBP or p300 are required for 
bim promoter activation (Figure 4.3).  Bim-LUC was not significantly activated following 
NGF withdrawal when antibodies against p300 or CBP were co-injected, compared to the 
control rabbit IgG.  This suggests that both p300 and CBP are important for efficient 
activation of the bim promoter following NGF withdrawal in sympathetic neurons.  
 
4.2.4  Binding  of  CBP  and  p300  to  the  bim  promoter  increases  after  NGF 
withdrawal.  
To confirm that p300 and CBP can bind to the endogenous bim promoter, I performed 
some chromatin immunoprecipitation (ChIP) assays using the p300 and CBP antibodies 
that had been used in antibody co-injection experiments, along with antibodies against 
MyoD and Bim as negative controls.  PC6-3 cells were differentiated in the presence of 
NGF for 7 days and then either maintained in the presence of NGF (+NGF) or withdrawn 
from NGF (-NGF) for 16 hours.  The binding of p300 or CBP to the bim proximal 
promoter  was  studied  by  PCR  amplification  of  the  immunoprecipitated  chromatin 
samples (Figure 4.4).  The PCR primers previously used to study the binding of NF-Y to 
the ICB were also used for p300 and CBP: they amplify a 331 base pair region of the bim    116 
Figure 4.2  The ICB is required for activation of the bim promoter by p300. 
 
(A) Co-microinjection of CMVp300 or pRc/RSV-mCBP with bim-LUC.  Sympathetic 
neurons were microinjected with bim-LUC at 10 ng/µl and pRL-TK at 5 ng/µl, along 
with CMVp300 or the control empty vector pcDNA3.1 at 50 ng/µl, or pRc/RSV-mCBP 
or  the  control  empty  vector  pBJ9Ω  at  50  ng/µl.    Following  injection  the  cells  were 
maintained in medium containing NGF overnight, after which time luciferase activity 
was measured.  Microinjection experiments were carried out 4 times and data is presented 
as the mean ± S.E.  Co-microinjection of CMVp300 induces a significant activation of 
bim-LUC  (**).    Co-microinjection  of  pRc/RSV-mCBP  also  induces  a  significant 
activation of bim-LUC (*). 
 
(B)  Co-microinjection  of  CMVp300  with  bim-LUC  or  bim-LUC  CCAAT(-).  
Sympathetic neurons were microinjected with bim-LUC or bim-LUC CCAAT (-) at 10 
ng/µl  and  pRL-TK  at  5  ng/µl,  along  with  CMVp300  or  the  control  empty  vector 
pcDNA3.1  at  50  ng/µl.    Following  injection  the  cells  were  maintained  in  medium 
containing  NGF  overnight,  after  which  time  luciferase  activity  was  measured.  
Microinjection experiments were carried out 5 times and data is presented as the mean ± 
S.E.  Co-microinjection of CMVp300 induces a significant activation of bim-LUC (**).  
Co-microinjection  of  CMVp300  does  not  activate  bim-LUC  CCAAT  (-).    As  shown 
previously (Figure 3.4), bim-LUC CCAAT (-) has a significantly lower basal promoter 
level compared to bim-LUC (***). 
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Figure 4.3  CBP and p300 are required for efficient activation of bim-LUC following 
NGF withdrawal. 
 
Co-injection  of  p300  or  CBP  antibodies  with  bim-LUC.    Sympathetic  neurons  were 
microinjected with bim-LUC at 10 ng/µl and pRL-TK at 5 ng/µl, together with the p300 
(C-20: Sc-585 X) or CBP (C-20: Sc-583 X) antibodies or rabbit IgG as a control, each at 1 
µg/µl.  The cells were maintained in medium containing NGF (+NGF) or withdrawn from 
NGF  (-NGF)  for  16  hours,  after  which  time  luciferase  activity  was  measured.  
Microinjection experiments were carried out 6 times and data is presented as the mean ± 
S.E.  Bim-LUC is activated significantly following NGF withdrawal when co-injected 
with rabbit IgG (***).  Bim-LUC is not activated significantly when co-injected with the 
p300 and CBP antibodies.  There is a significant decrease in the induction of bim-LUC 
following NGF withdrawal when co-injected with the p300 antibody (*) and the CBP 
antibody (*), compared to the control rabbit IgG.  
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proximal promoter that includes the ICB (Figure 3.3A).  The negative control antibodies, 
MyoD and Bim, immunoprecipitated background levels of bim promoter chromatin in the 
presence and absence of NGF.  In the presence of NGF, there was some binding of p300 
and  CBP  to  the  bim  promoter  but  this  was  significantly  enriched  following  NGF 
withdrawal (Figure 4.4A and B).  Therefore, p300 and CBP are bound to the same region 
of the bim promoter as NF-Y and the affinity of this interaction increases following NGF 
withdrawal.  Since the coactivators CBP and p300 do not contact the DNA directly, they 
must bind via proteins that are already bound to the bim promoter.  We already know that 
mutation of the ICB abolishes the activation of the bim-LUC reporter by p300 (Figure 
4.2) and that NF-Y is bound to the bim promoter in the presence and absence of NGF 
(Figure 3.3).  Taken together, this data suggests that CBP/p300 may activate the bim 
promoter through protein-protein interactions with NF-Y bound to the ICB.   
 
4.2.5  NF-Y  can  bind  to  CBP/p300  in  the  presence  of  NGF  or  following  NGF 
withdrawal. 
To confirm that NF-Y interacts with CBP/p300 in extracts from NGF-dependent cells, 
some co-immunoprecipitation (Co-IP) experiments were carried out (Figure 4.5).  These 
were performed by Dr. Mark Kristiansen in our group.  Nuclear extracts were prepared 
from  PC6-3  cells  differentiated  in  the  presence  of  NGF  for  7  days  and  then  either 
maintained in the presence of NGF (+NGF) or withdrawn from NGF (-NGF) for 16 
hours.    Initially,  +NGF  and  -NGF  nuclear  extracts  were  immunoprecipitated  with 
antibodies against p300, CBP, NF-YA or rabbit IgG.  Immunoblots were then carried out 
using an antibody against NF-YA (Figure 4.5A).  There was a large amount of NF-YA 
protein detected in the input control lanes and with the immunoprecipitate from the NF-
YA  antibody.    However,  there  was  also  NF-YA  protein  precipitated  with  antibodies 
against  p300  and  CBP,  compared  to  the  control  rabbit  IgG  (Figure  4.5A).    The 
experiment was then repeated by immunoprecipitating nuclear extracts with p300, CBP, 
NF-YA or rabbit IgG and then immunoblotting with antibodies against p300 or CBP 
(Figure 4.5B).  There was a considerable amount of p300 or CBP protein present in the 
input control samples and this was easily detected in the immunoprecipitates from p300 
or CBP, respectively.  However, there was also p300 and CBP protein precipitated with   120 
Figure 4.4  The binding of CBP and p300 to the bim promoter increases after NGF 
withdrawal.  
 
(A) PC6-3 cells were differentiated in the presence of NGF for 7 days.  The neuronally 
differentiated  cells  were  then  either  maintained  in  the  presence  of  NGF  (+NGF)  or 
withdrawn from NGF (-NGF) for 16 hours.  After 16 hours, the cells were cross-linked 
with 1% formaldehyde and chromatin immunoprecipitations were performed using the 
p300 (C-20: Sc-585 X) or CBP (C-20: Sc-583 X) antibodies.  Negative control reactions 
were  carried  out  with  a  Bim ( AB17003)  antibody  and  a  MyoD  (M-318:  Sc-760  X) 
antibody, respectively.  ChIP samples were analysed by semi-quantitative PCR and a 
representative image is shown.  The 1Kb+ DNA ladder was used as a molecular weight 
marker.   
 
(C) PCR was quantitated at 28 cycles and the average amount of bim promoter DNA, 
precipitated by each antibody, was calculated.  ChIP was performed 3 times and data is 
presented  as  the  mean  ±  S.E.    There  is  a  significant  increase  in  the  amount  of  bim 
promoter DNA precipitated by the p300 (**) and the CBP (*) antibodies following NGF 
withdrawal (-NGF), compared to in the presence of NGF (+NGF). 
 
 
 
 
 
 
   121 
A 
                    
                     
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   122 
the  NF-YA  antibody,  compared  to  the  control  rabbit  IgG  (Figure  4.5B).    There  also 
appears to be a modest increase in the affinity of p300 and CBP for NF-Y and of NF-Y 
for  p300  and  CBP  following  NGF  withdrawal  (Figure  4.5A  and  B).    These  results 
demonstrate that NF-Y interacts with CBP and p300 in vitro in the presence of NGF and 
following NGF withdrawal. 
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Figure 4.5  NF-Y can bind to CBP/p300 in the presence of NGF or following NGF 
withdrawal. 
 
(A)  Co-immunoprecipitation  of  NF-Y  with  antibodies  against  p300  and  CBP, 
respectively.    Nuclear  extracts  were  prepared  from  PC6-3  cells  differentiated  in  the 
presence of NGF for 7 days and then either maintained in the presence of NGF (+NGF) 
or  withdrawn  from  NGF  (-NGF)  for  16  hours.    The  nuclear  extracts  were 
immunoprecipitated with antibodies against p300 (C-20: Sc-585), CBP (C-20: Sc-583), 
NF-YA (H-209: Sc-10779) or rabbit IgG.  Immunoblots were then carried out on the 
precipitated  samples  using  an  antibody  against  NF-YA  (H-209:  Sc-10779).    Total 
ERK1/2 was used as a loading control (ERK1/2 antibody from Cell Signalling #9102).  
Several experiments were performed and representative blots are shown.  
 
(B) Co-immunoprecipitation of p300 and CBP with an antibody against NF-Y.  Nuclear 
extracts were prepared from PC6-3 cells differentiated in the presence of NGF for 7 days 
and then either maintained in the presence of NGF (+NGF) or withdrawn from NGF (-
NGF)  for  16  hours.    The  nuclear  extracts  were  immunoprecipitated  with  antibodies 
against p300 (C-20: Sc-585), CBP (C-20: Sc-583), NF-YA (H-209: Sc-10779) or rabbit 
IgG.  Immunoblots were then carried out on the precipitated samples using an antibody 
against p300 (C-20: Sc-585) or CBP (C-20: Sc-583), respectively.  Total ERK1/2 was 
used  as  a  loading  control  (ERK1/2  antibody  from  Cell  Signalling  #9102).    Several 
experiments were performed and representative blots are shown.  
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4.3 Discussion 
I originally hypothesised that the coactivators CBP/p300 may be important for efficient 
activation  of  the  bim  promoter  following  NGF  withdrawal  in  sympathetic  neurons.  
Initially, I demonstrated that CBP and p300 are expressed in sympathetic neurons where 
they localise to the nucleus.  There is no apparent change in the expression level of the 
proteins following NGF withdrawal, but since CBP and p300 are global coactivators then 
it is likely that they are involved in a number of transcriptional pathways in sympathetic 
neurons.  It is therefore not surprising that there is no change in total protein levels when 
cells are deprived of NGF.  I then overexpressed p300 or CBP in sympathetic neurons 
and found that this is sufficient to activate the bim-LUC reporter construct.  Interestingly, 
overexpression  of  p300  does  not  activate  the  bim-LUC  CCAAT(-)  construct,  thereby 
demonstrating that p300 requires the CCAAT box to be intact in order to activate bim 
transcription.  Furthermore, in Chapter 3 I demonstrated that the mutated CCAAT box 
cannot bind NF-Y, so these results indicated that there may be an interaction between 
NF-Y and p300/CBP.  In addition, a number of other studies have reported that NF-Y can 
recruit p300/CBP to the proximal promoters of different genes (Li et al., 1998; Franiello 
et al., 1999). 
  To  further  study  the  role  of  p300/CBP  in  this  context,  I  performed  some 
antibody co-injection experiments.  Loss of p300 or CBP by the injection of specific 
antibodies  significantly  decreases  the  activation  of  the  bim-LUC  reporter  construct 
following  NGF  withdrawal,  indicating  that  p300  and  CBP  are  important  for  efficient 
activation  of  the  bim  promoter  following  NGF  withdrawal  in  sympathetic  neurons.  
Again, as with NF-Y, it is possible that inhibition of CBP and p300 may have non-
specific effects in sympathetic neurons, as the loss of CBP and p300 is likely to affect 
other promoters as well as bim.  Nevertheless, this data indicates that CBP/p300 may play 
an important role in neuronal apoptosis induced by activation of the proapoptotic bim 
gene. 
   ChIP experiments were then performed and this data confirms that p300 and 
CBP can bind to the same region of the bim promoter as NF-Y, and that binding of both 
p300 and CBP increases significantly following NGF withdrawal.  The ChIP method that   126 
I have used has a long cross-linking time of 3 hours at room temperature.  Therefore, 
proteins bound to proteins can be immunoprecipitated along with proteins bound to DNA.  
Since CBP and p300 do not contact the DNA directly, they must bind via proteins that are 
already  bound  to  the  bim  promoter  in  this  location.    As  the  ICB  must  be  intact  for 
activation  of  bim  by  p300  then  this  data  suggests  that  p300/CBP  activates  the  bim 
promoter directly through NF-Y.  As further evidence to support this hypothesis, co-IP 
experiments demonstrate that NF-Y can interact with p300 and CBP in nuclear extracts 
from neuronally differentiated PC12 cells.   
  Following NGF withdrawal, FOXO3a translocates from the cytoplasm into the 
nucleus and binds to the two conserved FOXO sites in the bim promoter (Gilley et al., 
2003).  The FOXO sites are located within a 300 base pair region either side of the ICB.  
NF-Y  is  bound  to  the  bim  promoter  in  the  presence  of  NGF  and  following  NGF 
withdrawal  and  is  known  to  significantly  distort  DNA  to  facilitate  protein-protein 
interactions between DNA-binding factors (Ronchi et al., 1995; Liberati et al., 1998; 
Mantovani et al., 1999).  CBP/p300 binding to the bim promoter increases significantly 
after NGF deprivation and CBP/p300 can interact with NF-Y in vitro.  It has previously 
been shown that CBP/p300 can also interact with FOXO3a, and the other regulatory 
factors such as Myb and c-Jun that activate bim transcription, in other systems (Lee et al., 
1996; Giordano and Avantaggiati, 1999; Bessa et al., 2001; Mahmud et al., 2002; Perrot 
and Rechler, 2005).  Therefore I hypothesise that following NGF withdrawal, NF-Y, 
FOXO3a, and perhaps other DNA-binding factors such as c-Jun, form a stereospecific 
interaction surface to recruit CBP/p300 (Figure 4.6).  These interactions then form a 
stable  multi-protein  complex  that  may  integrate  the  several  signalling  pathways  that 
activate the bim promoter following NGF withdrawal in sympathetic neurons. 
 
 
 
 
 
 
   127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
   
 
Figure  4.6  Model  of  the  transcriptional  activation  of  the  bim  promoter  in 
sympathetic neurons in the presence of NGF and following NGF withdrawal.  
 
In sympathetic neurons deprived of NGF, FOXO3a translocates from the cytoplasm into 
the nucleus and binds to the two conserved FOXO sites in the bim promoter (Gilley et al., 
2003).  CBP/p300  binding  to  the  bim  promoter  increases  significantly  after  NGF 
withdrawal and CBP/p300 can interact with NF-Y in vitro.  CBP/p300 may also interact 
with FOXO3a and other regulatory factors that activate bim transcription.  Therefore 
following NGF withdrawal, NF-Y and FOXO3a may recruit CBP/p300 to form a stable 
multi-protein complex that increases the transcriptional activation of bim. 
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Chapter 5: Investigating the mechanism by which 
the  MEK/ERK  pathway  negatively  regulates  bim 
gene expression in sympathetic neurons. 
 
5.1 Introduction 
It  is  now  apparent  that  the  simultaneous  induction  of  independent 
transcriptional pathways in neurons contributes to the increase in bim mRNA level 
after NGF withdrawal.  The different signalling pathways that regulate bim expression 
control  the  activity  of  DNA-binding  transcription  factors  that  recognise  elements 
located  within  the  bim  promoter  or  first  intron,  as  discussed  in  the  previous  two 
chapters.    However,  relatively  little  is  known  about  regulatory  elements  located 
elsewhere  in  the  bim  gene  sequence.    The  multipart  structure  of  bim  is  highly 
conserved  between  mammals  with  the  mouse,  rat  and  human  genes  sharing  an 
identical exon/intron structure (Figure 1.7).  Considering the number of mechanisms 
that have, so far, been identified to safeguard the inappropriate activation of bim in 
neurons, it is probable that there are additional regulatory elements located outside of 
the bim promoter and first intron that are also important.  
Recent studies have provided evidence that Bim is not only regulated at the 
level of transcription and by post-translational modifications.  Over the last decade it 
has become evident that eukaryotic gene expression is subject to additional control 
mechanisms via post-transcriptional processing.  Here, a number of steps contribute to 
the formation of a mature mRNA.  For example, alternative splicing can give rise to 
many different transcripts from a single pre-mRNA.  While the 5  untranslated region 
(UTR) is principally involved in controlling mRNA translation, the 3  UTR regulates a 
range of processes that control the fate of an mRNA, such as mRNA localisation 
(Andreassi and Riccio, 2009).  The discovery of the complex nature of the 3  UTR has 
clarified why these non-coding regions are often so long and so important for the 
proper regulation of gene expression.  
The  3   UTR  is  often  the  target  for  post-transcriptional  regulation  by 
microRNAs  and  RNA-binding  proteins.    MicroRNAs  (miRNAs)  constitute  a  large   129 
family of small, 20-24 nucleotide long, non-coding RNAs that have been identified as 
key regulators of almost every eukaryotic cellular process (Filipowicz et al., 2008).  
Mature miRNA molecules are partially complementary to sequences that are typically 
located within the 3  UTR of an mRNA.  Here, miRNAs control gene expression 
most-commonly  by  regulating  mRNA  translation  or  stability  in  the  cytoplasm 
(Valencia-Sanchez  et  al.,  2006;  Pillai  et  al.,  2007;  Standart  and  Jackson,  2007).  
MiRNAs have been hailed as the ‘regulators of the master regulators’ since the up or 
down regulation of a single miRNA can have a profound effect on the normal function 
of  a  number  of  different  genes.    For  example,  an  early  study  which  targeted  the 
muscle-specific miRNA, miR-1-2, for deletion revealed numerous essential functions 
in the heart including regulation of cardiac morphogenesis, electrical conduction and 
cell-cycle control (Zhao et al., 2007).  Furthermore, mice with defects in the miRNA 
biogenesis pathway show early embryonic lethality indicating that miRNAs play a 
critical role in vertebrate development (Bernstein et al., 2003; Liu et al., 2004; Abbott 
et al., 2005).  Recently, several groups have reported that bim is a target for regulation 
by miRNAs.  For example, Bim expression is repressed by miR-17~92 during B cell 
development at the pro-B to pre-B transition and loss of miR-17~92 expression results 
in increased levels of Bim and inhibition of B cell development (Ventura et al., 2008). 
In addition to miRNA binding sites, the 3  UTR of an mRNA can contain a 
number  of  other  sequences  that  mediate  post-transcriptional  regulation.    AU-rich 
elements  (AREs)  are  sequences  rich  in  adenosine  and  uridine  bases  that  typically 
target their mRNA for decay (Barreau et al., 2005).  They are one of the most common 
destabilising elements and are frequently found in mRNAs that have a short half-life, 
for example those encoded by immediate early response genes such as c-fos (Chen et 
al.,  1994;  Chen  and  Shyu,  1995).    ARE  sequences  often  contain  the  AUUUA 
pentamer  and  can  bind  a  number  of  different  RNA-binding  proteins  (Roretz  and 
Gallouzi,  2008).    Furthermore,  some  examples  of  ARE-mediated  decay  have  been 
linked  to  miRNAs  (Jing  et  al.,  2005;  Vasudevan,  2007;  von  Roretz  and  Gallouzi, 
2008).  Studies with Baf-3 cells have revealed that bim mRNA is stabilised when 
cytokines are limiting and this regulation occurs via AREs found within the bim 3  
UTR (Matsui et al., 2007).   130 
As well as sequences involved in post-transcriptional regulation, a number of 
important transcriptional control elements can be found within the genomic region that 
contains the 3  UTR.  Enhancer elements are generally a closely grouped cluster of 
transcription factor binding sites that act cooperatively to enhance transcription from a 
distal location.  Enhancers are functionally similar to promoter elements but they may 
be  located  far  from  the  core  promoter,  for  example  within  introns  or  the  3   UTR 
(Blackwood and Kadonaga, 1998; Lettice et al., 2003).  It is thought that enhancer 
elements are brought into close proximity of the core promoter by ‘DNA looping’ 
(Szutorisz  et  al.,  2005).    Therefore,  the  orientation  and  spatial  organisation of  the 
transcription factor binding sites within an enhancer is often critical for its regulatory 
activity (Remenyi et al., 2004; Szutorisz et al., 2005).  Silencer elements share many 
of the same properties as enhancer elements in that they are transcriptional elements 
that  can  be  found  far  from  the  core  promoter  (Ogbourne  and  Antalis,  1998).  
Typically,  silencers  bind  repressors,  DNA-binding  proteins  that  have  a  repressive 
effect on transcription.  Repressors can recruit negative cofactors, corepressors, and in 
some cases the recruitment of different corepressors can change an activator into a 
repressor (Ogbourne and Antalis, 1998).  It is unclear precisely how silencer elements 
function but it is generally accepted that they repress transcription by one or more of 
three  mechanisms:  by  blocking  the  binding  of  an  activator  to  DNA,  by  recruiting 
histone modifying enzymes that stabilise the chromatin structure, or by inhibiting pre-
initiation complex formation (Chen and Widom, 2005; Maston et al., 2006).  
  The Raf-MEK-ERK pathway delivers important survival signals in a number 
of different cell types.  Knockout mice with loss of c-Raf-1 or B-Raf die as embryos 
with increased apoptosis in certain tissues (Wojnowski et al., 1997; Huser et al., 2001; 
Mikula et al., 2001).  A number of papers have reported that the MEK1/2/ERK1/2 
pathway negatively regulates the expression of BimEL (Ley et al., 2005a).  However, it 
is  not  known  whether  the  MEK/ERK  pathways  (either  MEK1/2/ERK1/2  or 
MEK5/ERK5)  control  bim  expression  in  an  additional  manner  prior  to  the 
phosphorylation of BimEL.  
 Weston  et  al.  (2003)  showed  that  bim  mRNA  levels  are  upregulated 
following  serum  withdrawal  in  RR1  cells  (a  cell  line  expressing   Raf-1:ER*,  the   131 
conditionally  active  form  of  the  Raf-1  protein  kinase),  but  a  mechanism  was  not 
investigated.    Moreover,  some  preliminary  experiments  have  suggested  that  the 
MEK/ERK pathway may play a role in the regulation of bim expression in sympathetic 
neurons.  Dr. Jonathan Gilley, a previous member of our group, carried out some 
initial  semi-quantitative  RT-PCR  experiments  that  indicated  that  the  MEK/ERK 
pathway negatively regulates bim expression by an unknown mechanism (unpublished 
data).  I wanted to further investigate this hypothesis in sympathetic neurons.  
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5.2 Results 
5.2.1  The  MEK/ERK  pathway  negatively  regulates  bim  mRNA  expression 
independently of the PI3-K pathway in sympathetic neurons. 
To confirm the preliminary observation, made by Jonathan Gilley, that the MEK/ERK 
pathway negatively regulates bim expression, I carried out some semi-quantitative RT-
PCR experiments.  Sympathetic neurons were either maintained in medium containing 
NGF, withdrawn from NGF or treated with LY294002 (50 µM) in the presence of 
NGF or with U0126 (10 µM) in the presence of NGF.  After 16 hours, total RNA was 
isolated and the amount of bim mRNA was analysed by semi-quantitative PCR relative 
to  neurofilament-M  mRNA  (neurofilament-M  was  used  as  a  house-keeping  gene) 
(Figure 5.1A).  It has been shown previously that the PI3-kinase (PI3-K) pathway 
negatively regulates bim expression via two conserved FOXO sites in the bim promoter 
and first intron (Gilley et al., 2003).  As a positive control sympathetic neurons were 
treated with the PI3-K inhibitor LY294002.  Upon treatment with LY294002 the level 
of bim mRNA increased by 2.2 fold (Figure 5.1B).  This is consistent with previous 
data  from  Gilley  et  al.  (2003).    When  I  treated  sympathetic  neurons  with  the 
MEK/ERK inhibitor U0126 there was also a significant induction of bim mRNA, 2.25 
fold (Figure 5.1B).  This data confirms the hypothesis that the MEK/ERK pathway 
negatively regulates bim expression in sympathetic neurons.  It is also important to 
note here that inhibition of either the PI3-K or the MEK/ERK pathway does not induce 
bim mRNA to the level that is seen after NGF withdrawal (Figure 5.1B).  This is 
because full activation of bim following NGF withdrawal appears to require changes in 
several signalling pathways, as discussed in the previous two chapters. 
  The  PI3-K  and  MEK/ERK  signalling  pathways  are  prosurvival  pathways 
activated by the small G protein Ras following the binding of NGF to TrkA (Figure 
5.2A).  As a control experiment I wanted to confirm that phospho-ERK1/ERK2 levels are 
reduced when sympathetic neurons are treated with U0126.  I therefore performed some 
immunoblots with extracts from sympathetic neurons either maintained in the presence of 
NGF or treated with increasing concentrations of U0126 in the presence of NGF (Figure   133 
Figure 5.1  The MEK/ERK pathway negatively regulates bim mRNA expression in 
sympathetic neurons. 
 
(A) Sympathetic neurons were either maintained in medium containing NGF, withdrawn 
from NGF for 16 hours, treated with the PI3-K inhibitor LY294002 at 50 µM or with the 
MEK/ERK inhibitor U0126 at 10 µM.  LY294002 and U0126 were dissolved in DMSO 
and therefore equal volumes of DMSO were added to untreated cells (+NGF and -NGF).  
Cells were treated with LY294002 or U0126 for 16 hours in the presence of NGF.  After 
16  hours,  total  RNA  was  isolated  and  analysed  by  semi-quantitative  RT-PCR.  
Representative images are shown for the bim and neurofilament-M mRNAs.  
 
(B) Quantitation of RT-PCR in Figure 5.1 A.  PCR was quantitated at 30 and 35 cycles 
and  the  average  mRNA  levels  were  calculated.    Relative  bim  mRNA  levels  were 
calculated  by  normalising  to  the  control  neurofilament-M.    The  experiment  was 
performed 6 times and data is presented as the mean ± S.E.  Endogenous bim mRNA 
levels increase significantly following NGF withdrawal and treatment with LY294002, 
respectively (*).  Treatment with U0126 also induces a significant increase in the level of 
bim mRNA (*). 
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5.2B).    Treatment  of  sympathetic  neurons  with  U0126  at  10 µM  strongly  reduced 
levels of phospho-ERK, whereas ERK protein levels were not altered (Figure 5.2B).  
This  data  confirms  that  treatment  of  sympathetic  neurons  with  U0126  at  10  µM 
inhibits MEK/ERK signalling.  I then performed another control experiment to confirm 
that  the  PI3-K  and  MEK/ERK  signalling  pathways  are  largely  independent  of  one 
another  in  sympathetic  neurons  and  that  the  increase  in  bim  mRNA  following 
treatment with U0126, as shown in Figure 5.1, is independent of PI3-K signalling.  
Immunoblots  were  carried  out  with  extracts  from  sympathetic  neurons  either 
maintained in the presence of NGF, withdrawn from NGF for 16 hours or treated with 
U0126 (10 µM) for 16 hours in the presence of NGF (Figure 5.2C).  Phospho-Akt 
levels were high when neurons were maintained in the presence of NGF and there was 
no  major  change  upon  treatment  with  U0126  (Figure  5.2C).    Gilley  et  al.  (2003) 
showed that phospho-Akt levels fall in sympathetic neurons deprived of NGF.  My 
data  reproduces  this  result  since  phospho-Akt  levels  are  low  following  NGF 
withdrawal whereas levels of Akt or ERK1/ERK2 are not altered (Figure 5.2C).  
  In  conclusion,  these  results  suggest  that  in  sympathetic  neurons  the 
MEK/ERK pathway negatively regulates bim mRNA expression and this regulation is 
independent of PI3-K signalling. 
 
5.2.2  The  MEK/ERK  pathway  negatively  regulates  bim  mRNA  expression  in 
sympathetic neurons via regulatory elements outside of the bim promoter and 
first intron. 
To investigate the mechanism by which the MEK/ERK pathway negatively regulates 
bim expression in sympathetic neurons it was important to establish which regions of 
the bim gene mediate this effect.  Initially, sympathetic neurons were microinjected 
with the bim-LUC reporter construct to determine whether there are any MEK/ERK-
responsive elements within the 5.2 kb fragment of bim that is cloned in bim-LUC.  This 
construct contains 2.5 kb of the bim promoter, the non-coding exon 1 and the 2.5 kb 
first  intron.    Following  injection,  the  cells  were  either  maintained  in  medium 
containing  NGF,  withdrawn  from  NGF  or  treated  with  LY294002  (50  µM)  in  the    136 
Figure  5.2  The  effect  of  U0126  on  the  phosphorylation  of  ERK  1/2  and  Akt  in 
sympathetic neurons.  
 
(A) PI3-Kinase and ERK signalling pathways in sympathetic neurons.  NGF activates the 
small G protein Ras via the tyrosine kinase receptor TrkA.  Ras activates MEK/ERK1/2 
signalling  and  this  can  be  inhibited  by  treatment  with  the  compound  U0126.    It  is 
important to note that U0126 can also inhibit the related MEK5/ERK5 pathway.  Ras also 
activates PI3-K/Akt signalling and this can be inhibited by treatment with the compound 
LY294002.  Withdrawal of NGF leads to the dephosphorylation of ERK1/2 and Akt.  The 
resulting decrease in Akt activity leads to a reduction in the phosphorylation of FOXO 
transcription factors, which can then translocate into the nucleus of sympathetic neurons 
(Gilley et al., 2003).  
 
(B)  Treatment  of  sympathetic  neurons  with  10  µM  U0126  completely  inhibits 
phosphorylation  of  ERK1/2.    Immunoblots  performed  with  whole  cell  extracts  from 
sympathetic neurons maintained in the presence of NGF and then left untreated or treated 
with 5 µM, 10 µM, 20 µM or 40 µM U0126 for 16 hours are shown.  Immunoblotting 
was  performed  with  antibodies  to  detect  total  ERK1/2  (Cell  Signalling  #9102)  and 
phospho-ERK1/2 (Cell Signalling #9101S).  Several experiments were performed and 
representative blots are shown. 
 
(C)  Phosphorylation  of  Akt  is  not  affected  by  treatment  with  U0126  in  sympathetic 
neurons.  Immunoblots performed with whole cell extracts from sympathetic neurons 
maintained in the presence of NGF, withdrawn from NGF for 16 hours, or treated with 10 
µM U0126 for 16 hours in the presence of NGF are shown.  Immunoblotting was carried 
out  with  antibodies  to  detect  total  Akt  (Cell  Signalling  #9272),  phospho-Akt  (Cell 
Signalling #9271S) and total ERK1/2 (Cell Signalling #9102).  Several experiments were 
performed and representative blots are shown. 
 
U0126 was dissolved in DMSO and therefore an equal volume of DMSO was added to 
the untreated cells.   137 
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presence of NGF or with U0126 (10 µM) in the presence of NGF.  After 16 hours 
relative luciferase activity was determined by the dual luciferase assay (Figure 5.3).  
Following NGF withdrawal bim-LUC was activated significantly to 1.7 fold (Figure 
5.3).  In dual luciferase assays, the induction of bim-LUC following NGF withdrawal 
varies from 1.5 fold to 2.5 fold in microinjected sympathetic neurons and a similar fold 
change in the level of the bim-LUC transcript has been measured by RT-PCR (Figure 
3.4; Gilley et al., 2003; Gilley and Ham, 2005).  However, the increase in the level of 
endogenous bim mRNA, measured by semi-quantitative RT-PCR, varies from 3 fold to 
5 fold in sympathetic neurons (Figure 5.1; Whitfield et al., 2001; Gilley et al., 2003).  
Therefore,  it  is  possible  that  there  are  some  elements  missing  from  the  bim-LUC 
reporter  construct  that  respond  to  NGF  withdrawal.    Treatment  with  LY294002 
activated bim-LUC 2.9 fold since the two FOXO sites, which mediate the effect of 
inhibiting PI3-K signalling, are located within the region of the bim gene cloned into 
bim-LUC (Figure 5.3).  However, when neurons were treated with U0126 there was no 
activation of bim-LUC (Figure 5.3).  This data indicates that there are no MEK/ERK-
responsive elements within the first 2.5 kb of the bim promoter, exon 1 or the first 
intron. 
 
5.2.3 The bim 3′ UTR contains elements that are responsive to NGF withdrawal. 
It is evident from Figure 5.3 that the region that mediates the regulation of bim by the 
MEK/ERK pathway is probably not located at the 5′ end of the bim gene.  Therefore, I 
hypothesised that the bim 3′ UTR may contain the appropriate region since the 3′ UTR 
of  an  mRNA  often  contains  a  number  of  regulatory  motifs  that  are  important  for 
modulating gene expression.  Little is known about the bim 3′ UTR.  It has been 
mapped for human and mouse bim and is ~4.2 kb and ~3.9 kb long, respectively.  
Initially, I mapped the rat bim 3′ UTR by 3′ RACE and found that it was 4239 bp long, 
a similar length to human bim and slightly longer than that of mouse bim.  I used 
MacVector 6.5.3 software to briefly analyse the level of conservation of the bim 3′ 
UTR across species.  I found that rat and mouse bim are highly homologous to each 
other throughout the 3′ UTR.  Both rodents display some conservation with human   139 
bim,  particularly  towards  the  3′  end  of  the  3′  UTR  where  there  is  over  60% 
conservation between rat and human bim within the last 2 kb. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
Figure 5.3  The MEK/ERK pathway negatively regulates bim mRNA expression 
in sympathetic neurons via regulatory elements outside of the bim promoter. 
 
Sympathetic neurons were microinjected with bim-LUC at 10 ng/µl along with pRL-
TK  at  5  ng/µl.    The  cells  were  either  maintained  in  medium  containing  NGF, 
withdrawn from NGF for 16 hours, treated with the PI3-K inhibitor LY294002 at 50 
µM or with the MEK/ERK inhibitor U0126 at 10 µM.  LY294002 and U0126 were 
dissolved in DMSO and therefore equal volumes of DMSO were added to untreated 
cells (+NGF and -NGF).  Cells were treated with LY294002 or U0126 for 16 hours in 
the  presence  of  NGF.    After  16  hours,  luciferase  activity  was  measured. 
Microinjection experiments were carried out 4 times and data is presented as the mean 
± S.E.  Bim-LUC is activated significantly following NGF withdrawal and treatment 
with LY294002, respectively (* and **).  Treatment with U0126 does not activate the 
bim-LUC reporter.   140 
bim,  particularly  towards  the  3′  end  of  the  3′  UTR  where  there  is  over  60% 
conservation between rat and human bim within the last 2 kb. 
  To determine if the 3′ UTR of bim is the region responsible for MEK/ERK 
regulation I constructed a bim-LUC+3′UTR reporter (Figure 5.4).  Following 3′ RACE 
to  determine  the  end  point  of  the  rat  bim  3′  UTR,  I  amplified  the  region  as  two 
overlapping  fragments  by  PCR  (Figure  5.4).    I  then  systematically  cloned  the  two 
fragments into pGEM-T for sequence confirmation and the full-length rat bim 3′ UTR 
was assembled in pBluescript SK (Figure 5.4).  Finally, the 4.3 kb rat bim 3′ UTR was 
sub-cloned  into  our  bim-LUC  reporter  construct,  downstream  of  luciferase  and 
upstream of the SV40 late poly (A) signal (Figure 5.4).  I decided to construct the bim-
LUC+3′UTR reporter in a number of sequential steps following many unsuccessful 
attempts to directly clone the 3′ UTR into bim-LUC.   
  To compare the bim-LUC+3′UTR reporter to our original bim-LUC reporter, 
sympathetic neurons were microinjected with bim-LUC+3′UTR or bim-LUC, together 
with the control Renilla luciferase construct, pRL-TK.  The injected cells were then 
either maintained in the presence of NGF (+NGF) or withdrawn from NGF (-NGF) for 
16  hours,  after  which  time  relative  luciferase  activity  was  determined  by  the  dual 
luciferase assay.  Addition of the 3′ UTR greatly reduces the basal level of the bim-
LUC reporter construct (Figure 5.5B).  Therefore, this indicates that the bim 3′ UTR 
contains sequences that reduce luciferase activity either at the level of transcription, 
RNA  stability  or  translation.    Critically,  addition  of  the  3′  UTR  to  the  bim-LUC 
reporter significantly increases its induction from 1.8 fold to 3 fold, following NGF 
withdrawal (Figure 5.5C).  This data suggests that the bim 3′ UTR contains elements 
that are responsive to NGF withdrawal.  The bim-LUC+3′UTR construct may be more 
representative  of  endogenous  bim  than  our  original  bim-LUC  reporter  since 
endogenous bim mRNA levels increase ~3 fold following NGF withdrawal (Figure 
5.1). 
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Figure 5.4  Construction of the bim-LUC+3′ UTR reporter. 
 
3′ RACE was performed on rat poly A+ RNA to determine the end point of the rat bim 3′ 
UTR.  Once defined, the rat bim 3′ UTR was amplified by PCR as two overlapping 
fragments, a 2.57 kb fragment 1 (F1) and a 1.88 kb fragment 2 (F2).  The two fragments 
were then cloned into pGEM-T using the pGEM-T easy vector system for DNA sequence 
confirmation.  Fragment 1 was excised from pGEM-T using a SpeI restriction site at the 
5′ end (the SpeI site was incorporated by PCR) and a unique BglII restriction site within 
the  3′  UTR.    Fragment  2  was  excised  from  pGEM-T  using  the  same  unique  BglII 
restriction site and a SpeI restriction site at the 3′ end (the SpeI site was incorporated by 
PCR).  The 4.3 kb rat bim 3′ UTR was assembled in pBluescript SK and then excised 
using SpeI and sub-cloned into bim-LUC using an XbaI restriction site.  The bim-LUC 
reporter contains one other Xba1 restriction site (within bim intron 1) that was abolished 
by site-directed mutagenesis to leave the XbaI site used here as unique. 
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Figure  5.5  The  bim 3 ′  UTR  contains  additional  sequences  that  respond  to  NGF 
withdrawal in sympathetic neurons.  
 
Sympathetic neurons were microinjected with bim-LUC at 10 ng/µl or bim-LUC+3′UTR 
at  14  ng/µl,  along  with  pRL-TK  (5  ng/µl).    The  cells  were  maintained  in  medium 
containing NGF (+NGF) or withdrawn from NGF (-NGF) for 16 hours, after which time 
luciferase activity was measured.  Microinjection experiments were carried out 5 times 
and data is presented as the mean ± S.E. 
 
(A) Structure of the bim-LUC and bim-LUC+3′UTR reporters.  The bim-LUC reporter 
contains 2.5 kb of the rat bim promoter, the non-coding Exon 1 and the 2.5 kb intron 
cloned  upstream  of  the  firefly  luciferase  gene.    The  bim-LUC+3′UTR  reporter  was 
constructed  by  cloning  and  inserting  the  4.2  kb  rat  bim  3′  UTR  into  the  bim-LUC 
reporter, upstream of the SV40 late poly (A) signal and downstream of the Luciferase 
reporter gene.  The location of conserved FOXO binding sites, Myb binding sites and the 
ICB are shown.   
 
(B) Bim-LUC is activated significantly following NGF withdrawal.  Addition of the bim 
3′ UTR significantly decreases the basal promoter level of bim-LUC (***). 
 
(C) The basal levels of bim-LUC and bim-LUC+3′UTR were normalised to 1 and the 
induction factors of the two constructs were compared.  Addition of the bim 3′ UTR 
significantly increases the induction of bim-LUC following NGF withdrawal (*). 
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5.2.4 The bim 3  UTR is a target of the MEK/ERK pathway in sympathetic 
neurons. 
To answer the major question of whether the bim 3  UTR mediates an effect by the 
MEK/ERK pathway, sympathetic neurons were microinjected with bim-LUC+3 UTR 
or  bim-LUC,  along  with  pRL-TK.    Following  injection,  the  cells  were  either 
maintained in medium containing NGF or treated with U0126 (10 µM) in the presence 
of  NGF.    After  16  hours,  relative  luciferase  activity  was  determined  by  the  dual 
luciferase assay (Figure 5.6).  Following inhibition of the MEK/ERK pathway with 
U0126, bim-LUC was not significantly activated (Figure 5.6).  This confirms my initial 
data  that  there  are  no  MEK/ERK  responsive  elements  at  the  5   of  the  bim  gene.  
However,  when  bim-LUC+3 UTR  was  treated  with  U0126  there  was  a  significant 
activation  of  the  reporter  to  2.5  fold  (Figure  5.6B).    Endogenous  bim  is  activated 
following treatment with U0126 to 2.25 fold (Figure 5.1B).  Therefore, this suggests 
that the regulation of bim mRNA level via the MEK/ERK-pathway is mediated by the 
3  UTR. 
 
5.2.5 The role of conserved AU-rich elements in the bim 3  UTR.  
AU-rich elements (AREs) are typically found in the 3  UTR of genes that require a 
very  precise  spatial  and  temporal  expression  pattern.    AREs  generally  mediate  the 
rapid degradation of an mRNA and this helps to ensure that in unstimulated cells there 
is a very low level of expression of a potent protein (Barreau et al., 2005).  The rat bim 
3  UTR contains 10 AUUUA repeats whereas the human bim 3  UTR and the mouse 
bim 3  UTR contain 8 and 6, respectively.  Many of the AREs in the bim 3  UTR are 
conserved between rat and mouse although just 4 are conserved across rat, mouse and 
human bim (Figure 5.7A).  Since the bim 3  UTR contains a number of AREs, I wanted 
to investigate their role in bim expression in sympathetic neurons.  I was also interested 
to establish whether there is a link between mRNA stability and the regulation of bim 
mRNA  level  by  the  MEK/ERK  pathway.    In  order  to  generate  bim-
LUC+3 UTR(4xAREmut), a U to G point mutation was introduced at the central U of 
the 4 conserved AUUUA pentamers in the rat bim 3  UTR, in the context of bim-
LUC+3 UTR.  Previous studies have shown that mutation of the central U of this type    146 
Figure  5.6  The  MEK/ERK  pathway  negatively  regulates  bim  expression  in 
sympathetic neurons via the 3′ UTR.  
 
Sympathetic neurons were microinjected with bim-LUC at 10 ng/µl or bim-LUC+3′UTR 
at  14  ng/µl,  along  with  pRL-TK  (5  ng/µl).    The  cells  were  maintained  in  medium 
containing NGF and either left untreated (-U0126) or treated with U0126 (+U0126) for 
16 hours, after which time luciferase activity was measured.  Microinjection experiments 
were carried out 6 times and data is presented as the mean ± S.E.  U0126 was dissolved 
in DMSO and therefore an equal volume of DMSO was added to the untreated cells. 
 
(A) Bim-LUC+3′UTR is activated significantly following inhibition of the MEK/ERK 
pathway by treatment with U0126 (*).  Bim-LUC is not activated significantly following 
treatment with U0126. 
 
(B) The basal levels of bim-LUC and bim-LUC+3′UTR were normalised to 1 and the 
induction factors of the two constructs, following treatment with U0126, were compared.  
Addition of the bim 3′ UTR causes a significant increase in the induction of bim-LUC 
upon inhibition of the MEK/ERK pathway with U0126 (*). 
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of ARE results in a significant decrease in the destabilising efficiency of the ARE 
(Winzen et al., 2004).  Sympathetic neurons were microinjected with bim-LUC, bim-
LUC+3 UTR  or  bim-LUC+3 UTR(4xAREmut),  along  with  pRL-TK.    Following 
injection, the cells were either maintained in medium containing NGF or withdrawn 
from NGF.  After 16 hours relative luciferase activity was determined by the dual 
luciferase  assay  (Figure  5.7).    Mutation  of  the  4  AREs  in  the  bim  3   UTR  (bim-
LUC+3 UTR(4xAREmut) reporter) did significantly increase the basal level compared 
to  the  wild  type  construct  (bim-LUC+3 UTR  reporter),  a  2.2  fold  increase  (Figure 
5.7B).  However, the basal level of the bim-LUC+3 UTR(4xAREmut) reporter was 
still greatly reduced compared to the bim-LUC reporter (Figure 5.7B).  To further 
support the data in Figure 5.5, there was a significant increase in the activation of the 
bim-LUC+3 UTR reporter following withdrawal of NGF compared to the bim-LUC 
reporter  (Figure  5.7C).    Mutation  of  the  4  AREs  in  the  bim  3   UTR  (the  bim-
LUC+3 UTR(4xAREmut) reporter) did result in a decrease in its activation compared 
to  bim-LUC+3 UTR,  but  this  difference  was  not  significant  (Figure  5.7C).    Taken 
together  this  data  suggests  that  the  four  conserved  AREs  partly  contribute  to  the 
increased induction factor of bim-LUC+3 UTR.  However, since mutation of the four 
AREs  does  not  result  in  a  significant  decrease  in  the  induction  factor  of  bim-
LUC+3 UTR and only has a modest effect on basal level, it is likely that there are 
additional  elements  in  the  bim 3    UTR  that  control  bim  basal  level  and  that  are 
responsive to NGF withdrawal.  These might be one or more of the non-conserved 
AREs in the rat bim 3  UTR or other types of regulatory element. 
   
5.2.6 The whole of the bim 3  UTR is required for its effects on bim-LUC activity 
in sympathetic neurons. 
As the next step to investigate the mechanism by which the bim 3  UTR is negatively 
regulated by the MEK/ERK pathway, I decided to try to identify the general region of 
the  3   UTR  that  is  responsive  to  NGF  withdrawal  and  a  target  of  the  MEK/ERK 
pathway.  It is likely that this is the same region/effect, since MEK/ERK signalling is 
inhibited following NGF withdrawal, so this may account for the increased activation    149 
 
Figure 5.7  The role of conserved AU-rich elements in the bim 3′ UTR.  
 
(A) Schematic of the 3′ end of the bim gene.  Coloured boxes indicate coding regions 
whereas  white  boxes  indicated  untranslated  regions.    The  AU-rich  elements  that  are 
conserved in rat, mouse and human bim are represented by grey bars.  (Not to scale).    
 
(B) The conserved AU-rich elements in the bim 3′ UTR contribute to the low basal level 
of the bim-LUC+3′UTR reporter.  The four conserved AU-rich elements were mutated by 
site-directed  mutagenesis,  in  the  context  of  bim-LUC+3′UTR,  to  generate  bim-
LUC+3′UTR(4xAREmut).  Sympathetic neurons were microinjected with bim-LUC at 10 
ng/µl,  or  bim-LUC+3′UTR  or  bim-LUC+3′UTR(4xAREmut)  at  14  ng/µl,  along  with 
pRL-TK (5 ng/µl).  The cells were maintained in medium containing NGF (+NGF) or 
withdrawn  from  NGF  (-NGF)  for  16  hours,  after  which  time  luciferase  activity  was 
measured.  Microinjection experiments were carried out 5 times and data is presented as 
the mean ± S.E.  Following NGF withdrawal all 3 constructs are activated significantly 
(**),  (*)  and  (*),  respectively.    Mutation  of  the  4  AU-rich  elements  significantly 
increases the basal level of bim-LUC+3′UTR (*). 
 
(B) The conserved AU-rich elements in the bim 3′ UTR partly contribute to the induction 
of bim following NGF withdrawal.  The basal level of the bim-LUC+3′UTR reporter The 
basal  levels  of  bim-LUC,  bim-LUC+3′UTR  and  bim-LUC+3′UTR(4xAREmut)  were 
normalised to 1 and the induction factors of the three constructs were compared. There is 
a  significant  increase  in  the  induction  of  bim-LUC+3′UTR  compared  to  bim-LUC 
following NGF withdrawal (*).  There is no significant difference in the induction factors 
between bim-LUC and bim-LUC+3′UTR(4xAREmut), or between bim-LUC+3′UTR and 
bim-LUC+3′UTR(4xAREmut). 
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of  bim-LUC+3 UTR  compared  to  bim-LUC.    Also,  selectively  inhibiting  only  the 
MEK/ERK pathway activates the bim-LUC+3 UTR reporter 2.5 fold, which is almost 
to the level of NGF withdrawal.  To try to identify the relevant region of the 3  UTR, I 
constructed a bim-LUC+3 UTR(F2) reporter construct that only contains the second 
half (F2) of the rat bim 3  UTR.  This 2.5 kb stretch of the bim 3  UTR is highly 
conserved across species, thereby indicating that there may be important regulatory 
elements  located  there.    Sympathetic  neurons  were  microinjected  with  bim-
LUC+3 UTR(F2) or bim-LUC, together with the control Renilla luciferase construct, 
pRL-TK.    The  injected  cells  were  then  either  maintained  in  the  presence  of  NGF 
(+NGF)  or  withdrawn  from  NGF  (-NGF)  for  16  hours,  after  which  time  relative 
luciferase activity was determined by the dual luciferase assay (Figure 5.8).  Following 
NGF withdrawal both constructs were activated significantly, but there was only a 
moderate increase in the activation of bim-LUC+3 UTR(F2) compared to bim-LUC 
(Figure 5.8B).  In addition to this, there was only a small decrease in the basal level of 
bim-LUC+3 UTR(F2) compared to bim-LUC (Figure 5.8A).  This suggests that the 
whole of the bim 3  UTR is required for its effects on bim-LUC activity in sympathetic 
neurons, since the bim-LUC+3 UTR(F2) reporter does not reproduce the properties of 
the bim-LUC+3 UTR reporter.  
 
5.2.7 Regulation of bim expression by the MEK/ERK pathway is not an effect on 
mRNA stability in sympathetic neurons. 
As the MEK/ERK-responsive elements are located within the bim 3  UTR, initially I 
wanted to investigate a link with mRNA stability.  However, it is evident that the four 
conserved AREs are not primarily responsible for this effect.  In addition, TargetScan 
predicts that a large number of miRNA binding sites are located in the bim 3  UTR so 
this would require extensive investigation.  Therefore, before pursuing this hypothesis 
any further I decided to investigate whether the MEK/ERK pathway alters the stability 
of the endogenous bim mRNA in sympathetic neurons.  
  Sympathetic neurons were treated with actinomycin-D to inhibit transcription.  
Martin et al. (1988) found that the use of RNA and protein synthesis inhibitors protects 
sympathetic neurons against NGF withdrawal-induced death, and these results have    152 
 
Figure 5.8 The whole of the bim 3′ UTR is required for its effects on bim-LUC 
activity in sympathetic neurons.  
 
(A) The highly conserved fragment 2 (F2) of the bim 3′ UTR does not have the same 
effects on basal promoter activity and induction after NGF withdrawal as the full-length 
3′ UTR. Sympathetic neurons were microinjected with bim-LUC at 10 ng/µl or bim-
LUC+3′UTR (F2) at 14 ng/µl, along with pRL-TK (5 ng/µl).  The cells were maintained 
in medium containing NGF (+NGF) or withdrawn from NGF (-NGF) for 16 hours, after 
which time luciferase activity was measured.  Microinjection experiments were carried 
out 4 times and data is presented as the mean ± S.E.  Bim-LUC and bim-LUC+3′UTR 
(F2) are both activated significantly following withdrawal of NGF (*).  Although the 
basal activity of bim-LUC+3′UTR(F2) is 30% lower than bim-LUC this is difference is 
not significant.  
 
(B) The basal levels of bim-LUC and bim-LUC+3′UTR (F2) were normalised to 1 and 
the induction factors of the two constructs were compared.  Addition of the second half 
(F2)  of  the  bim  3′  UTR  does  not  significantly  increase  the  induction  of  bim-LUC 
following withdrawal of NGF.  
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been reproduced by several other groups.  In their study they used actinomycin-D at 
0.1 µg/ml, therefore I also used this concentration of the inhibitor in these experiments.  
Initially,  sympathetic  neurons  were  treated  with  actinomycin-D  over  a  time  course 
from time point 0 hours to 16 hours, as 16 hours is the time point at which the original 
effect of U0126 was observed (Figure 5.1; Figure 5.6).  Sympathetic neurons were 
either maintained in medium containing NGF (-U0126) or treated with U0126 at 10 
µM in the presence of NGF (+U0126) (Figure 5.9).  Actinomycin-D and U0126 were 
added to the cells together and then total RNA was isolated at the time points indicated 
(Figure 5.9A).  The level of bim mRNA was analysed by Q-PCR relative to the level of 
the  transcripts  for  the  house-keeping  genes  Hprt  1  and  Gapdh  (Figure  5.9).    Both 
house-keeping genes behaved in a similar way as neither was affected by the addition 
of U0126 or actinomycin-D.  Therefore only bim mRNA levels relative to Hprt 1 are 
shown (Figure 5.9A, B and C).  Following the addition of actinomycin-D, bim mRNA 
decays over the 16-hour time course in the absence of U0126 (Figure 5.9).  The half-
life of the rat bim mRNA appears to be between 2 and 4 hours in NGF-maintained 
sympathetic neurons (Figure 5.9A and B).  Importantly, the addition of U0126 did not 
significantly increase the stability of the bim mRNA over the 16 hour time course 
(Figure  5.9A).    To  be  certain  that  this  was  a  representative  result,  I  repeated  the 
experiment by pre-treating sympathetic neurons with U0126 for 16 hours prior to the 
addition of actinomycin-D (for +U0126 conditions) (Figure 5.9B and C).  This would 
therefore rule out the possibility that actinomycin-D was interfering with the activity of 
U0126.  However, the same result was obtained with no significant difference in the 
stability  of  the  bim  mRNA  in  sympathetic  neurons  treated  with  or  without  U0126 
(Figure 5.9B).  I can therefore conclude that U0126 does not increase bim mRNA 
levels by altering mRNA stability, in sympathetic neurons.  
  The initial experiments with U0126 were performed by semi-quantitative RT-
PCR (Figure 5.1).  Q-PCR is a much more sensitive technique for determining mRNA 
levels  than  semi-quantitative  RT-PCR,  therefore  it  was  important  to  reproduce  my 
initial  conclusions  by  Q-PCR.    Following  treatment  with  U0126  for  16  hours 
(+U0126), the level of bim mRNA is significantly elevated compared to the control 
cells (-U0126) (Figure 5.9C).  At time point 0 (prior to the addition of actinomycin-D)    155 
Figure 5.9  U0126 does not alter bim mRNA stability in sympathetic neurons.  
 
(A) Sympathetic neurons were treated with actinomycin-D at 0.1 µg/ml in the presence of 
NGF.  The cells were either maintained in medium containing NGF (-U0126) or treated 
with U0126 at 10 µM in the presence of NGF (+U0126).  Actinomycin-D and U0126 
were added to the cells together and then total RNA was isolated at time point 0 hours, 2 
hours, 4 hours, 8 hours and 16 hours.  The level of bim mRNA was analysed by Q-PCR 
relative to the level of the mRNAs encoded by the house-keeping genes Hprt 1 and 
Gapdh.  Bim mRNA levels relative to Hprt 1 are shown here.  Q-PCR experiments were 
carried out 5 times and data is presented as the mean ± S.E.  There is no significant 
difference in the stability of bim mRNA in sympathetic neurons treated with or without 
U0126 over 16 hours. 
 
(B) Sympathetic neurons were treated with actinomycin-D at 0.1 µg/ml in the presence of 
NGF.  The cells were either maintained in medium containing NGF (-U0126) or treated 
with U0126 at 10 µM in the presence of NGF (+U0126).  U0126 was added to the cells 
for 16 hours prior to the addition of actinomycin-D and U0126 together (for +U0126 
conditions).  Following addition of actinomycin-D, total RNA was isolated at time point 
0 hours, 2 hours, 4 hours, 8 hours and 16 hours.  The level of bim mRNA was analysed 
by Q-PCR relative to the house-keeping genes Hprt 1 and Gapdh.  Bim mRNA levels 
relative to Hprt 1 are shown here.  Q-PCR experiments were carried out 3 times and data 
is presented as the mean ± S.E.  There is no significant difference in the stability of bim 
mRNA in sympathetic neurons treated with or without U0126 over 16 hours.  
 
U0126 was dissolved in DMSO and therefore an equal volume of DMSO was added to 
untreated cells (-U0126). 
 
(C) Q-PCR data from (B) with raw bim mRNA levels at timepoint 0 (+U0126 and -
U0126 bim mRNA levels have not been normalised to 1).  Treatment with U0126 for 16 
hours elevates bim mRNA levels significantly (**). 
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bim mRNA levels are ~3 fold higher after 16 hours in the presence of U0126 (Figure 
5.9C).  Therefore, this result confirms my initial finding that the MEK/ERK pathway 
negatively regulates bim expression in sympathetic neurons. 
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5.3 Discussion 
I have demonstrated that the MEK/ERK signalling pathway negatively regulates bim 
expression in sympathetic neurons via the bim 3′ UTR.  This effect is independent of 
the PI3-K/Akt pathway and represses bim transcription in the presence of NGF (Figure 
5.10). 
  After initially establishing that the 5′ end of the bim gene does not mediate the 
effect of the MEK/ERK pathway, I mapped the rat bim 3′ UTR by 3′ RACE and 
constructed  a  bim-LUC+3′UTR  reporter  construct  to  investigate  this  mechanism 
further (Figure 5.3; Figure 5.4).  This proved to be a useful tool.  Not only does it 
demonstrate that the bim 3′ UTR mediates the regulatory effect that is exerted on bim 
expression  by  MEK/ERK  signalling,  but  this  construct  better  represents  the 
endogenous bim gene with low basal expression levels in the presence of NGF and an 
increased induction factor following NGF withdrawal, compared to our original bim-
LUC reporter construct (Figure 5.5; Figure 5.6). 
  The 3′ UTR of a gene is often a target for post-transcriptional regulation by 
microRNAs and RNA-binding proteins.  Therefore, I hypothesised that the MEK/ERK 
pathway may control bim expression at the level of mRNA stability or translation.  I 
scanned the bim 3′ UTR using TargetScan software (Lewis et al., 2005) and found that 
the bim 3′ UTR contains hundreds of predicted miRNA binding sites.  At that time 
there was no published work indicating that bim is a target for regulation by miRNAs 
and due to the scale of a miRNA study I decided to exam other possible regulatory 
mechanisms first.  I found that the bim 3′ UTR contains a number of AU-rich elements 
(AREs), which are known to control the stability of an mRNA by targeting it for rapid 
degradation (Barreau et al., 2005; Roretz and Gallouzi, 2008).  Matsui et al. (2007) 
also studied AU-rich elements in the bim 3′ UTR.  They focused on 3 AREs within a 1 
kb stretch of the bim 3′ UTR, these are the most 3′ out of the 4 conserved AREs that I 
investigated here (Figure 5.7).  They used the Baf-3 cell line to show that heat shock 
cognate protein 70 (Hsc 70) binds to the AREs and enhances bim mRNA stability.  
They found that Hsc 70 is regulated by a number of different co-chaperones and these 
are  regulated  when  cytokines  activate  Ras  pathways.    Since  Ras  is  upstream  of   159 
MEK/ERK  signalling  it  was  possible  that Matsui et al. had also been 
studying the  negative regulation of bim  by the MEK/ERK pathway 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
   
 
 
 
Figure 5.10 Model of the transcriptional regulation of bim expression by prosurvival 
signalling pathways in sympathetic neurons.   
 
The MEK/ERK pathway negatively regulates bim expression at the level of transcription 
via  the  3′  UTR  by  an  unknown  mechanism.    PI3-K/Akt  signalling  inhibits  FOXO 
transcription factors which can bind to conserved FOXO sites in the bim promoter, as 
indicated by the dark blue squares (Gilley et al., 2003).  Both prosurvival pathways are 
activated following the binding of NGF to TrkA and act independently of each other to 
reduce bim expression. 
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MEK/ERK signalling it was possible that Matsui et al. had also been studying the 
negative regulation of bim by the MEK/ERK pathway.  I found that mutation of the 
AREs described by Matsui et al. in the context of the bim-LUC+3′UTR construct, does 
partially reverse the increase in bim activation following NGF withdrawal conferred by 
the addition of the 3′ UTR, although this result was not significant.  Therefore, it 
appears that the AREs studied by Matsui et al. do make some contribution to the 
induction of bim following NGF withdrawal in this context (Figure 5.7).  Of course, it 
is possible that more than the 4 conserved AREs in the rat bim 3′ UTR may need to be 
mutated in order to see a striking effect.  As the next step to investigate the mechanism 
by which the bim 3′ UTR is negatively regulated by the MEK/ERK pathway, I decided 
to  try  to  identify  the  general  region  of  the  3′  UTR  that  is  responsive  to  NGF 
withdrawal.  I found that the highly conserved second half of the bim rat 3′ UTR does 
not fully reproduce the effect of the whole region (Figure 5.8).  Additionally, this data 
provides  evidence  that  the  mechanism  I  have  investigated  is  not  the  same  as  that 
described by Matsui et al. (2007), since the 1 kb region of the bim 3′ UTR that they 
studied is within the 2.5 kb region that I studied here. 
  I found that bim mRNA levels are significantly elevated at 16 hours following 
addition of U0126 (Figure 5.1; Figure 5.9).  Therefore, the mechanism by which the 
MEK/ERK  pathway  regulates  bim  expression  must  either  be  at  the  level  of 
transcription or at the level of mRNA stability.  I studied mRNA stability by treating 
sympathetic neurons with an inhibitor of transcription, actinomycin-D.   I observed bim 
mRNA decay over a 16 hour time course and found that U0126 does not enhance bim 
mRNA stability (Figure 5.9).  Taken together, my data indicates that the MEK/ERK 
pathway does not affect the stability of bim mRNA and therefore the mechanism that I 
have been investigating must be a transcriptional effect. 
  There are a number of important elements that can be found within genomic 
sequences that encode the 3′ UTR that contribute to the transcriptional regulation of a 
gene.  Enhancer elements and silencer elements are transcriptional elements found far 
from  the  core  promoter  (Ogbourne  and  Antalis,  1998).    Enhancer  elements  are 
generally one or more transcription factor binding sites that acting cooperatively and 
are able to interact with the core promoter by ‘DNA looping’ (Szutorisz et al., 2005).    161 
Typically, silencer elements bind DNA-binding proteins that have a repressive effect 
on transcription (Ogbourne and Antalis, 1998).  It is unclear whether the bim 3′ UTR 
harbours transcriptional enhancers and/or silencers and which of these are relevant in 
this context.  However, based on what has been learned so far about the complex 
nature of the bim 3′ UTR, it is likely that there are a number of transcriptional elements 
within this 4.3 kb region.  I found that the whole 3′ UTR is necessary to reproduce the 
full regulation of bim following NGF withdrawal (Figure 5.8), therefore there may be a 
number  of  transcriptional  elements  within  the  bim 3 ′  UTR  that  act  cooperatively 
following  the  inhibition  of  the  MEK/ERK  pathway  that  occurs  when  sympathetic 
neurons are deprived of NGF, or treated with U0126. 
  As a further complication, U0126 also inhibits the most-recently identified 
member of the MAPK family, ERK5 (Balmanno and Cook, 2009).  Previously there 
were no compounds that could distinguish between these two closely related MAPK 
signalling  pathways.    However,  selective  ERK1/ERK2  inhibitors  have  now  been 
developed such as PD0325901 (Bain et al., 2007).  Finegan et al. (2009) showed that 
the in vitro deletion of erk5 in sympathetic neurons resulted in an increase in apoptosis.  
In contrast to my findings, Finegan et al. found that our bim-LUC reporter construct is 
activated  when  the  PC6-3  subline  of  PC12  cells  are  treated  with  10  µM  U0126.  
However, the authors observed this effect following incubation with U0126 for 36 
hours, replacing the inhibitor every 12 hours.  In sympathetic neurons the level of bim 
RNA peaks at 16 hours after NGF withdrawal (Whitfield et al., 2001; Gilley et al., 
2003).  At 16 hours following treatment with U0126, I have shown that the bim-LUC 
reporter  is  not  activated  whereas  the  bim-LUC+3′UTR  reporter  is  significantly 
activated (Figure 5.3, Figure 5.6).  It is possible that the activation of bim-LUC after 36 
hours incubation with U0126, as shown by Finegan et al. (2009) is an indirect effect. 
   Very recently Terasawa et al. (2009) also established a link between bim 
mRNA  expression  and  MEK/ERK  signalling.    They  used  PC12  cells  to  identify  a 
mechanism in which NGF withdrawal and subsequent inhibition of the MEK/ERK 
pathway leads to a decrease in the level of miR-221/222.  The overexpression of miR-
221 or miR-222 in PC12 cells suppressed the activity of a bim-LUC reporter construct 
that contained a 3′ region of the bim 3′ UTR.  Taken together with my findings, this   162 
suggests  that  MEK/ERK  signalling  can  regulate  bim  expression  at  the  level  of 
transcription and at the level of mRNA stability/translation in neuronal cells. 
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Chapter 6: General discussion 
 
Bim is a critical regulator of apoptosis in many cell types and as such, its deregulation has 
been  implicated  in  certain  human  pathologies  (Bouillet  et  al.,  2001b;  Biswas  et  al., 
2007a; Doonan et al., 2007; McKerman and Cotter, 2007; Perier et al., 2007).  Since the 
Bim protein was identified as a potent inducer of cell death via the intrinsic pathway there 
has been significant research into the different modes of Bim regulation.  Consequently, it 
is now evident that a number of complex regulatory mechanisms are in place to constrain 
the expression and activity of the Bim protein and this has been complicated by the fact 
that many of these appear to be cell type specific.  I have used the well-characterised 
model  of  NGF-dependent  developing  sympathetic  neurons  to  further  study  the 
mechanisms by which the bim gene is regulated. 
  Until now, little was known about the function of the TATA-less bim proximal 
promoter.  In this study I have shown that an NF-Y-binding CCAAT box controls the 
majority of bim basal promoter activity and that expression of a dominant negative NF-
YA protein prevents the transcriptional activation of a bim reporter construct following 
NGF  withdrawal.    Moreover,  NF-Y  activity  is  required  for  the  expression  of  the 
endogenous  Bim  protein  and  thereby  contributes  to  apoptosis  induced  by  NGF 
withdrawal.    Additionally,  I  have  demonstrated  that  the  transcriptional  coactivators 
CBP/p300 are required for efficient activation of bim-LUC when sympathetic neurons are 
deprived of NGF.  My findings also indicate that CBP and p300 are recruited to the 
endogenous  bim  promoter  in  neuronally  differentiated  PC12  cells  following  NGF 
withdrawal, where they may interact with NF-Y to enhance bim transcription. 
     However,  a  number  of  unanswered  questions  remain.    For  example,  does 
FOXO3a interact with CBP/p300 in this context?  If my predicted model (Figure 4.6) is 
accurate then there should be limited interaction, if any, between CBP/p300 and FOXO3a 
in the presence of NGF, since active Akt phosphorylates FOXO3a, which would then be 
sequestered in the cytoplasm by 14-3-3 proteins (Gilley et al., 2003).  Following NGF 
withdrawal FOXO3a translocates into the nucleus in sympathetic neurons where it would 
be able to bind to the two FOXO sites in the bim promoter and possibly interact with 
CBP/p300.    Therefore,  in  NGF-deprived  sympathetic  neurons  there  should  be  a   164 
significant  increase  in  the  amount  of  FOXO3a  bound  to  CBP/p300  in  the  nucleus.  
Activation  of  the  bim  promoter  by  FOXO3a  was  previously  studied  by  Gilley  et  al. 
(2003):  These authors showed that the 5′ end of the bim gene contains two conserved 
FOXO sites, one in the promoter and one just downstream of exon 1, which can bind a 
GST-FOXO3a fusion protein in vitro in EMSA experiments.  Essafi et al. (2005) also 
showed in BV137 cells (a human lymphoid CML cell line) that the upstream FOXO site 
can bind FOXO3a in ChIP experiments.  However, it will be important to study whether 
the  binding  of  FOXO3a  to  both  FOXO  sites  increases  after  NGF  withdrawal  in 
neuronally differentiated PC12 cells.  This would be predicted to be the case since it was 
necessary to mutate both FOXO sites in our bim-LUC reporter construct to significantly 
reduce the activation of bim-LUC, by overexpression of a constitutively active FOXO3a 
mutant and following NGF withdrawal (Gilley et al., 2003; Gilley and Ham, 2005).  It 
would  also  be  interesting  to  establish  whether  CBP/p300  interacts  with  the  other 
transcription factors that bind to the bim promoter, for instance c-Jun.  The role of c-Jun 
in NGF withdrawal-induced death and the induction of bim has been well documented 
(Estus et al., 1994; Ham et al., 1995; Xia et al., 1995; Virdee et al., 1997; Eilers et al., 
1998; Harding et al., 2001; Harris and Johnson, 2001; Whitfield et al., 2001; Palmada et 
al., 2002; Besirli et al., 2005), and some conserved AP-1 binding sites located at the 5′ 
end of the bim gene are occupied by c-Jun in chromatin IP experiments (R. Randall, J. 
Gilley, R. Hughes and J. Ham, unpublished data).  However, further work is necessary to 
understand the precise role of each of these AP-1 sites in bim promoter induction.  
  Previous studies have highlighted the importance of CBP/p300 in p53-dependent 
apoptosis (Goo and Roeder, 1997; Avantagiatti et al., 1999; Iyer et al., 2004).  However, 
the work described here is one of the first studies to investigate the role of CBP/p300 in 
NGF withdrawal-induced cell death.  By microinjecting specific antibodies I showed that 
both CBP and p300 contribute to the induction of the bim-LUC reporter construct after 
NGF withdrawal.  However, in the future it will be important to show that CBP and p300 
contribute to the induction of the endogenous bim gene in sympathetic neurons.  One way 
to do this would be to isolate sympathetic neurons form cbp
FL/FL and p300
FL/FL mice and 
infect them with an adenovirus expressing CRE recombinase (Kasper et al., 2006).  The   165 
effect  of  the  conditional  knockout  of  the  cbp  and/or  p300  genes  on  Bim  protein 
expression could then be measured. 
  The simultaneous interaction of multiple transcription factors with CBP/p300 
has been proposed to contribute to transcriptional synergy (Vo and Goodman, 2001).  
Therefore, further Co-IP experiments to investigate the protein-protein interactions of 
CBP/p300  with  FOXO3a,  c-Jun  and  the  Myb  proteins,  may  yield  interesting  results.  
Further to this, it is possible that like the IFN-β promoter, the transcription factors known 
to  occupy  the  bim  promoter  following  NGF  withdrawal,  together  with  other 
transcriptional  cofactors  and  the  coactivators  CBP/p300,  form  a  multi-protein 
enhanceosome.  The assembly of a number of regulatory proteins on the IFN-β promoter 
creates a stereospecific interaction surface for the recruitment of CBP/p300 and the basal 
transcription machinery (Kim et al., 1998; Merika et al., 1998; Wathelet et al., 1998; Yie 
et  al.,  1999).    The  resulting  multi-protein  structure,  an  enhanceosome,  promotes  pre-
initiation complex formation and allows multiple rounds of transcription to proceed (Kim 
et al., 1998; Merika et al., 1998; Wathelet et al., 1998; Yie et al., 1999).  Furthermore, 
NF-Y has been demonstrated to associate with the TATA-box binding protein (TBP), 
TBP-associated  factors  (TAFs)  and  TFIID  and  can  therefore  facilitate  preinitiation 
complex formation and recruit RNA polymerase II to the promoters of CCAAT box-
containing genes (Bellorini et al., 1997; Frontini et al., 2002; Kabe et al., 2005).  Since 
bim lacks a TATA box, NF-Y bound to the ICB may well play a role in recruiting the 
basal transcription machinery to the bim promoter and initiating transcription from the 
major transcriptional start site, which is 29 bp downstream of the ICB in the rat bim gene. 
    I have shown that NF-Y binds to the bim promoter in the presence of NGF and 
following NGF withdrawal, but it is unclear whether NF-Y is the target of regulatory 
mechanisms other than direct protein-protein contact with CBP/p300.  For instance, a 
number of reports have shown that NF-Y is a target for acetylation by CBP/p300 (Li et 
al., 1998; Franiello et al., 1999; Manni et al., 2008).  In addition, the NF-YA subunit can 
be phosphorylated and a phosphorylation-deficient mutant form of NF-YA has impaired 
DNA-binding activity (Yun et al., 2003).  It is not known whether NF-Y is regulated by 
post-translational  modifications  in  sympathetic  neurons  or  whether  the  state  of  the 
trimeric  NF-Y  protein  changes  following  NGF  withdrawal.    However  this  could  be   166 
studied in the future by performing immunoblotting experiments with antibodies to each 
NF-Y subunit and extracts from sympathetic neurons cultured in the presence of NGF 
and following NGF withdrawal.  Changes in the phosphorylation of the subunits might 
lead  to  changes  in  the  mobility  of  NF-YA,  B  or  C  in  SDS  polyacrylamide  gels.  
Furthermore,  it  will  be  interesting  to  determine  whether  other  transcription  factors, 
regulated by NGF withdrawal, bind to sites in the bim promoter that are immediately 
adjacent to the ICB.  In some systems, NF-Y has been shown to bind cooperatively to the 
DNA with transcription factors whose activity is regulated by signalling pathways.  For 
example, some promoters activated by ER stress contain ER stress-responsive elements 
that consist of a CCAAT box and adjacent ATF6 binding site.  ATF6 is activated by ER 
stress  and  translocates  into  the  nucleus  where  it  binds  cooperatively  with  NF-Y.  
Mutation of either the CCAAT box or ATF6 site in such promoters inhibits the response 
to ER stress (Yoshida et al., 2000). 
  My findings suggest that NF-Y is a critical regulator of bim expression in NGF 
withdrawal-induced apoptosis.  However, is NF-Y important for bim expression in other 
systems considering that many of the regulatory mechanisms controlling bim activity 
appear to be cell type specific?  As discussed previously, functional NF-Y levels are 
regulated by the concentration of the NF-YA subunit present within the cell, whereas NF-
YB and NF-YC appear to be constitutively expressed in most cell types (Manni et al., 
2008).  This is why the YA13m29 mutant was generated to target NF-YA activity and 
also  why  I  have  focused  on  the  NF-YA  subunit  in  this  study.    NF-YA  encodes  two 
isoforms generated through alternative splicing (Mantovani, 1999).  Zhu et al. (2003) 
demonstrated that the short transcript of NF-YA is highly expressed in immature c-kit
+ 
bone marrow cells, but following haematopoietic differentiation, its expression declines 
rapidly.  A later study from the same authors provided evidence that NF-Y might be a 
master gene in the processes of haematopoietic self-renewal and differentiation (Zhu et 
al., 2005).  It would be interesting to examine whether bim expression also changes in 
these cells during this time when the cellular concentration of NF-YA becomes limiting.  
It would also be of interest to investigate whether NF-YA expression changes during the 
development  of  sympathetic  neurons  and  which  of  two  NF-YA  transcripts  is 
predominantly  expressed  in  these  cells.    Furthermore,  it  is  possible  that  other  genes   167 
involved in the cell death programme are NF-Y targets, since CCAAT boxes are present 
in around 30% of eukaryotic promoters and NF-Y is the major CCAAT-binding protein 
(Bucher, 1990; Mantovani, 1999). 
  Due to the well-established role of NF-Y in cell cycle control, and the potential 
role of NF-Y as a p53 target in oncogenesis, there has been increasing interest to develop 
small  molecule  drugs  to  inhibit  NF-Y  binding.    Recently,  GWL-78,  a 
pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugate, has been shown to inhibit NF-
Y binding to CCAAT box sequences and also to displace NF-Y that is already bound to 
the promoter of CCAAT box-containing genes (Kotecha et al., 2008).  This drug could 
provide a tool to further study the importance of NF-Y in neurons and other cell types.   
  As a second area of this study, I investigated the negative regulation of bim 
expression by the MEK/ERK signalling pathway in sympathetic neurons.  I found that 
when sympathetic neurons are treated with the compound U0126, an inhibitor of the 
MEK/ERK  pathway,  the  steady-state  level  of  bim  mRNA  in  the  presence  of  NGF 
increases significantly.  By mapping the rat bim 3′ UTR by 3′ RACE and generating a 
bim-LUC+3′UTR  reporter  construct,  I  localised  the  region  responsive  to  MEK/ERK 
signalling to the 3′ UTR and investigated possible mechanisms for this regulation.  Taken 
together,  my  data  demonstrates  that  the  MEK/ERK  signalling  pathway  negatively 
regulates bim gene expression independently of the PI3-K/Akt pathway via the genomic 
region that contains the 3′ UTR in sympathetic neurons. 
  The precise mechanism by which the MEK/ERK signalling pathway represses 
bim expression in the presence of NGF remains unclear.  I chose to investigate the role of 
conserved AU-rich elements in the bim 3′ UTR.  However, the results were not entirely 
conclusive because mutation of the four conserved AREs only produced a partial effect.  
The results suggest that either the AREs located in the bim 3′ UTR do not play a major 
role, or that more of the 10 AUUUA repeats, found in the rat bim 3′ UTR, must be 
mutated to see a significant effect.  This may well be the case since AREs are known to 
cooperate with each other for full function (Chen and Shyu, 1995).  However, in contrast, 
class  I  AREs  (individual,  scattered  AUUUA  repeats),  as  identified  within  the bim 3 ′ 
UTR, tend to be present as no more than 3 functional binding sites (Chen and Shyu, 
1995; Bakheet et al., 2006).   168 
  Despite the possible role of AU-rich elements in regulating bim expression, I 
obtained evidence that the MEK/ERK signalling pathway does not regulate bim mRNA 
stability in sympathetic neurons.  Treatment of sympathetic neurons with U0126 and an 
inhibitor  of  transcription,  actinomycin-D,  demonstrated  that  inhibition  of  MEK/ERK 
signalling does not increase the stability of the bim mRNA over a 16 hour time course.  
Therefore,  I  can  conclude  that  the  mechanism  that  I  have  identified  in  sympathetic 
neurons is yet another means to control bim expression at the level of transcription, either 
through cis-acting enhancer or silencer elements within the bim 3′ UTR.  In the future, 
transcription factor binding sites in the bim 3′ UTR could be identified and studied by 
using  a  similar  approach  as  I  have  used  to  investigate  the  role  of  the  NF-Y-binding 
CCAAT box in the bim proximal promoter.  Since the only other reports to study the 
function of the bim 3′ UTR in regulating bim expression have been associated with bim 
mRNA stability, it is likely the mechanism that I have investigated here has not been 
observed in other cell types.  Again, these findings prompt the question of whether this is 
a level of regulation that is specific to neuronal cells.  
  Further  experiments  will  also  determine  which  of  the  MAPK  signalling 
pathways  targets  this  region  of  the  bim  gene,  since  in  sympathetic  neurons  both  the 
MEK1/2/ERK1/2 and the MEK5/ERK5 signalling pathways are stimulated in response to 
NGF  and  are  activated  downstream  from  Ras  (Kaplan  and  Miller,  2000;  Wang  and 
Tournier,  2006).    A  number  of  studies  have  described  the  importance  of 
MEK1/2/ERK1/2  signalling  in  the  post-translational  control  of  the  Bim  protein  in 
different cell types (Biswas and Greene, 2002; Luciano et al., 2003; Ley et al., 2004; 
Marani  et  al.,  2004;  Ley  et  al.,  2005b;  Ewings  et  al.,  2007).    The  downstream 
transcriptional  events  involved  in  MEK5/ERK5  signalling  in  neurons  are  less  well 
established,  but  recent  data  suggests  that  ERK5  may  play  an  important  role  in 
neurotrophin-mediated  survival,  and  deletion  of  the  erk5  gene  results  in  a  significant 
increase in apoptosis in developing sympathetic neurons (Finegan et al., 2009). 
  BH3-only  proteins  are  ultimately  the  mediators  of  proapoptotic  signals  that 
predominantly activate the intrinsic pathway of apoptosis within a cell.  Bim is one of the 
best-studied BH3-only proteins and consequently much has been learned about its role in 
the  cell  death  programme.    The  diverse  nature  of  the  mechanisms  that  regulate  bim   169 
expression in different cell types suggests that the control of bim activity is multifaceted, 
and  this  therefore  introduces  a  further  level  of  complexity  to  the  regulation  of  bim 
function in response to different apoptotic stimuli.  It has previously been suggested that 
the bim promoter acts as a coincidence detector in neuronal cells (Biswas et al., 2007b).  
This may well be an accurate description in sympathetic neurons, in which multiple, 
seemingly  non-redundant  signalling  pathways  are  involved  in  the  activation  of  bim 
transcription and the loss of only one activating pathway is enough to significantly impair 
the induction of bim transcription in response to NGF withdrawal.  Therefore, the highly 
complex and stringent nature of bim regulation in neurons ensures that apoptosis, and 
ultimately the suicide of a cell, is initiated only when absolutely necessary. 
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